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Summary 
 
Compared to the adult mammalian brain, the brain of the adult zebrafish Danio rerio exhibits a 
very high proliferative and regenerative potential. The adult mammalian brain in contrast has a 
very limited neurogenic capacity mainly restricted to two zones, the subventricular zone of the 
lateral telencephalic ventricles and the subgranular zone of the dentate gyrus of the 
hippocampus. In contrast, the zebrafish brain harbours 16 proliferation zones distributed all 
over the brain. The zebrafish has thus become a model for the study of adult neurogenesis 
and regeneration of nervous tissue. I characterized the expression of the two transcription 
factors p53 and p73 in the adult zebrafish brain. Both p53 and p73 were shown to play crucial 
roles in mammalian adult neurogenesis: p53 suppresses the self-renewal of adult neural stem 
cells and is involved in apoptotic death of neurons following damage. p73 is relevant for the 
survival of neurons, self-renewal and maintenance of neural stem cells as well as 
differentiation of precursor cells. It was thus of interest whether these genes have similar roles 
in the adult zebrafish brain. 
I established a detailed map of the expression pattern of p53 and p73 mRNA and p53 protein 
in the adult zebrafish brain. p53 and p73 mRNA expression overlaps in many regions including 
neurogenic zones. The p53 protein is expressed in most of these regions indicating that the 
mRNA expression reflects the protein expression. The p53 protein is expressed in mature 
neurons, Type I cells (non-dividing radial glial cells) and Type IIIa and Type IIIb cells 
(neuroblasts) in the adult zebrafish telencephalon. In cells of the oligodendrocyte lineage and 
in Type II cells (dividing radial glial cells) an expression of the p53 protein is not detectable. 
After stab injury of the adult zebrafish telencephalon both p53 and p73 genes are up-
regulated. p53 is up-regulated in Type I cells. In contrast to the uninjured brain, p53 is 
expressed in cells of the oligodendrocyte lineage following injury. Furthermore, target genes of 
p53 are up-regulated and apoptosis is induced after stab injury. These results suggest a role 
for p53 in constitutive and regenerative neurogenesis. However, tp53M214K mutant zebrafish 
do not show any phenotype. The structurally related p73 is expressed in a very similar pattern 
as p53 in the uninjured and injured zebrafish brain. Therefore, redundancy between p53 and 
p73 may occlude the manifestation of a phenotype in the p53 mutant. Taken together, the 
analysis of expression of both p53 and p73 in the adult zebrafish brain suggests a role of 
these genes during constitutive and regenerative neurogenesis. The future elucidation of the 
precise function of the two genes in these processes requires, however, double mutant 
analysis.    
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Zusammenfassung 
 
Im Gegensatz zum Gehirn von adulten Säugetieren weißt das Gehirn des adulten 
Zebrabärblings Danio rerio eine sehr hohe Möglichkeit zur Proliferation und Regeneration auf. 
Das Gehirn von adulten Säugetieren hat im Gegensatz dazu eine sehr eingeschränkte 
Fähigkeit zur Neurogenese, welche hauptsächlich auf zwei Zonen beschränkt ist, die 
subventrikuläre Zone der lateralen Ventrikel des Telencephalons und die subgranuläre Zone 
des Gyrus dentatus des Hippocampus. Das Gehirn des Zebrabärblings besitzt indessen 16 
proliferative Zonen, welche über das gesamte Gehirn verteilt sind. Der Zebrabärbling wurde 
deshalb zu einem Modell für die Untersuchung der adulten Neurogenese und Regeneration 
von Nervengewebe. Ich habe die Expression der beiden Transkriptionsfaktoren p53 und p73 
im Gehirn von adulten Zebrabärblingen charakterisiert. Es wurde gezeigt, dass sowohl p53 als 
auch p73 wichtige Rollen in der adulten Neurogenese von Säugetieren spielen: p53 hemmt 
die Selbsterneuerung von adulten neuralen Stammzellen und ist am apoptotischen Zelltod von 
Neuronen nach einer Schädigung beteiligt. p73 ist wichtig für das Überleben von Neuronen, 
Selbsterneuerung und Erhaltung von neuralen Stammzellen und ebenso für die 
Differenzierung von Vorläuferzellen. Deshalb war es von Interesse, ob diese Gene ähnliche 
Rollen im Gehirn von adulten Zebrabärblingen besitzen. 
Ich entwickelte eine detaillierte Karte von den Expressionsmustern von p53 und p73 mRNA 
und p53 Protein im adulten Gehirn von Zebrabärblingen. Die Expression von p53 und p73 
mRNA überschneidet sich in vielen Bereichen inklusive neurogener Zonen. Das p53 Protein 
ist in den meisten dieser Bereiche exprimiert, was darauf hindeutet, dass die mRNA 
Expression die Expression des Proteins widerspiegelt. Das p53 Protein wird im Telencephalon 
von adulten Zebrabärblingen in reifen Neuronen, Typ I Zellen (sich nicht teilende radiale 
Gliazellen) und Typ IIIa und Typ IIIb Zellen (Neuroblasten) exprimiert. Eine Expression des 
p53 Proteins ist nicht erkennbar in Zellen die von Oligodendrozyten abstammen und in Typ II 
Zellen (sich teilende radiale Gliazellen). Nach einer Stichverletzung des Telencephalons von 
adulten Zebrabärblingen ist sowohl das p53 als auch das p73 Gen hochreguliert. p53 ist in 
Typ I Zellen hochreguliert. Im Gegensatz zu einem unverletzten Gehirn ist p53 nach einer 
Stichverletzung in Zellen die von Oligodendrozyten abstammen exprimiert. Des Weiteren sind 
nach einer Stichverletzung Zielgene von p53 hochreguliert und Apoptose wird induziert. Diese 
Ergebnisse weißen darauf hin, dass p53 eine Rolle in der konstitutiven und regenerativen 
Neurogenese spielen könnte. Allerdings weißen Zebrabärblinge mit einer tp53M214K Mutation 
keinen Phänotyp auf. Das strukturell verwandte p73 zeigt ein ähnliches Expressionsmuster als 
p53 im unverletzten und verletzten Gehirn von Zebrabärblingen. Daher könnte eine 
Redundanz zwischen p53 und p73 eine Manifestation des Phänotyps in der p53 Mutante 
verdecken. Zusammengefasst, die Analyse der Expression von sowohl p53 als auch p73 im 
 III
 
 
Gehirn des adulten Zebrabärblings deutet auf eine Rolle dieser Gene während der 
konstitutiven und regenerativen Neurogenese hin. Die künftige Aufklärung der genauen 
Funktion dieser beiden Gene bei diesen Vorgängen benötigt jedoch die Analyse von 
doppelten Mutanten. 
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Chapter 1 
 
Introduction 
1 Introduction 
1.1 Adult neurogenesis 
 
For a long time it was thought that no new neurons can be generated in the adult mammalian 
brain. Now it is known that adult neurogenesis still takes place in the mammalian brain, 
including humans. However, compared to zebrafish, the neurogenic and regenerative 
capacities of mammals are very limited. It is important to investigate why adult zebrafish are 
endowed with such an enormous potential to generate new neurons and to repair lesions of 
the brain. This knowledge may guide efforts to develop therapies for human 
neurodegenerative diseases or brain injuries in the future.  
 
 
1.1.1 Adult neurogenesis in mammals 
 
To date the mouse brain is the best-studied model used for adult neurogenesis research. 
Two regions where adult neural stem cells are located and neurogenesis takes place 
predominantly are present in the adult mouse brain, namely the subventricular zone (SVZ) of 
the lateral ventricles and the subgranular zone (SGZ) of the dentate gyrus (DG) in the 
hippocampus (Alvarez-Buylla and Garcia-Verdugo, 2002; Doetsch et al., 1999a; Garcia et 
al., 2004; Seri et al., 2001; Taupin and Gage, 2002). Both the SVZ and the SGZ are part of 
the telencephalon and contain neural stem cells characterized by a slow proliferation rate, 
the potential for self-renewal and generation of progeny of all neural lineages, notably 
neurons, astrocytes and oligodendrocytes. 
 
 
1.1.1.1 Adult neurogenesis in the subventricular zone (SVZ) 
 
The SVZ, which lies in the lateral walls of the lateral ventricles, is the most prominent site of 
adult neurogenesis in mammals. It contains four different cell types, ependymal cells, neural 
stem cells (NSCs), transit amplifying cells and neuroblasts, that form the neurogenic niche 
(Figure 1 A and B) (Doetsch et al., 1997).  
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Ependymal cells (E-cells) are multi-ciliated cells that build up an epithelium directly lining the 
wall of the ventricle. The E-cells are in direct contact with the cerebrospinal fluid (CSF) 
(Figure 1 B) and control the transport of factors from the CSF into the parenchyma. The 
beating of their cilia is essential for a normal CSF flow and concentration gradient formation 
of factors (Del Bigio, 1995; Riquelme et al., 2008). It was demonstrated that ependymal cells 
secrete noggin, which inhibits bone morphogenetic proteins (BMPs) thereby stimulating 
neurogenesis in the SVZ (Lim et al., 2000). Initially E-cells were thought to function as neural 
stem cells (Johansson et al., 1999) since they originate from embryonic radial glial cells 
which act as neural stem cells during development (Spassky et al., 2005). However, it was 
shown by several studies that ependymal cells do not seem to be the actual neural stem 
cells (Capela and Temple, 2002; Doetsch et al., 1999a; Spassky et al., 2005). Though, after 
injury E-cells are able to transform into radial glial-like cells and function as adult neural stem 
cells (Coskun et al., 2008; Johansson et al., 1999; Zhang et al., 2007). Since ependymal 
cells show no self-renewal and thus lack an important characteristic of stem cells, these cells 
may rather constitute a reservoir that can be activated upon injury (Carlen et al., 2009). 
Directly underneath the ependymal cell layer the B-cells, which are the stem cells of the SVZ, 
are located. They exhibit electrophysiological and ultrastructural features of astrocytes. In 
addition B-cells express astrocytic markers as glial fibrillary acidic protein (GFAP), astrocytic-
specific glutamate transporter (GLAST) and others (Doetsch, 2003; Doetsch et al., 1999a; 
Doetsch et al., 1997; Garcia et al., 2004; Seri et al., 2001). B-cells stem from embryonic 
radial glial cells and possess properties of these embryonic neural stem cells. For example, 
B-cells also contact the ventricle with short processes that extend through the ependymal 
layer. Additionally, they express the same markers such as Nestin and SRY-box containing 
gene 2 (Sox2). Moreover, they contact blood vessels as well with a long basal process 
(Figure 1 B). Therefore, like radial glia during development, B-cells retain an apical-basal 
polarity and are part of the ventricular epithelium (Mirzadeh et al., 2008; Shen et al., 2008). It 
was suggested that B-cells do not form a homogeneous population of neural stem cells in the 
SVZ (Merkle et al., 2007). 
It has been shown in several studies that B-cells act as neural stem cells in the SVZ 
(Doetsch et al., 1999a; Doetsch et al., 1999b; Imura et al., 2003). B-cells give rise to C-cells, 
which are rapidly dividing transit amplifying progenitors. Due to this proliferation mode, 
relatively quiescent stem cells are able to divide infrequently, which protects them from 
accumulating mutations during each division. Type C-cells are characterized by the 
expression of markers like distal less homeobox gene 2 (Dlx2), mammalian achaete-scute 
homolog 1 (Mash1) or epidermal growth factor receptor (Egfr). Many signals like sonic 
hedgehog (Shh), nitric oxide or dopamine converge on C-cells. Thus they are emerging as 
important factors of the stem cell lineage (Ahn and Joyner, 2005; Hoglinger et al., 2004; 
Introduction 
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Romero-Grimaldi et al., 2008). Moreover, C-cells can give rise both to neuroblasts and to 
oligodendrocyte progenitor cells (OPCs) that give rise to mature oligodendrocytes (Kim et al., 
2007; Menn et al., 2006). 
As already mentioned above, C-cells give rise to neuroblasts, which are also called A-cells. 
Neuroblasts migrate as chains ensheated by astrocytes along the rostral migratory stream 
(RMS) into the olfactory bulbs (OBs) (Figure 1 C).There they differentiate into periglomerular 
interneurons and GABAergic granule neurons and integrate into the existing circuitry. A-cells 
show an expression of markers like polysialylated neural cell adhesion molecule (PSA-
NCAM) or doublecortin (Dcx) (Doetsch and Alvarez-Buylla, 1996; Doetsch et al., 1997; Lois 
and Alvarez-Buylla, 1994; Lois et al., 1996; Luskin, 1993; Peretto et al., 1997). Moreover, it 
was shown that T-box brain 2 (Tbr2)-expressing A-cells are able to generate glutamatergic 
neurons as well in the OBs (Brill et al., 2009). Neuroblasts can be recruited to sites of 
neuronal death or injury in the cortex (Brill et al., 2009; Chen et al., 2004; Magavi et al., 
2000). Furthermore, following demyelinating lesions the neuronal fate of neuroblasts is 
changed to a glial fate that leads to the generation of oligodendrocytes (Jablonska et al., 
2010). In addition, it was demonstrated that cortical lesion induces enhanced proliferation 
and neurogenesis in the SVZ. Some of the newly generated neural progenitors migrate into 
the injured area where they differentiate into glial cells and to a lesser extent into neurons 
(Saha et al., 2013).  
Until recently it was not clear whether adult neurogenesis and migration of neuroblasts do 
also exist in the adult human brain (Curtis et al., 2007; Sanai et al., 2004). However, it was 
shown that SVZ astrocytes exist in the walls of the human anterior lateral ventricles and 
some of them function as stem cells in vitro (Quinones-Hinojosa et al., 2006; Sanai et al., 
2004). Additionally it was demonstrated that neuroblasts are continuously present in the 
anterior ventral SVZ and the RMS of the adult human brain (Wang et al., 2011). 
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Figure 1: Adult neurogenesis in the SVZ of the mouse brain. 
(A) Coronal view of the SVZ. (B) Enlarged view of the boxed area in (A) which shows the neurogenic 
niche of the SVZ comprised of E-, B-, C- and A-cells. Multiciliated ependymal cells (E-cells, brown) 
line the wall of the lateral ventricle. Neural stem cells (B-cells, blue) are located underneath the 
epidermal layer and are in contact with the ventricle and blood vessels (red). B-cells give rise to transit 
amplifying cells (C-cells, green) which in turn generate neuroblasts (A-cells, orange). A-cells migrate 
into the OBs via the RMS where they differentiate into interneurons. (C) Sagittal view of the mouse 
brain showing neuroblasts (red) migrating from the SVZ to the OB. Modified from (Gonzales-Roybal 
and Lim, 2013). 
 
 
1.1.1.2 Adult neurogenesis in the subgranular zone (SGZ) of the hippocampus 
 
Besides the SVZ, the SGZ of the DG in the hippocampus is the second site of adult 
neurogenesis in the mammalian brain (Figure 2 A) (Gage, 2000; Kempermann et al., 2004a). 
Neurogenesis in this region plays a role in memory and learning. Furthermore, abnormal 
hippocampal neurogenesis could be linked to epilepsy and depression for example 
(Dranovsky and Hen, 2006; Parent et al., 2006; Zhao et al., 2008).(Gao and Chen)showed, 
that traumatic brain injury promotes proliferation of NSCs in the hippocampus but 
neurogenesis is not increased since most of the newborn cells are glia. 
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There are distinct types of progenitors present in the SGZ that express different markers and 
show different morphological features. Radial glia like type 1 progenitors express progenitor 
markers as Nestin and Sox2 and, like B-cells in the SVZ, astrocytic markers as GFAP 
(Figure 2 B) (Encinas et al., 2006; Garcia et al., 2004; Kempermann et al., 2004b; Steiner et 
al., 2006; Suh et al., 2007). Contrary to B-cells in the SVZ, type 1 progenitors exhibit a radial 
morphology with a long apical process similar to embryonic radial glia (Figure 2 B) and they 
express radial glia markers like Vimentin or brain lipid binding protein (BLBP) (Encinas et al., 
2006). Type 1 progenitors are thought to give rise to transit amplifying progenitors, which 
have only short processes and do not show a radial morphology.  
The several types of transit amplifying progenitors can be distinguished by marker 
expression and morphology (Encinas et al., 2006; Lugert et al., 2010; Suh et al., 2007). Type 
2A cells still express Sox2 and give rise to Type 2B (late stage transit amplifying progenitors) 
or Type 3 (neuroblasts) cells. Type 2B cells are characterized by the expression of both 
Nestin and Dcx, an immature neuronal marker. Whereas Type 3 cells are Nestin-negative 
and express only Dcx  (Figure 2 B) (Dhaliwal and Lagace, 2011). When immature neurons 
differentiate finally into mature glutamatergic granule neurons there is down-regulation of Dcx 
and up-regulation of NeuN and calretinin (Figure 2 B). Newly generated neurons in the SGZ 
mature functionally and structurally within six to eight weeks (Jessberger and Kempermann, 
2003; van Praag et al., 2002; Zhao et al., 2006).  
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Figure 2: Adult neurogenesis in the SGZ of the mouse brain. 
(A) Sagittal view of the mouse brain. The boxed area shows the hippocampus. (B) In the SGZ of the 
DG in the hippocampus radial glia-like cells give rise to transit amplifying progenitor cells, immature 
and mature granule neurons. The different cell types during the different stages of the differentiation 
process are characterized by the expression of distinct markers. Modified from (A) (Hsieh, 2012) and 
(B) (Bonaguidi et al., 2011). 
 
 
Sox2-positive type 2 progenitors with a non-radial morphology are able to self-renew. 
Moreover, a single Sox2-positive type 2 progenitor cell can give rise to an astrocyte and a 
neuron. In addition, non-radial type 2 progenitors can give rise to radial type 1 progenitors, 
which suggests a reciprocal relationship between these progenitor states. It was 
hypothesized that the non-radial Sox2-positive Type 2 cells are the self-renewing, multipotent 
neural stem cells in the hippocampus. These NSCs can give rise to quiescent Type 1 radial 
progenitors, which could function as a reservoir of rarely dividing cells (Suh et al., 2007). 
These findings indicate that the lineage relationship between progenitor cells in the SGZ is 
still controversial. Thus there is need of further lineage tracing studies to identify the 
relationships between the distinct progenitors in the SGZ.  
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In contrast to the SVZ (see chapter 1.1.1.1), adult neurogenesis in the human DG has been 
consistently reported and 700 new neurons are added in an adult human hippocampus each 
day (Beckervordersandforth et al., 2014; Eriksson et al., 1998; Spalding et al., 2013). 
 
 
 
1.1.2 Adult neurogenesis in zebrafish 
 
In comparison to mammals (Figure 3 A), zebrafish show a much higher proliferative and 
regenerative potential. In the adult zebrafish brain 16 regions could be identified where adult 
neurogenesis takes place (Figure 3 B) (Adolf et al., 2006; Grandel et al., 2006; Kaslin et al., 
2008; Zupanc et al., 2005). In these regions homologs of the two mammalian stem cell 
niches in the SVZ and the hippocampus are included, as well as additional stem cell niches 
in the telencephalon and all other subdivisions of the brain.   
 
 
 
Figure 3: Adult neurogenesis in the mouse and zebrafish brain. 
Parasagittal schematic overview of the adult mouse (A) and zebrafish (B) brain showing the 
proliferation zones. In the adult mouse brain proliferation (red) and neurogenesis (orange) take place 
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in only two regions of the telencephalon, the SVZ of the lateral ventricles and the SGZ of the 
hippocampal DG. Whereas the adult zebrafish brain shows proliferation and neurogenesis in all 
subdivisions of the brain. Modified from (Kaslin et al., 2008).     
 
 
Due to these characteristics of the adult zebrafish telencephalon, it is an interesting model for 
studying adult neurogenesis from a comparative point of view. The olfactory bulbs and the 
dorsolateral telencephalon of the adult zebrafish brain which was suggested to be 
homologous to the mammalian hippocampus (Broglio et al., 2005) can be used to compare 
the homologous proliferation zones of mammals and zebrafish.  
However, the development of the teleostean telencephalon differs from the development of 
the mammalian telencephalon. The telencephalon of teleosts is formed by eversion which 
leads to the formation of an external ventricle. Therefore, the proliferative zones of the adult 
zebrafish telencephalon are located both internally and at the outer surface of the 
telencephalon. In contrast, the mammalian telencephalon is generated by evagination of the 
neural tube that leads to an internal ventricular zone (Figure 4) (Broglio et al., 2005; 
Folgueira et al., 2012; Mueller and Wullimann, 2009; Wullimann and Mueller, 2004).    
 
 
 
Figure 4: Development of the telencephalon. 
Schematic representation of the process of eversion and evagination of the neural tube during the 
development of the telencephalon of actinopterygians (ray-finned fish) and non-actinopterygians, 
respectively. Eversion (outward folding) of the actinopterygian telencephalon leads to a ventricular 
zone that is present internally but also covers the outer surface (red). Evagination (inward folding) of 
the non-actinopterygian telencephalon results in a ventricular zone that is only located internally (red).    
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A: amygdale; DP: dorsal pallium; H: hippocampus; LP: lateral pallium; MP: medial pallium; P1, P2, P3: 
the three main subdivisions of the pallium; V: ventricle. Modified from (Broglio et al., 2005). 
 
 
The progenitor cells located in the adult zebrafish telencephalon are heterogeneous 
concerning their proliferation rate. The proliferation intensity varies along the dorsoventral 
and rostrocaudal axis of the telencephalon. In the anterior telencephalon proliferation can be 
detected along the complete ventricular zone. However, in more posterior parts of the 
telencephalon proliferation is restricted to different subdomains (Lindsey et al., 2012). The 
most proliferative region is present in the ventral subpallium near the OBs (Vv) (Figure 5 A) 
(Adolf et al., 2006; Ganz et al., 2010; März et al., 2010a). In this region almost exclusively 5-
Bromo-2`deoxyuridine (BrdU)-positive and S100 calcium binding protein β (S100β)-negative 
cells are present and any quiescent cells are located there (Lindsey et al., 2012; März et al., 
2010a). This region in the medial subpallium is homologous to the mammalian SVZ and 
mainly generates neurons that migrate to the OBs via the RMS as well (Adolf et al., 2006; 
Byrd and Brunjes, 1998, 2001; Grandel et al., 2006; Kishimoto et al., 2011). Additionally, this 
region is able to generate neurons that migrate to the adjacent parenchyma, which is in 
contrast to mammals (Adolf et al., 2006; Kishimoto et al., 2011). In the posterolateral zone of 
the dorsal telencephalic area at the border between Dl and Dp (Figure 5 A and B), which is 
homologous to the hippocampus of mammals, and also in other ventricular regions the 
proliferation rate is lower (Grandel et al., 2006; März et al., 2010a; Zupanc et al., 2005). 
Though, proliferating cells are not only located at the ventricular zone. In the parenchyma 
proliferating cells could be detected as well. These cells are OPCs that give rise to mature 
oligodendrocytes and self-propagate (Adolf et al., 2006; März et al., 2010b).   
Furthermore, zebrafish do not possess an ependyma, a multi-ciliated ependymal layer 
covering the whole ventricular surface, like mammals (Duan et al., 2008; Johansson et al., 
1999). In zebrafish only the roof of the telencephalic ventricle and the dorsomedial regions of 
the proliferative zones are covered by an ependymal layer (DEL, dorsal ependymal lining) (D 
and Dm; Figure 5 A and B) (Lindsey et al., 2012). Thus, the stem cell niche of zebrafish 
bears resemblance to the fragmented ependymal lining of the stem cell niches of birds and 
reptiles (Garcia-Verdugo et al., 2002). 
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Figure 5: Anatomy of the adult zebrafish telencephalon. 
Schematic of transverse sections through the anterior (A) and posterior (B) zebrafish telencephalon. 
The different anatomical subdomains are indicated. Proliferative periventricular zones are shown in 
green. (C) Radial glial cells possess long processes that end at the pial surface. The radial glial cells 
in the adult zebrafish telencephalon are marked by immunostaining against GFP in the Tg(GFAP-
GFP) line. Co-staining with the proliferation marker proliferating cell nuclear antigen (PCNA) allows to 
distinguish between PCNA-negative Type I and PCNA-positive Type II cells (see (März et al., 2010a)).  
Cantd: commissural anterior, pars dorsalis; Cantv: commissural anterior, pars ventralis; Dc: central 
zone of the dorsal telencephalic area (D); Dd: dorsal zone of D; DEL: dorsal ependymal lining; DiV: 
diencephalic ventricle; Dl: lateral zone of D; Dm: medial zone of D; Dp: posterior zone of D; Lot: lateral 
olfactory tract; ENd: entopeduncular nucleus, dorsal part; ENv: entopeduncular nucleus, ventral part; 
LFB: lateral forebrain bundle; Mot: medial olfactory tract; PPa: parvocellular preoptic nucleus, anterior 
part; PVZ: periventricular zone; SY: sulcus ypsiloniformis; TelV: telencephalic ventricle; Vc: ventral 
nucleus of the ventral telencephalic area (V); Vd: dorsal nucleus of V; Vl: lateral nucleus of V; Vp: 
postcommisural nucleus of V; Vs: supracommisural nucleus of V; Vv: ventral nucleus of V. From 
(Schmidt et al., 2013).  
 
 
1.1.2.1 Constitutive adult neurogenesis in zebrafish 
 
1.1.2.1.1 Neural progenitors in the telencephalon of adult zebrafish 
 
During mammalian development radial glial cells act as embryonic neural stem cells. At the 
end of development most of the radial glial cells convert into astrocytes and ependymal cells. 
Some of these astrocytes retain stem cell potential in the SGZ and SVZ (Alvarez-Buylla and 
Garcia-Verdugo, 2002; Alvarez-Buylla et al., 2001; Alvarez-Buylla et al., 2002; Doetsch, 
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2003; Kriegstein and Alvarez-Buylla, 2009). The adult neural stem cells in the zebrafish 
telencephalon are so-called radial glial cells (RGCs). The cell bodies of these RGCs are 
located at the ventricular zone. They are able to self-renew and to generate new neurons. 
Furthermore, the RGCs exhibit a radial morphology which is characterized by a large 
triangular soma and a long radial process that reaches the pial surface of the telencephalon 
(Figure 5 C). There, the RGCs terminate with their endfeet either at the pial surface itself or 
on blood vessels (Lam et al., 2009; Lindsey et al., 2012; Rothenaigner et al., 2011). 
Moreover, the RGCs in the adult zebrafish telencephalon express the same markers as 
embryonic radial glia, like S100β, Nestin, GFAP and BLBP (Adolf et al., 2006; Lam et al., 
2009; Pellegrini et al., 2007). In contrast to the mammalian brain, no bona fide astrocytes 
have been identified in the adult zebrafish brain until now (Adolf et al., 2006; Grandel et al., 
2006; März et al., 2010a; März et al., 2011). Since the adult zebrafish brain seems to retain 
embryonic features it might thus be more capable of regeneration and adult neurogenesis. 
The two different types of RGCs in the adult zebrafish telencephalon can be distinguished by 
the expression of the proliferation marker proliferating cell nuclear antigen (PCNA) (Figure 5 
C), which is highly expressed in the G1-phase of the cell cycle and maintained throughout 
division (Bravo et al., 1987), or incorporation of BrdU, which labels the S-phase of the cell 
cycle (Gratzner, 1982). Both cell types express the markers mentioned above. Quiescent 
Type I cells are characterized by the expression of S100β, GFAP and BLBP but lack PCNA 
expression and are negative for BrdU (S100β+, GFAP+, BLBP+, PCNA-, BrdU-). Whereas 
slowly cycling Type II cells express S100β, GFAP and BLBP and additionally PCNA and they 
incorporate BrdU (S100β+, GFAP+, BLBP+, PCNA+, BrdU+) (Figure 6) (März et al., 2010a; 
Schmidt et al., 2013). Most of the RGCs are Type I cells and therefore quiescent. Activated 
Type II RGCs are both able to self-renew by symmetric division and to give rise to 
neuroblasts (Type III cells) by asymmetric division (Figure 6) (Rothenaigner et al., 2011). The 
newly generated neuroblasts carry on to proliferate and start to express markers for a 
neuronal differentiation state like PSA-NCAM and proneural markers like achaete-scute 
complex-like 1a (Ascl1a) (Figure 6). Subsequently they either enter the RMS to reach the 
OBs or they leave the periventricular zone and migrate deeper into the parenchyma (Schmidt 
et al., 2013). The two different types of neuroblasts can be characterized by the expression 
of distinct markers. Both Type IIIa and Type IIIb cells express PCNA and PSA-NCAM but 
only Type IIIa cells express Nestin and glial markers. Furthermore, all the different progenitor 
cell types express the progenitor and stem cell marker Sox2 (März et al., 2010a). There 
exists heterogeneity in marker expression and cellular composition of stem cell niches in the 
adult zebrafish telencephalon. Type II cells are not evident in the RMS where Type III cells 
are predominantly located and Type I cells are clustered in the ventral ventricular zone of the 
subpallium for example. In the rest of the telencephalic ventricular zone these distinct cell 
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types are present in a scattered fashion (Ganz et al., 2010; März et al., 2010a). It has been 
hypothesized that there are additional cell types present in the stem cell niches that are 
either additional types of progenitors or cells that contribute to the architecture of the stem 
cell niche (Lindsey et al., 2012). 
 
 
 
Figure 6: The different types of progenitor cells in the adult zebrafish telencephalon. 
The markers expressed by Type I, II and III cells are indicated. Type II cells give rise to Type III cells 
and are able to self-renew. Activation of notch pushes Typ2 II radial glial cells into quiescence 
whereas blocking of notch leads to the transformation of quiescent Type I into proliferating Type II 
cells (Chapouton et al., 2010). Modified from (Schmidt et al., 2013). 
 
 
In the embryonic mouse brain (Nadarajah et al., 2001) but also in the embryonic fish brain 
(Peukert et al., 2011) the long processes of RGCs provide a scaffold for new-born neurons 
that migrate out of the ventricular zone. It was suggested that this is also the case in the 
adult zebrafish brain (Lam et al., 2009; Pellegrini et al., 2007) but evidence for this 
hypothesis is still missing. Furthermore it was shown that in anterior regions of the RMS 
neuroblasts are associated with blood vessels during migration towards the OBs (Kishimoto 
et al., 2011). Therefore, it could be that blood vessels are more important guidance cues 
than the processes of RGCs. However this has to be further investigated. In addition, it has 
been demonstrated that most of the new-born neurons do not migrate to the pial surface but 
settle in periventricular areas (Kroehne et al., 2011).  
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Furthermore, adult neurogenesis in the zebrafish brain is linked to circadian clock activity. 
The core clock feedback loop was shown to be active in all known progenitor cell types of the 
telencephalon (Weger et al., 2013). Moreover, the progesterone receptor (pgr) is widely 
expressed in the adult zebrafish brain showing the highest expression in RGCs. The 
expression of pgr is up-regulated by estrogens (Diotel et al., 2011). Estrogen treatment leads 
to a reduced cell proliferation in several brain regions and most likely affects survival and cell 
migration without affecting differentiation (Diotel et al., 2011; Makantasi and Dermon, 2014). 
 
 
1.1.2.1.2 Additional neurogenic sites in the adult zebrafish brain 
 
Not only the adult zebrafish telencephalon but also other regions of the brain possess 
proliferative potential. However, other neurogenic sites than the telencephalon are less well 
investigated. Nevertheless it was suggested that the different stem cell niches in the adult 
zebrafish brain differ in terms of their architecture. These differences may lead to different 
neurogenic potentials of the distinct niches. 
Especially the cerebellum exhibits substantial neurogenesis (Grandel et al., 2006). 
Proliferating neural progenitors in the cerebellum express the progenitor markers Meis 
homeobox 2 (Meis2), Musashi homolog 1 (Drosophila) (Msi1), Sox2 and Nestin. Additionally, 
these cells express cytoskeletal elements such as atypical protein kinase C (aPKC), zona 
occludens protein 1 (ZO-1), γ-tubulin and β-catenin and thus show neuroepithelial 
characteristics (Kaslin et al., 2009). The proliferating cells in the cerebellum do not express 
radial glial markers but there are some radial glial-like cells present in the neurogenic niche 
that express Vimentin, BLBP and GFAP. These cells seem not to be stem cells but rather 
function as a scaffold for migrating neuroblasts. Since blocking of fibroblast growth factor 
(Fgf) leads to a decreased proliferation, Fgf may be crucial for the activity of stem cells in the 
cerebellum (Kaslin et al., 2009).  
A second site of adult neurogenesis in the zebrafish brain is present in the optic tectum. The 
caudal, medial and lateral margins of the periventricular grey zone (PGZ) exhibit proliferating 
cells (Grandel et al., 2006; Ito et al., 2010; Kaslin et al., 2008; Marcus et al., 1999; Zupanc et 
al., 2005). Dividing cells in these regions do not express glial markers but the neural 
progenitor markers Sox2 and Msi1 and PCNA (Ferri et al., 2004; Kaneko et al., 2000). As in 
the cerebellum the proliferating cells exhibit neuroepithelial properties and express aPKC, 
ZO-1 and γ-tubulin (Del Bene et al., 2008; Oteiza et al., 2008). Furthermore non-proliferating 
radial glial-like cells can be found next to dividing neuroepithelial-like progenitors and they 
can be detected in the deeper layer of the PGZ (Ito et al., 2010). Moreover, the progenitor 
cells build up a multipotent progenitor pool since they can differentiate into oligodendrocytes 
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and radial glia as well as in GABAergic and glutamatergic neurons (Higashijima et al., 2004; 
Ito et al., 2010; Marusich et al., 1994; Mueller and Wullimann, 2002). 
The boundary between the midbrain and the hindbrain harbours another neurogenic site 
(Chapouton et al., 2006). In this region of the brain, cells expressing her5:gfp form a cluster 
at the ventricle of the midbrain/hindbrain boundary. These her5:gfp-positive cells exhibit 
features of stem cells. Some of these cells divide slowly, express stem cell markers as 
BLBP, GFAP, Msi1 or Sox2 and are able to differentiate into glia and neurons (Chapouton et 
al., 2006). 
 
 
1.1.2.1.3 Oligodendrocytes in the adult zebrafish telencephalon 
 
In the adult mammalian brain slowly cycling OPCs, which express the transcription factors 
SRY-box containing gene 10 (Sox10) and Olig2, are the major proliferating cell population 
(Dawson et al., 2003; Geha et al., 2010). They are distributed throughout the brain and 
produce oligodendrocytes that can take part in myelin repair (Gensert and Goldman, 1997; 
Nait-Oumesmar et al., 1999; Polito and Reynolds, 2005). It was shown that OPCs act as 
multipotent stem cells in vivo (Rivers et al., 2008; Zawadzka et al., 2010). In the parenchyma 
of the adult zebrafish telencephalon mature oligodendrocytes, proliferating OPCs, slowly 
proliferating OPCs and quiescent OPCs are located. These cells belonging to the 
oligodendrocyte lineage also express Sox10 and Olig2 like in mammals. Furthermore, 
quiescent OPCs seem to be the major cell type present in the parenchyma of the adult 
zebrafish telencephalon. In contrast to the mammalian CNS, where more oligodendrocytes 
than OPCs are present, in the zebrafish telencephalon much more OPCs than mature 
oligodendrocytes exist. They probably form a pool of resting OPCs that can be activated to 
proliferate when there is need of. Since more neurons, which have to be myelinated, are 
produced in the zebrafish than in the mammalian brain, more OPCs may be required to 
produce enough mature oligodendrocytes (März et al., 2010b). 
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1.1.2.2 Regenerative adult neurogenesis in zebrafish 
 
The zebrafish central nervous system (CNS) exhibits enormous regenerative properties. In 
contrast, in the mammalian brain regenerative adult neurogenesis is very limited. It is likely 
that the local environment in most areas of the mammalian brain is not suited for a long-term 
survival of newly generated neurons and that the zebrafish brain environment could be more 
permissive to regeneration. Furthermore, the number of newly generated neurons in the 
mammalian brain is far too low to replace the lost neurons (Arvidsson et al., 2002; Chen et 
al., 2004; Kroehne et al., 2011; Zupanc, 2008). After stroke for example, reactive 
neurogenesis is induced in the mammalian brain but the majority of newborn neurons is not 
maintained for a long time due to lack of functional integration into the circuitry and a 
permissive environment (Arvidsson et al., 2002; Nakatomi et al., 2002; Yamashita et al., 
2006). In addition, after traumatic brain injury a proliferative response of progenitor cells 
takes place, which leads only to the production of new astrocytes but any neurons are 
generated (Buffo et al., 2008). Therefore the question arises why zebrafish show this 
exceptional ability for regeneration of not only axons but also whole neurons. Since zebrafish 
show a life-long body growth, that also includes the formation and incorporation of new 
neurons, this continuous growth could lead to a suitable environment for regeneration of 
injured neural tissue. 
 
 
1.1.2.2.1 Regeneration of the retina 
 
Contrary to mammals, zebrafish have a huge ability to regenerate injured organs including 
kidney, heart, fins as well as the CNS (Becker and Becker, 2008; Diep et al., 2011; Kuscha 
et al., 2012; Lien et al., 2012; Singh et al., 2012). The adult zebrafish retina is able to 
regenerate completely after distinct types of lesion, notably light-induced damage of 
photoreceptors (Vihtelic and Hyde, 2000), stab lesions (Fausett and Goldman, 2006; Senut 
et al., 2004), heat damage (Raymond et al., 2006), toxic lesion of inner retinal neurons 
(Fimbel et al., 2007) and surgical excision of retinal tissue (Cameron, 2000). The 
regeneration process is dependent on Fgf signaling (Hochmann et al., 2012). In the zebrafish 
retina two different sources are present, that can generate new cells during neurogenesis 
and regeneration, the Müller glia cells (MGC) and the ciliary marginal zone (CMZ). The MGC 
are located in the inner nuclear layer (INL) of the retina. They are able to generate 
photoreceptor progenitors of the rod lineage. The CMZ is located at the interface between 
ciliary epithelium and neural retina. Cells in the CMZ allow for a life-long growth of the retina 
and neurogenesis since they give rise to all types of neurons. Furthermore the CMZ is 
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associated with blood vessels. The MGC play a role after injury since they show an up-
regulation of GFAP and re-enter the cell cycle. In addition they de-differentiate and acquire 
characteristics of multipotent retinal progenitors in the CMZ (Raymond et al., 2006). MGC 
give rise to proliferating multipotent progenitor cells, which generate all types of neurons to 
repair the damaged tissue (Bernardos et al., 2007; Fausett and Goldman, 2006; Fimbel et 
al., 2007; Goldman, 2014; Lenkowski and Raymond, 2014). 
 
 
1.1.2.2.2 Regeneration of the optic nerve 
 
In addition to the retina, zebrafish are also capable of regenerating the optic nerve. They are 
able to recover visual function within 20-25 days (Kaneda et al., 2008), which is very fast in 
comparison to goldfish (30-50 days) (Kato et al., 1999), the major model organism used to 
investigate optic nerve regeneration in fish. In mammals such as rat and mouse, optic nerve 
injury leads to massive cell death and irreversible impairment of the visual system (Agudo et 
al., 2008; Berkelaar et al., 1994; Bonfanti et al., 1996). Contrary, lower vertebrates like frogs 
(Humphrey and Beazley, 1985; Scalia et al., 1985) or zebrafish can restore visual function 
owing to survival of retinal ganglion cells.  
Thus, the reason for optic nerve regeneration is rather the survival and regeneration of 
original retinal ganglion cells than proliferation of these cells. This is in contrast to 
regeneration of the retina (see chapter 1.1.2.2.1) and the spinal cord (see chapter 1.1.2.2.3) 
where proliferation of progenitor cells is crucial for proper regeneration. It was demonstrated 
that after optic nerve crush or transsection almost all retinal ganglion cells survive. More than 
half of the surviving cells regrew their axons to the target area within one week after injury. In 
addition, multipotent retinal stem cells are able to generate new cells to replace lost ones 
after damage (Zou et al., 2013).  
 
 
1.1.2.2.3 Regeneration of the spinal cord 
 
After spinal cord transsection spinal cord axons are regenerated (Becker et al., 1997) and 
whole neuronal assemblies are rebuilt with complete restoration of function after injury (Ayari 
et al., 2010; Cameron, 2000; Clint and Zupanc, 2001; Ito et al., 2010; Kirsche, 1965; Reimer 
et al., 2008; Zupanc, 2008; Zupanc and Ott, 1999; Zupanc and Zupanc, 2006). Fish show an 
almost normal swimming behavior 6 weeks after injury as demonstrated by behavioral tests 
(Becker et al., 2004). However, when challenged by swimming against a flow they show a 
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worse performance than uninjured fish. Thus, the recovery process is limited in some 
aspects (van Raamsdonk et al., 1998). The regenerating spinal cord motor neurons originate 
from olig2:EGFP-positive ependymoradial glial cells. This process is regulated by Shh 
signaling (Reimer et al., 2009; Reimer et al., 2008). 
 
 
1.1.2.2.4 Regeneration of the brain 
 
The reactions of the mammalian brain following stab injuries have intensively been 
investigated (for example (Buffo et al., 2005; Dimou et al., 2008; Hampton et al., 2004; 
Magnus et al., 2007; Robel et al., 2011)). Immediately after injury recruitment and 
proliferation of microglia takes place. Microglia remove the cell debris and via their signaling 
activity they participate in a process called reactive gliosis, which is the major hallmark of the 
reaction to mammalian brain injury (Hampton et al., 2004; Koshinaga et al., 2000). Reactive 
gliosis is characterized by hypertrophy of astrocytes and in severe lesions proliferation of 
astrocytes as well. Moreover, GFAP and other astrocytic markers and immature glial markers 
as nestin and BLBP are up-regulated in astrocytes (Buffo et al., 2008; Robel et al., 2011; 
Sofroniew, 2009). Additionally, the transcription factor Olig2 is highly up-regulated at the site 
of the lesion and OPCs start to proliferate near the lesion. These events result in impaired 
neuronal regeneration (Buffo et al., 2005; Dimou et al., 2008; Hampton et al., 2004; Magnus 
et al., 2007; Robel et al., 2011; Sofroniew, 2009). Altogether, these different reactions can 
finally lead to the formation of a glial scar. On the one hand, this scar seals the injured tissue 
off but on the other hand it also prevents regeneration of axons and neurons (Robel et al., 
2011; Sofroniew, 2009).  
Initially, proliferative and cellular responses to injury of the brain of adult teleosts had been 
mainly studied in the cerebellum of Apteronotus leptorhynchus. It was shown that apoptosis 
reaches a maximum at 30 min after the damage and declines from 2 to 20 days post lesion 
(dpl) (Zupanc et al., 1998). Furthermore, proliferation peaks at 5 dpl (Zupanc and Ott, 1999) 
and microglia/macrophages exhibit increased levels from 3 dpl onwards with the highest 
level at 10 dpl (Zupanc et al., 2003). Moreover, GFAP-positive radial fibers start to increase 
from 8 dpl onward and their levels remain elevated until 100 dpl (Clint and Zupanc, 2001).  
In mammalian neural tissue, necrotic cell death is predominant after injury (Liou et al., 2003; 
Vajda, 2002). However, apoptosis does also occur in regions surrounding the necrotic injury 
core (Liou et al., 2003). Necrosis leads to much stronger inflammatory responses than 
apoptosis, which results in a progressive loss of neural cells and scar formation (Zhang et al., 
1997). In contrast, in lesions of the adult cerebellum of fish apoptosis seems to remove 
damaged cells (Zupanc et al., 1998). The different mechanisms to eliminate damaged cells 
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may be one of the factors that account for the enormous regenerative potential of injured 
neural tissue in fish. 
In the injured adult zebrafish telencephalon microglia are rapidly recruited to the site of injury. 
Additionally, radial fibers get disorganized and over 90% of newborn cells express the 
neuronal marker Hu at 7 dpl. Prokineticin 2 (Prok2) is transiently up-regulated near the lesion 
site (Ayari et al., 2010).  
 (März et al.)showed that after stab injury of the adult zebrafish telencephalon first microglia 
accumulate at the site of the lesion and start to proliferate, which is similar to results from 
other teleosts and mouse. Another early response to injury in zebrafish is accumulation of 
OPCs at the lesion site. In contrast to the mammalian brain, this accumulation is only 
transient and the OPCs show only a moderate proliferation. Thus, there is no formation of a 
glial scar as in the mammalian brain. Subsequently, RGCs up-regulate expression of Nestin, 
S100β and GFAP and some cells show hypertrophic swellings, which is also observed in 
mammalian astrocytes (März et al., 2011). In agreement with data from mouse (Robel et al., 
2011) and Apteronotus leptorhynchus (Clint and Zupanc, 2001), zebrafish show also a 
delayed increase of GFAP expression. Furthermore, Type II and Type III cells strongly 
proliferate at the ventricular zone and generate new neurons. However, proliferation is 
restricted to the injured hemisphere. In all, the lack of a strong response of OPCs and the 
massive increase in proliferation following stab injury of the adult zebrafish telencephalon 
may be the reason for the high regenerative ability of the zebrafish brain (März et al., 2011). 
In contrast to the observations made by(März et al.)another study did not observe an 
accumulation of OPCs at the site of the lesion. This may be due to the different injury 
techniques used in the two studies (Baumgart et al., 2012). 
Moreover, it was demonstrated that after injury of the adult zebrafish telencephalon new 
neurons are born. her4.1-positive radial glial progenitor cells residing at the ventricular zone 
proliferate and give rise to neuroblasts. These neuroblasts migrate to the site of the lesion 
and differentiate into neurons which express mature neuronal markers and survive for more 
than 3 months (Kroehne et al., 2011). Accordingly,(Baumgart et al.)confirmed the generation 
and long-term survival of neurons following injury of the adult zebrafish telencephalon. 
Contrary to constitutive neurogenesis, where newborn neurons settle mainly at the 
subventricular zone, in regenerative neurogenesis newborn neurons migrate longer 
distances into the injured parenchyma (Baumgart et al., 2012; Kroehne et al., 2011). In a 
further study it was shown that the transcription factor Gata3 plays an important role in 
regenerative neurogenesis of the adult zebrafish telencephalon. It is only expressed in 
lesioned brains and knock-down of Gata3 decreases the proliferative response of RGCs after 
injury. Furthermore, the generation of new neurons as response to an injury is also reduced. 
The induction of Gata3 following injury may be dependent on Fgf. Thus, Gata3 seems to be 
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necessary for proliferation of progenitors and generation and migration of neurons following 
injury (Kizil et al., 2012b). In addition, cxcr5, a chemokine receptor, is involved in 
regenerative neurogenesis. Cxcr5 is expressed both in neurons and at the ventricular zone 
of the adult zebrafish telencephalon and it is up-regulated upon injury. Knock-down of cxcr5 
leads to reduced production of new neurons but proliferation of RGCs is not changed. 
Therefore, cxcr5 may play a role in the differentiation of RGCs into neurons but may not be 
required for their proliferation (Kizil et al., 2012a). Another factor that influences regenerative 
neurogenesis may be inflammation. Inflammation is necessary and sufficient to induce 
reactive proliferation and regenerative neurogenesis. In addition, inflammation is able to 
induce the expression of Gata3 (Kyritsis et al., 2012). Contrary, in mammals inflammation 
prevents regeneration of neural tissues (Hoehn et al., 2005; Iosif et al., 2006). Furthermore, it 
was shown that in aged zebrafish brains neurogenesis is decreased due to enhanced 
quiescence of RGCs. In addition, regenerative neurogenesis is much weaker than in younger 
zebrafish (Edelmann et al., 2013).  
Moreover, it was demonstrated that excitotoxic brain injury by using quinolinic acid results in 
cell death, recruitment of microglia and enhanced proliferation and neurogenesis in the 
injured telencephalic hemisphere. RGCs generate neurons, which migrate to the site of the 
injury and survived for at least 8 weeks. In the mammalian brain neuroblasts migrate to the 
lesion site as well, but in contrast to the zebrafish brain, these neurons fail to survive for a 
long time (Skaggs et al., 2014). Thus, the reactions to excitotoxic brain injury in zebrafish are 
similar to the reactions following stab injury.  
 
 
 
 
1.2 The p53 family of transcription factors 
 
The p53 family of transcription factors consists of three members, namely p53, p63 and p73. 
p53, which was discovered first in 1979 (DeLeo et al., 1979; Kress et al., 1979; Lane and 
Crawford, 1979; Linzer and Levine, 1979; Melero et al., 1979), is the best-known and the 
most prominent member since it is an important tumor suppressor inducing cell cycle arrest 
and apoptosis. The two p53-related proteins p63 (Yang et al., 1998) and p73 (Kaghad et al., 
1997) were discovered almost 20 years later in 1998 and 1997, respectively.  
All three members of the p53 family of transcription factors show a high similarity of the 
domain structure, especially in the DNA-binding domain. However, p63 and p73 are much 
more closely related to each other than to p53 (Belyi et al., 2010; Kaelin, 1999). Due to their 
similarity, p63 and p73 are able to transactivate p53 target genes which causes apoptosis 
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and cell cycle arrest. However, it is assumed that several p53 target genes respond 
differently to p53, p63 and p73 (Levrero et al., 2000; Murray-Zmijewski et al., 2006). p53, p63 
and p73 exhibit overlapping functions but they also have distinct physiological roles in cells 
(De Laurenzi and Melino, 2000; Levrero et al., 2000; Murray-Zmijewski et al., 2006; Pietsch 
et al., 2008).  
The transcription factors p53, p63 and p73 oligomerize and bind to the DNA as tetramers, 
which is essential for their functions. It was shown that p53 forms only homotetramers, 
whereas p63 and p73 are also capable of forming heterotetramers in vitro (Davison et al., 
1999; Joerger et al., 2009).   
It is well known that p53 is a tumor suppressor protein and that the p53 gene is frequently 
mutated in human cancers (Hollstein et al., 1996; Hollstein et al., 1991). However, the 
situation for the two other members of the p53 family is contradictory. Since p63 and p73 
map to regions in the human genome, that often show alterations in cancers, this suggests 
that both are tumor suppressors as well (Kaelin, 1999; Kaghad et al., 1997; Yang et al., 
1998). Though, it was revealed, that p63 and p73, in contrast to p53, are only rarely mutated 
in human tumors (Deyoung and Ellisen, 2007; Irwin and Kaelin, 2001a; Melino et al., 2003). 
Furthermore, in most cases p53-deficient mice develop normally but they are prone to 
develop spontaneous tumors (Donehower et al., 1995; Donehower et al., 1992). However, 
few female p53-deficient embryos die because they exhibit a failure of neural tube closure, 
which leads to exencephaly and subsequent anencephaly. Additionally, these embryos often 
show craniofacial malformations (Armstrong et al., 1995; Sah et al., 1995). In contrast to p53-
deficient mice, p63- and p73-deficient mice are less cancer prone but they all show severe 
developmental defects (Mills et al., 1999; Yang et al., 1999; Yang et al., 2000). 
However,(Flores et al.)found out that mice heterozygous for mutations both in p63 and p73 
(p63+/-;p73+/-) developed a variety of tumors. Moreover, they demonstrated that mice 
heterozygous for mutations both in p53 and p63 (p53+/-;p63+/-) or p53 and p73 (p53+/-;p73+/-) 
developed more metastatic tumors and showed a higher tumor burden than heterozygous 
p53 mutant (p53+/-) mice (Flores et al., 2005). Although p63 and p73 are not mutated in 
human tumors, the tumors often show an altered expression of p63 and p73, respectively. 
Some human tumors express higher levels of p73 compared to the normal tissue, like 
colorectal carcinoma (Sunahara et al., 1998), bladder cancer (Yokomizo et al., 1999), lung 
cancer (Mai et al., 1998), breast cancer (Zaika et al., 1999), ovarian cancer (Concin et al., 
2004), neuroblastoma (Kovalev et al., 1998), rhabdomyosarcoma (Cam et al., 2006), 
hepatocellular carcinoma (Tannapfel et al., 1999b), glioma (Wager et al., 2006) and 
cholangiocellular carcinoma (Tannapfel et al., 1999a), for example. Also downregulation of 
p73 could be observed in lymphoblastic leukemias and Burkitt´s lymphoma (Corn et al., 
1999; Kawano et al., 1999). Likewise, p63 was shown to be overexpressed in human tumors 
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such as head and neck squamous cell carcinoma (Sniezek et al., 2004; Weber et al., 2002), 
lung cancer (Massion et al., 2003), cervical carcinoma (Wang et al., 2001), lymphoma 
(Pruneri et al., 2005) and bladder carcinoma (Park et al., 2000). But also loss of p63 
expression was detected in bladder cancer (Koga et al., 2003; Urist et al., 2002). These 
findings suggest that p63 and p73 definitively play a role in cancer development and 
progression. However, it is controversially discussed if p63 and p73 can be denoted tumor 
suppressors (Davis and Dowdy, 2001; Deyoung and Ellisen, 2007; Flores et al., 2005; 
Kaelin, 1999; Melino et al., 2002; Pietsch et al., 2008; Rosenbluth and Pietenpol, 2008). 
 
 
 
1.2.1 p53 
 
p53 was discovered as a protein, which binds to the oncogenic T antigen from the SV40 
virus (DeLeo et al., 1979; Kress et al., 1979; Lane and Crawford, 1979; Linzer and Levine, 
1979; Melero et al., 1979). It is one of the most important tumor suppressor proteins. The 
p53 gene is mutated or inactivated in over 50 % of human cancers (Hollstein et al., 1996; 
Hollstein et al., 1991; Joerger and Fersht, 2007; Olivier et al., 2002). p53 mutant protein often 
accumulates in tumor cells, since mutant p53 is not able to induce the expression of its 
negative regulator Mdm2 (see chapter 1.2.1.2) (Midgley and Lane, 1997). Moreover, 
heterotetramerization of wildtype and mutant p53 leads to dominant-negative activities of 
mutant p53 protein because the wildtype p53 protein is inhibited and not able to activate 
transcription of target genes (de Vries et al., 2002; Harms and Chen, 2006; Ko and Prives, 
1996). Germ-line mutations of one allele of p53 occur in the Li-Fraumeni syndrome, a 
disorder where affected persons are highly tumor-prone (Li and Fraumeni, 1969; Li et al., 
1988; Malkin, 1993; Srivastava et al., 1990). Furthermore, mice deficient for p53 (p53 -/-) 
show also a very high risk to develop spontaneous tumors (Donehower et al., 1995; 
Donehower et al., 1992).  
p53 is a transcription factor that regulates the expression of genes which play a role in 
apoptosis, cell cycle arrest and senescence, thereby preventing the division of cells 
containing damaged DNA and thus cancer formation. Under normal conditions p53 is present 
at a very low level within a cell but after cellular stress, like DNA damage, p53 becomes 
rapidly activated which leads to apoptosis, senescence or cell cycle arrest (reviewed 
in(Boehme and Blattner, 2009; el-Deiry, 1998; Ko and Prives, 1996; Levine, 1997; Oren, 
1999; Prives and Hall, 1999; Vousden and Lu, 2002). Therefore, p53 is also called the 
„guardian of the genome” (Lane, 1992).  
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p53 is well established as a transcriptional activator, however it was shown that p53 is also 
able to suppress the transcription of particular genes (reviewed in(el-Deiry, 1998; Laptenko 
and Prives, 2006). Furthermore, p53 is not only involved in central mechanisms as apoptosis 
and cell cycle arrest that are important to preserve the genomic integrity. It coordinates 
several other processes which are also important for the p53 stress response and contribute 
to cancer formation and progression as angiogenesis (Menendez et al., 2006; Teodoro et al., 
2006), metabolism (Green and Chipuk, 2006; Matoba et al., 2006) or immune response 
(Taura et al., 2008).  
 
 
1.2.1.1 Structure and isoforms of the p53 protein 
 
The human, mouse and zebrafish p53 gene is composed of 11 exons and gives rise to a 
protein of 393, 387 and 373 amino acids, respectively, with a modular structure. The N-
terminal transactivation domain (TAD) of the p53 protein is separated from the central DNA-
binding domain (DBD) by a proline-rich domain (PR). The DBD is followed by a nuclear 
localization signal (NLS) and by a C-terminal oligomerization/tetramerization domain (OD, 
TET), a nuclear export signal (NES) and by a basic regulatory domain (REG) (Figure 7) 
(Boehme and Blattner, 2009). These different domains exhibit distinct functions. The N-
terminal TAD (activation domain 1, AD1) activates transcription after binding of p53 to a 
specific promoter and associates with the acetylase and co-activator p300/CBP, factors of 
the basal transcriptional machinery, Mdm2 (see chapter 1.2.1.2), Mdm2-homologue 
MdmX/Mdm4 and many others. Acetylation of lysines in the C-terminus of p53 by p300/CBP 
leads to a stronger binding of p53 with the DNA binding domain to promoters of target genes 
thereby increasing the proapoptotic activity (Boehme and Blattner, 2009; Knights et al., 
2006). The PR contains a weak second transactivation domain AD2 (activation domain 2), 
which is a weaker transcriptional activator for p53 target genes than AD1. AD1 seems to be 
important for transactivation and cell cycle arrest, whereas AD2 seems to be necessary for 
p53-dependent apoptosis. The PR itself is required for induction of apoptosis, accounts for 
growth suppression and plays a role as a protein binding site (Candau et al., 1997; Harms 
and Chen, 2005, 2006; Lin et al., 1994; Sakamuro et al., 1997; Scoumanne et al., 2005; 
Venot et al., 1998; Venot et al., 1999; Walker and Levine, 1996; Zhu et al., 1998b). As a 
sequence-specific transcription factor p53 binds to specific p53 responsive elements via its 
DBD. The central DBD is highly conserved among different species and most of the 
mutations of the p53 gene in cancer are missense mutations occurring in the DBD (Harms 
and Chen, 2006; Scoumanne et al., 2005). Due to the NLS and NES p53 is able to shuttle 
between the nucleus and the cytoplasm (Harms and Chen, 2006; O'Keefe et al., 2003; 
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Scoumanne et al., 2005). p53 binds to the DNA as a homotetramer, which is crucial for the 
function of p53. This oligomerization is mediated through the OD or TET (reviewed in(Chene, 
2001). The REG is supposed to be an important regulatory domain affecting p53 activities 
both negatively and positively. It is subjected to various posttranslational modifications and 
interacts with several other proteins (Harms and Chen, 2005, 2006; Scoumanne et al., 2005). 
 
 
 
Figure 7: Schematic drawing of the human p53 protein. 
The p53 protein has a modular structure and consists of several functional domains, namely a N-
terminal transactivation domain (TAD), a proline-rich domain (PR), a central DNA-binding domain 
(DBD), a nuclear localization signal (NLS), a C-terminal oligomerization/tetramerization domain 
(OD/TET), a nuclear export signal (NES) and a regulatory domain (REG). The numbers indicate the 
amino acid residues. 
 
 
Due to alternative splicing, alternative translation initiation sites and usage of distinct 
promoters, at least 9 different isoforms of the human p53 protein could be identified. The N-
terminal isoform ∆40p53 (also called ∆Np53) is produced by either alternative splicing of 
intron 2 or by alternative initiation of translation. There are two other N-terminal isoforms, 
∆133p53, which is generated by an alternative promoter located in intron 4 and usage of 
AUG 133, and the full-length p53 protein (TAp53). Alternative splicing of exon 9 results in the 
β and γ isoforms, where the ODs are replaced by 10 and 15 additional residues, respectively. 
Combination of the three N- and three C-terminal isoforms leads to 9 different p53 isoforms 
in all (TAp53α (full-length p53), TAp53β, TAp53γ, ∆40p53α, ∆40p53β, ∆40p53γ, ∆133p53α, 
∆133p53β and ∆133p53γ). Recent findings suggest the existence of a 10th p53 isoform 
which is called ∆p53. This isoform is generated by a noncanonical splicing between exon 7 
and 9, which leads to the deletion of 198 nucleotides being part of the DBD and NLS. There 
was also an additional ∆N isoform identified, ∆160p53. This isoform is generated by using 
the internal promoter in intron 4 and AUG 160.  
TA-isoforms contain the entire TAD and α-isoforms posses the longest C-terminal domain. 
∆40p53 isoforms lack the first TAD and ∆133p53 and ∆160p53 lack the entire TAD and part 
of the DBD. β and γ isoforms lack the OD (Figure 8) (Bourdon et al., 2005; Courtois et al., 
2002; Flaman et al., 1996; Ghosh et al., 2004; Khoury and Bourdon, 2010; Marcel et al., 
2011; Marcel et al., 2010; Rohaly et al., 2005; Yin et al., 2002). The different isoforms have 
distinct functions and the ∆N isoforms can act in a dominant negative manner towards full-
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length isoforms (De Laurenzi and Melino, 2000; Pietsch et al., 2008). Furthermore, the ∆N 
isoforms support proliferation whereas the TA isoforms promote apoptosis, senescence and 
cell cycle arrest (Dotsch et al., 2010). Thus, the different isoforms can have distinct activities 
in which TA isoforms act as tumor suppressors and ∆N isoforms act as oncogenes (Stiewe 
and Putzer, 2002; Stiewe et al., 2002). Therefore, the balance of the different isoforms within 
a cell may determine the fate of this cell (Dotsch et al., 2010). 
Besides the full-length zebrafish p53 protein, only the N-terminally truncated isoforms 
∆113p53, which is a homologue to human ∆133p53, and ∆Np53, which is a homologue to 
human ∆40p53, could be identified in zebrafish until now (Figure 8) (Chen et al., 2005; 
Davidson et al., 2010; Marcel et al., 2011). 
 
 
 
 
Figure 8: Schematic drawing of human and zebrafish p53 protein isoforms. 
(A) Structure of the human p53 gene consisting of 11 exons. Several p53 isoforms are expressed due 
to alternative splicing and the usage of alternative translation initiation sites and promoters. (B) The 
different human p53 protein isoforms. (C) The different zebrafish p53 protein isoforms. For a detailed 
explanation of the characteristics of the different isoforms and how they are generated see text above. 
Modified from (Marcel et al., 2011). 
 
 
1.2.1.2 Regulation of p53 
 
Since p53 possesses an anti-proliferative capacity and is able to induce apoptosis, the 
activity of p53 has to be strictly regulated. p53 and its main regulator the RING-finger E3 
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ubiquitin ligase and oncoprotein mouse double minute-2 (Mdm2) are connected in an 
autoregulatory feedback loop (Wu et al., 1993). In normal, unstressed cells where p53 is not 
required, the p53 protein has a very short half-life (about 30 minutes) and the p53 level is 
kept low because p53 is rapidly degraded. Mdm2 binds to p53 at the N-terminal 
transactivation domain and inhibits the transcription of p53 target genes (Kussie et al., 1996; 
Momand et al., 1992). Furthermore, p53 becomes ubiquitinated by Mdm2 (Honda et al., 
1997) and a few other ubiquitin ligases as constitutively photomorphogenic 1 (COP1) 
(Dornan et al., 2004) and Pirh2 (Leng et al., 2003), which results in the degradation of the 
p53 protein by the 26S proteasome (Haupt et al., 1997; Kubbutat et al., 1997). However, 
after cellular stress, like DNA damage caused by ultraviolet (UV) or ionizing irradiation, 
hypoxia or oncogene activation, when the activity of p53 is needed, p53 and Mdm2 
dissociate. In addition p53 becomes also posttranslationally modified. Thus p53 is activated, 
rescued from degradation and is able to accumulate to high levels. Subsequently the 
transcription factor p53 can activate its target genes, which leads to cell cycle arrest (p21), 
apoptosis (Bcl-2-associated X protein (Bax), p53-up-regulated modulator of apoptosis 
(Puma) and noxA) or senescence (Figure 9). p53 is also capable of inducing DNA repair 
(Gatz and Wiesmuller, 2006; Helton and Chen, 2007). After damage cell cycle arrest allows a 
cell to repair the caused damage and if the damage is too severe apoptosis is induced. 
Moreover, p53 additionally induces the transcription of its own negative regulator Mdm2 
(Barak et al., 1993; Juven et al., 1993). Therefore, Mdm2 facilitates the degradation of p53 
whereas p53 induces the transcription of its target gene and negative regulator Mdm2 (Barak 
et al., 1993; Bond et al., 2005; Haupt et al., 1997; Honda et al., 1997; Juven et al., 1993; 
Kubbutat et al., 1997; Kussie et al., 1996); reviewed in(Boehme and Blattner, 2009). The 
importance of Mdm2 as negative regulator of p53 is demonstrated by the fact that Mdm2 
knock-out mice show early embryonal lethality because of p53-mediated apoptosis. When 
p53 is inactivated simultaneously this lethal phenotype is rescued and the embryos develop 
normal (Jones et al., 1995; Montes de Oca Luna et al., 1995). Furthermore, it was shown 
that p53 residing in the cytoplasm is able to induce apoptosis transcription-independently as 
well by interacting with Bcl-2 family proteins located at the membranes of mitochondria 
(Galluzzi et al., 2008). 
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Figure 9: The p53-Mdm2 autoregulatory feedback loop. 
Under normal conditions p53 becomes ubiquitinated by Mdm2, which targets p53 for degradation. 
After cellular stress p53 becomes activated, accumulates and is able to activate target genes, which 
leads to the induction of cell cycle arrest (p21) or apoptosis (noxA, Bax, Puma). p53 also induces its 
own negative regulator Mdm2. Modified from (Marine and Lozano, 2010).  
 
 
Not only the stability and therefore the amount of the p53 protein is regulated but also the 
activity of p53 molecules present in a cell. This regulation is achieved by interaction of p53 
with other proteins and by post-translational modifications, like phosphorylation, methylation, 
ribosylation and acetylation. The best-studied post-translational modification of p53 is 
phosphorylation and besides few sites that are phosphorylated in resting cells, most of 
phosphorylation occurs after cellular stress, mainly on serines and threonines. 
Phosphorylation of p53 after ionizing or UV irradiation is mediated by several kinases, as 
Ataxia telangiectasia mutated (ATM), Ataxia telangiectasia and Rad3-related protein (ATR), 
mitogen-activated protein (MAP)-kinases and checkpoint kinase 2 (Chk2) for example. Which 
kinases phosphorylate p53 on distinct residues depends on the sort of stimulation of p53 and 
leads to different responses. Furthermore it was demonstrated that acetylation of lysines has 
major influence on p53 activity and that acetylation is increased as well after cellular stress. 
Most acetylations are necessary for induction of pro-apoptotic genes and are performed by 
p300/CBP.  
The majority of proteins that interact with p53 bind to the N-terminal transactivation or the 
DNA binding domain, thereby modulating the transcriptional activity of p53. Proteins binding 
to the DBD either inhibit or promote p53 activity (reviewed in(Boehme and Blattner, 2009; 
Pietsch et al., 2008).  However, IASSP binds to the proline-rich domain of p53 as an inhibitor. 
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Furthermore, Mdm2 heterodimerizes with its homologue MdmX (Mdm4), which results in a 
better ubiquitin ligase for p53 than Mdm2 homodimers. Additionally, MdmX binds to the N-
terminus of p53 and antagonizes transactivation, like Mdm2 (Kawai et al., 2007; Linares et 
al., 2003; Marine et al., 2006; Okamoto et al., 2009). In contrast, it was shown that binding of 
MdmX stabilizes p53 because Mdm2-mediated degradation is delayed (Jackson and 
Berberich, 2000; Sharp et al., 1999). 
Another means to regulate p53 is to interact with Mdm2. p14ARF (p19ARF in mouse) binds 
to Mdm2 which inhibits ubiquitination of p53 by Mdm2 (Honda and Yasuda, 1999; Midgley et 
al., 2000; Pomerantz et al., 1998). It was also suggested, that in unstressed cells p53 protein 
is able to negatively regulate the translation of p53 mRNA by binding to the 5´UTR (Mosner 
et al., 1995).  
 
 
1.2.1.3 p53 in zebrafish (Danio rerio) 
 
Zebrafish p53 is 48% identical to human p53 (Cheng et al., 1997) and it is also negatively 
regulated by Mdm2 (Thisse et al., 2000). Furthermore, p21 is a target gene of p53 in 
zebrafish as well (Langheinrich et al., 2002). Zebrafish p53 exhibits the same anti-
proliferative and pro-apoptotic functions like human p53 after cellular stress (Storer and Zon, 
2010). Therefore, p53 plays an important role in induction of apoptosis in zebrafish, like in 
mammals and other model organisms (Langheinrich et al., 2002; Storer and Zon, 2010). 
p53 is mostly present in zygotes and early embryos. In the early zebrafish embryo p53 is 
ubiquitously expressed (Thisse et al., 2000). At 1 hour post fertilization (hpf) p53 expression 
starts to decrease, at 24-48 hpf (pharyngula stage) p53 is predominantly expressed in the 
head region and it is barely detectable at 48 hpf (Cheng et al., 1997; Thisse et al., 2000). As 
observed in mice, enhanced expression of p53 in zebrafish embryos caused by knock-down 
of Mdm2 via morpholinos, results in severe developmental defects. These defects can be 
rescued by co-injection of p53-specific morpholinos (Langheinrich et al., 2002). 
The expression of p53 in older zebrafish embryos can be induced by cellular stress and p53-
activating chemicals. It is enhanced following treatment with R-roscovitine, a cyclin-
dependent kinase inhibitor that downregulates Mdm2 expression thereby activating p53 
(Kotala et al., 2001; Lu et al., 2001), or ionizing irradiation, for instance. At 2 days post 
fertilization (dpf) the expression of p53 can be induced in several tissues of the zebrafish 
embryo. Whereas at 5 dpf a much more restricted expression of p53 can be observed. The 
induction of p53 in zebrafish embryos depends on the inducing signal and is tissue-specific 
and p53 seems to be regulated in a temporal- and spatial-specific manner. Furthermore, also 
p53 target genes, like p21 or Mdm2, are up-regulated following treatment of embryos with 
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p53-activating agents. In contrast to mammals where p53 protein but not mRNA levels 
increase rapidly after DNA damage due to post-translational modifications, the p53 mRNA is 
up-regulated as well after DNA damage in zebrafish. This suggests that there are other 
mechanisms additional to posttranslational modifications in zebrafish that may regulate the 
activity of p53 after cellular stress (Lee et al., 2008). Furthermore, translational control of 
zebrafish p53 was also reported. It was shown by(Zhao et al.)that zebrafish p53 protein is 
able to bind to the 3´UTR of endogenous p53 mRNA in zebrafish embryos, which enhances 
the translational efficiency of p53 mRNA following treatment with camptothecin, an anti-
cancer compound that inhibits topoisomerase I (Langheinrich et al., 2002), or irradiation with 
UV. This results in delayed development of these zebrafish embryos (Zhao et al., 2012). The 
most prominent consequence of p53 up-regulation during zebrafish development is neural 
apoptosis (Langheinrich et al., 2002; Robu et al., 2007). 
(Berghmans et al.)demonstrated that zebrafish containing a point mutation in the DNA binding 
domain of p53 (tp53M214K) at a site, which is often mutated in human tumors, develop 
normally but the embryos do not induce expression of target genes or apoptosis after 
irradiation since the transcriptional activity of p53 is inactivated. As knock-down of p53 by 
morpholinos does also not lead to developmental defects p53 seems to be dispensable for 
early zebrafish development (Langheinrich et al., 2002). Like p53-deficient mice, tp53M214K 
mutant zebrafish are also tumor-prone and they start to develop malignant peripheral nerve 
sheath tumors (MPNSTs) at the age of 8.5 months (Berghmans et al., 2005). Moreover it 
was shown, that very high levels of mutant p53 protein persisted in tp53M214K mutant 
zebrafish embryos after irradiation, because mutant p53 is not able to induce its negative 
regulator Mdm2 and it accumulates until it is degraded by other processes. Additionally, 
mutant p53 protein accumulated in spontaneous tumors of adult tp53M214K mutant zebrafish 
(Guo et al., 2013).  
As already mentioned above (see chapter 1.2.1.1), two isoforms of the p53 protein could be 
identified in zebrafish, ∆113p53 and ∆Np53 (Chen et al., 2005; Davidson et al., 2010; Marcel 
et al., 2011). It was demonstrated that the expression of ∆113p53 is regulated by digestive-
organ expansion factor (def) (Chen et al., 2005; Tao et al., 2013). ∆113p53 regulates the 
activity of p53 both during development and after cellular stress. It was shown that the 
induction of ∆113p53 after genotoxic stress in zebrafish embryos is dependent on full-length 
p53 protein and that the apoptotic activity of p53 is antagonized by ∆113p53 by up-regulating 
expression of anti-apoptotic genes like Bcl-2L. Protein-protein interaction between full-length 
p53 and ∆113p53 is required for the anti-apoptotic function of ∆113p53 (Ou et al., 2014). It 
could be speculated that the function of the ∆113p53 isoform is protection of zebrafish 
embryos against environmental stress conditions by inhibition of p53-dependent apoptosis 
(Chen et al., 2009; Chen and Peng, 2009).(Guo et al.)demonstrated that the induction of 
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p53-dependent transcription of target genes, like Mdm2, Puma and p21, is reduced by 
expression of ∆113p53. This indicates a novel feedback loop where ∆113p53 is induced by 
full-length p53 in response to DNA-damaging or developmental signals and regulates the 
p53 response by activating anti-apoptotic genes (Chen et al., 2009; Guo et al., 2010). 
Furthermore, the ∆Np53 isoform is also induced by ionizing irradiation in zebrafish embryos 
and counteracts the lethal effects of full-length p53. Contrary to the ∆113p53 isoform, 
overexpression of ∆Np53 leads to developmental defects of zebrafish embryos due to full-
length p53-dependent activation of p21 (Davidson et al., 2010).  
Moreover, zebrafish models for neurodegenerative diseases exist showing that p53 plays a 
role in these processes. DJ-1, which is one of the genes involved in Parkinson´s disease 
(Abeliovich and Flint Beal, 2006), protects neurons against oxidative stress (Kim et al., 2005; 
Taira et al., 2004; Yang et al., 2005). In zebrafish, loss of DJ-1 expression results in 
enhanced susceptibility of dopaminergic neurons to H2O2 (hydrogen peroxide). This leads to 
death of neurons caused by increased apoptotic activity of p53 and Bax (Bretaud et al., 
2007). p53-dependent apoptosis plays a role in a zebrafish model of Alzheimer´s disease as 
well, where presenilin enhancer (Pen-2) is necessary to control neuronal cell survival and 
protection from apoptosis (Campbell et al., 2006). Furthermore, a zebrafish model for the Li-
Fraumeni syndrome does also exist (Parant et al., 2010). 
 
 
1.2.1.4 p53 in the developing mammalian nervous system 
 
p53 is expressed in proliferative regions, like the SVZ and SGZ of the DG, the RMS and the 
cells of the external granular layer of the cerebellum, during embryonic and postnatal 
development of rodents (Jori et al., 2003; van Lookeren Campagne and Gill, 1998). 
Additionally to the proliferative regions, p53 is also expressed in post-mitotic neurons of the 
cerebral cortex and the hippocampus in the developing brain. During postnatal development 
the amount of p53 protein decreases in the brain (Medrano and Scrable, 2005; van Lookeren 
Campagne and Gill, 1998).(Forsberg et al.)showed in vivo that p53 is highly expressed in the 
embryonic telencephalon during neurogenesis and after this period p53 is present to a lesser 
extent. The expression of p53 persists in proliferating neuronal precursor cells of the adult 
SVZ (van Lookeren Campagne and Gill, 1998).  
As already mentioned above (see chapter 1.2.1), some female p53-deficient mice show 
developmental defects like exencephaly, which results from a lack of apoptosis of progenitor 
cells (Jacobs et al., 2006; Jacobs et al., 2004). Therefore, p53 seems to be important for a 
normal neuronal development (Frenkel et al., 1999; Tedeschi and Di Giovanni, 2009). During 
development of the nervous system there are two phases where apoptosis occurs and is 
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essential for the correct development of the nervous system. The first phase takes place just 
before the onset of neurogenesis to eliminate progenitors that have not differentiated 
properly and to guarantee the generation of the correct number of cells in the distinct 
structures like the cerebral cortex (Blaschke et al., 1996; Jacobs et al., 2004; Miller et al., 
2000). It was suggested that p53, probably together with full-length p63 and/or p73 isoforms, 
is important for elimination of neural progenitors and new-born neurons that did not 
differentiate properly (Jacobs et al., 2006; Jacobs et al., 2004; Miller et al., 2000). The 
second period of naturally occurring neuronal death occurs primarily during the first 2 weeks 
after birth and it was suggested that p53 plays a pro-apoptotic role in sympathetic neurons 
during development (Jacobs et al., 2006; Jacobs et al., 2004; Murase et al., 2011). During 
this second period of neuronal death differentiated neurons migrate to their target location 
and compete for nerve growth factor (NGF) and other trophic factors. Neurons that do not 
obtain enough trophic factors undergo apoptosis (Jacobs et al., 2006; Jacobs et al., 2004). 
By apoptosis of up to one-half of the present neurons, the number of neurons is matched to 
the size of the target tissue (Jacobs et al., 2004; Oppenheim, 1991). The neurons, that 
survive this neuronal death period during development, become comparatively invulnerable 
to injury leading to a long-term survival (Jacobs et al., 2006; Jacobs et al., 2004). In contrast 
to numerous observations, where p53 is important for developmental neuronal death,(D'Sa-
Eipper et al.)claim, that p53 is not crucial for apoptosis of neural progenitor cells during 
development.  
It has been hypothesized that p53 plays a role in cell fate decisions and differentiation during 
development of the nervous system but this role is controversial. It was reported, that p53 
mRNA is increased during differentiation of early neuronal precursor cells in the brain and it 
decreases during terminal differentiation (Rogel et al., 1985; Schmid et al., 1991; Tedeschi 
and Di Giovanni, 2009). Accordingly, it was illustrated by(Ferreira and Kosik)that p53 is 
expressed in fetal proliferating cerebellar neuroblasts and when the migrating neurons reach 
their final location p53 becomes down-regulated during terminal differentiation. Loss of p53 
results in an accelerated terminal differentiation of the neurons, which suggests that p53 
probably inhibits neuronal differentiation (Ferreira and Kosik, 1996).(Liu et al.)showed in vitro 
and in vivo that there is a high level of p53 expression during neuronal differentiation and p53 
most likely prevents proliferation and neural differentiation of NSCs but it positively regulates 
gliogenesis. The BMP-Smad1 pathway and inhibitor of DNA binding 1 (Id1), which is a target 
gene of this pathway, seem to play a role in this process. p53 is able to repress the 
expression of Smad1 and also Id1 and p53 deficiency leads to an enhanced expression of 
Smad1 and Id1, which results in increased proliferation and neuronal differentiation of NSCs 
but less gliogenesis (Liu et al., 2013). In contrast to other observations, where Id1 reacts as a 
negative regulator of neural differentiation of NSCs (Miyazono and Miyazawa, 2002), 
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enhanced expression of Id1 results in increased neuronal differentiation of NSCs deficient for 
p53 (Liu et al., 2013). However, another in vitro study demonstrated that the level of 
expression of p53 is not changed during differentiation of NSCs but the activity of p53 is 
increased. p53 might be necessary for early neuronal differentiation via suppression of 
Forkhead box O3a (FOXO3A )/Id1 signaling since knock-down of p53 delays neuronal 
differentiation, which is in contrast to other observations where p53 suppresses 
differentiation (Aranha et al., 2009). 
Furthermore, p53 plays a role in the development of oligodendrocytes and the differentiation 
of OPCs since the number of oligodendrocytes is decreased and the number of OPCs is 
increased in optic nerves of p53-deficient mice (Billon et al., 2004). Moreover, it was shown 
that opposite actions of the p19ARF (p14ARF in humans)-p53 and Myc pathway are 
necessary to regulate self-renewal, proliferation and cell fate choices of neural stem cells 
during development (Nagao et al., 2008). Additionally, it was demonstrated by(Armesilla-Diaz 
et al.)that p53 is important for differentiation and proliferation of stem cells in the olfactory 
bulb of mouse embryos in vitro. Stem cells lacking p53 show an increased proliferation and 
tend to produce more neurons than wildtype cells at the expense of astrocytes (Armesilla-
Diaz et al., 2009). Thus, p53 seems to play a role in the differentiation of progenitor cells in 
which it is able to both inhibit and permit differentiation in distinct situations.  
 
 
1.2.1.5 p53 in the adult mammalian nervous system 
 
In the adult mammalian brain the tumor suppressor p53 is expressed in SVZ cells (Jori et al., 
2003; van Lookeren Campagne and Gill, 1998) and it is also highly expressed in the RMS 
and the DG (Medrano and Scrable, 2005). Furthermore, the expression of p53 can be 
observed in few glial cells in the parenchyma (Martin et al., 2001) and in Purkinje cells of the 
cerebellum (Wood and Youle, 1995). It was shown that p53 expression in the adult 
cerebellum is essential for rapid walking synchronization (Campana et al., 2003).(Meletis et 
al.)detected p53 mRNA expression in ependymal cells, which line the ventricle, in astrocytes 
and in progenitor cells. Differentiating neuroblasts in the RMS show a weak p53 expression. 
Therefore, p53 shows a higher expression in the neural stem cell lineage compared to other 
cells and it is especially expressed in stem and progenitor cells (Meletis et al., 2006). Under 
normal conditions the amount of p53 mRNA in the SVZ is very low but it increases after 
irradiation, particularly along the lateral walls of the ventricles (Gil-Perotin et al., 2006).  
In the adult brain p53 plays a critical role in regulating the number of cells in the SVZ 
because it modulates self-renewal, differentiation and proliferation of these cells (Gil-Perotin 
et al., 2006). It was shown in vitro and in vivo, that proliferation of brain stem cells is highly 
Introduction 
32 
 
 
increased in p53-deficient mice. This enhanced proliferation leads to regions of hyperplasia 
in the subventricular zone of the brain since the number of neuroblasts (A cells) and adult 
neural stem cells (B cells) (see chapter 1.1.1.1) is increased by loss of the anti-proliferative 
p53 protein (Gil-Perotin et al., 2006). Due to the rapid differentiation of these SVZ cells the 
number of new oligodendrocytes and neurons is enhanced by loss of p53 (Gil-Perotin et al., 
2006; Li et al., 2008). 
(Meletis et al.)demonstrated in vitro and in vivo that p53 negatively regulates self-renewal, 
that means survival and proliferation, of adult neural stem cells but it does not influence their 
differentiation. However, a role for p53 in neural cell differentiation in vitro has been proposed 
by(Jori et al.)and also(Gil-Perotin et al.)could observe an increased differentiation without 
p53. Furthermore, it was shown by(Meletis et al.)that there are more proliferating cells 
detectable in p53 knock-out mice in comparison to wildtype mice, as observed by(Gil-Perotin 
et al.)It was suggested that it could be crucial to suppress self-renewal of stem cells by p53 
for long-term maintenance of the stem cell population since enhanced proliferation could lead 
to premature senescence (Meletis et al., 2006). Moreover, it was hypothesized, that p53 
prevents post-mitotic neurons to re-enter the cell cycle, at least in vitro, thereby preserving 
the post-mitotic character of differentiated neurons (Miller et al., 2003).  
In a model of aging using mice that over-express ∆Np53 (also called ∆40p53 or p44) (Maier 
et al., 2004), these aged mice show a reduced number of NSCs in the SVZ and the number 
of neurons in the OB is decreased due to a reduced ability of NSCs to proliferate. Over-
expression of ∆Np53 results in a constitutive activation of p53 and subsequent expression of 
p21 in NSCs and thereby to a reduction in proliferation. Thus, p53 is important for 
maintaining neurogenesis of the adult brain because it controls the proliferation of progenitor 
and stem cells (Medrano et al., 2009). p53 seems to be crucial for the right balance between 
proliferation and quiescence of NSCs since loss of p53 leads to increased and over-
expression of p53 results in decreased proliferation. Furthermore it was shown that the level 
of p44 in the mouse brain increases with age and that p44 stimulates the phosphorylation of 
tau, that plays a role in Alzheimer´s disease, thereby leading to a modified tau metabolism 
which is symptomatic for aging (Pehar et al., 2013).  
Neuronal apoptosis does not only occur during development but also following excitotoxic, 
ischemic and traumatic injury of the nervous system or neurodegenerative conditions 
(Beattie et al., 2000; Bengzon et al., 2002; Graham and Chen, 2001; Wood and Youle, 1995; 
Yuan et al., 2003). p53 is up-regulated and crucial for the induction of apoptosis after injury 
of the mature nervous system and over-expression of p53 in cultured postmitotic neurons is 
sufficient to induce apoptosis (Slack et al., 1996). Therefore, p53 is an essential factor for 
neuronal death following distinct forms of acute damage, caused by treatment with ionizing 
irradiation, camptothecin, glutamate or kainate for example, or chronic neurodegenerative 
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diseases (Culmsee and Mattson, 2005; Miller et al., 2000; Morrison and Kinoshita, 2000; 
Morrison et al., 2003; Napieralski et al., 1999; Xiang et al., 1998; Yonekura et al., 2006). p53 
is constitutively expressed at low levels in neurons but it becomes up-regulated in injured 
adult neuronal cells by DNA damage, for instance. It is predominantly located in the nucleus 
in injured cells in contrast to uninjured cells where it shows a weak cytoplasmic staining 
(Inamura et al., 2001; Plesnila et al., 2007). Neuronal injury leads to the production of 
reactive oxygen species (ROS) which causes accumulation of DNA strand breaks that 
activate p53 by phosphorylation by ATM and Chk2 kinase, for example. A severe damage 
leads to the induction of apoptosis by the mitochondrial/intrinsic pathway. p53 induces Puma, 
which interacts both with anti-apoptotic proteins like Bcl-2 or Bcl-XL and with pro-apoptotic 
proteins like Bax. Bax translocates to the mitochondria which leads to release of cytochrome 
c from the mitochondria and activation of caspases. The mitochondrial pathway also 
functions in developing neurons and p53 induces apoptosis after damage of neurons during 
development as well (Cregan et al., 1999; Culmsee and Mattson, 2005; D'Sa et al., 2003; 
Jacobs et al., 2006; Jacobs et al., 2004; Johnson et al., 1998; Martin et al., 2001; Morris et 
al., 2001; Morrison and Kinoshita, 2000; Niizuma et al., 2009; Xiang et al., 1998). Moreover, 
apoptosis inducing factor (AIF) can be released from the mitochondria triggered by p53, 
translocate to the nucleus, degrade DNA and induce cell death independent of caspases 
(Cregan et al., 2002). p53 is also able to induce apoptosis of neural progenitors via the 
extrinsic apoptotic pathway. It was shown in vitro that Fas/CD95, a death receptor, plays a 
p53-dependent role in the response after exposure of neural progenitors to γ-irradiation 
(Semont et al., 2004). p53 is also capable of inducing apoptosis of neurons transcription-
independently after ischemia via translocation to the mitochondria where it interacts with Bcl-
XL followed by release of cytochrome c in vivo (Endo et al., 2006).(Geng et al.)showed in 
vitro that cytoplasmic p53 can trigger apoptosis of neural precursor cells transcription-
independently by interacting with Bax. Furthermore(Martin et al.)demonstrated in vitro, that 
differentiated neurons are less sensitive to DNA damaging agents than immature neurons. 
The kind of stress stimulus determines which stress signaling pathway is activated after 
neuronal damage and finally p53-mediated apoptosis is induced (Akhtar et al., 2006). Loss of 
p53 protects neurons from cell death after induced damage also in vivo (Culmsee and 
Mattson, 2005; Martin et al., 2001). Furthermore, ∆Np73 and perhaps ∆Np63 take care that 
apoptosis is only induced if the damage of the adult neuron is severe (Jacobs et al., 2004).  
Moreover, p53-mediated neuronal death may also play a role in neurodegenerative disorders 
like Alzheimer´s disease (AD), Parkinson´s disease (PD), amyotrophic lateral sclerosis (ALS) 
and Huntington´s disease (Bae et al., 2005; Culmsee and Mattson, 2005; de la Monte et al., 
1997; Eve et al., 2007; Jacobs et al., 2006; Martin, 2000; Mogi et al., 2007; Nair et al., 2006; 
Yuan and Yankner, 2000). In contrast to these observations,(Tomasevic et al.)claim, that p53 
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is in fact activated after neuronal injury but it may not be responsible for the death of neurons 
in vivo and it was shown by(Maeda et al.)that p53-deficiency worsens brain injury after 
ischemia in vivo. In addition, p53 appears to play a role in apoptosis of glial cells caused by 
oxidative stress in vitro as well (Bonini et al., 2004; Kitamura et al., 1999).  
Mutations of p53 often occur in brain tumors and they lead to tumor development and growth 
(Sidransky et al., 1992). Furthermore, it was shown that p53 is often mutated or deleted in 
glial tumors (Hayashi et al., 2004; Sung et al., 2000; von Deimling et al., 1992; Watanabe et 
al., 1996). However, loss of p53 is not sufficient for the development of spontaneous glial 
tumors (Donehower et al., 1992; Philipp-Staheli et al., 2004). But as it leads to areas of 
hyperplasia due to a proliferative advantage of slow- and fast-proliferating SVZ cells followed 
by their rapid differentiation, an additional mutagenic stimulus could then lead to tumor 
development (Gil-Perotin et al., 2006).  
 
In summary, the transcription factor and tumor suppressor p53 is expressed in a similar 
pattern in the mammalian brain during development and in adulthood. Additionally, p53 is 
involved in similar cellular processes in the developing and in the adult central nervous 
system such as proliferation and differentiation of precursor cells and apoptotic death of 
neurons. 
 
 
1.2.1.6 p53 in the Medaka (Oryzias latipes) brain 
 
Like zebrafish (see chapter 1.1.2.1), medaka contain several proliferation zones in the adult 
brain (Kuroyanagi et al., 2010) and it was demonstrated that p53 is expressed in most of 
them (Isoe et al., 2012). In contrast to the observations that were made in the adult 
mammalian brain, where p53 suppresses proliferation of neural stem cells (see chapter 
1.2.1.5),(Isoe et al.)showed that a p53 null mutation (Taniguchi et al., 2006) does not 
increase but inhibit neurogenesis in the telencephalon of medaka. Two different mutants 
were used in this study, p53E241X and p53Y186X. Both mutations lead to a stop codon in the 
DNA binding domain that results in the expression of a truncated non-functional p53 protein 
(Taniguchi et al., 2006). Wildtype medaka exhibit a greater number of BrdU-positive, thus 
proliferating, progenitor cells that migrate from proliferation zones in the telencephalon than 
p53 mutant fish one week after BrdU administration. However, the number of BrdU-positive 
cells 4 hours after BrdU treatment was not affected by mutant p53. Thus, in contrast to stem 
cells in the adult mammalian brain, p53 deficiency does not affect highly proliferating stem 
cells in medaka probably because p63 and/or p73 could take over the functions of p53. 
Furthermore, the number of apoptotic cells is not different between wildtype and mutant 
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medaka which indicates that the discrepancy in proliferating progenitor cells one week after 
BrdU administration is not due to increased cell death but to repressed proliferation. 
Therefore, contrary to the mammalian brain, p53 seems to positively regulate neurogenesis 
in the medaka brain (Isoe et al., 2012). However, the positive role of p53 in regulating 
neurogenesis in medaka has to be further investigated.  
 
 
 
1.2.2 p63 
 
The transcription factor p63 has a crucial function during development and plays the most 
prominent role of the three members of the p53 family during development. p63-deficient 
mice show severe developmental defects. These mice are born without stratified epithelia 
(skin, urothelia, breast, prostate) and they also lack hair follicles, teeth, mammary, salivary 
and lachrymal glands. In addition their limbs are missing or the limbs are truncated due to a 
defective apical ectodermal ridge and they exhibit craniofacial malformations. p63-deficient 
mice normally die shortly after birth because of dehydration (Mills et al., 1999; Yang et al., 
1999). In humans germ-line mutations of p63 lead to the Ectrodactyly, ectodermal dysplasia, 
and cleft lip/palate syndrome (EEC syndrome) and nonsyndromic split hand-split foot 
malformation (SHFM) amongst others (Celli et al., 1999; Rinne et al., 2007; van Bokhoven et 
al., 2001). p63 may be necessary for ectodermal differentiation and/or maintenance of 
progenitor cells during development. However, it is not clear if p63 plays a role in both 
differentiation and stem cell self-renewal or just in one of these processes (Koster et al., 
2004; Mills et al., 1999; Su et al., 2009; Yang et al., 1999).  
Moreover, p63 is able to induce the expression of p53-responsive genes like p21, Mdm2, 
Bax, noxA and Puma and thus to cause cell cycle arrest and apoptosis. (De Laurenzi and 
Melino, 2000; Levrero et al., 2000; McKeon and Melino, 2007; Murray-Zmijewski et al., 2006; 
Pietsch et al., 2008). p63 is capable of inducing apoptosis via intrinsic or extrinsic apoptotic 
pathways (Candi et al., 2007; Gressner et al., 2005). Furthermore, the level of p63 protein 
also increases in vitro after treatment with DNA-damaging agents which is most likely due to 
post-translational modifications of p63 (Katoh et al., 2000; Okada et al., 2002). Notably it was 
demonstrated that p53 requires p63 or p73 to function properly after DNA damage and to 
induce several target genes associated with apoptosis like Bax or NoxA for example. 
Contrary, the induction of p21 or Mdm2 does not require the presence of p63 or p73 (Flores 
et al., 2002). Furthermore, p63 does not interact with Mdm2 as p53 (see chapter 1.2.1.2) but 
nevertheless it may be degraded by proteasomes in the absence of cellular stress (Okada et 
al., 2002). 
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1.2.2.1 Structure and isoforms of the p63 protein 
 
Human and mouse p63 consists of 14 and zebrafish p63 consists of 12 exons. It gives rise to 
a protein of 680 or 588 amino acids, respectively. The structure of p63 is very similar to that 
of p53 (see chapter 1.2.1.1). The p63 protein also contains a N-terminal TAD, several PRs 
that are scattered throughout the coding region (Irwin and Kaelin, 2001b), a central DBD and 
a C-terminal OD. However, unlike p53, p63 does not possess a basic REG but a sterile alpha 
motive (SAM) domain (Thanos and Bowie, 1999), which is a protein-protein interaction 
domain, and a transcription inhibition domain (TID), which inhibits the transcriptional activity 
of TAp63 by interacting with the TA domain (Serber et al., 2002), at the C-terminus (Benard 
et al., 2003; Bourdon, 2007; Danilova et al., 2008a; De Laurenzi and Melino, 2000; Levrero 
et al., 2000). p63 also contains a NLS and a NES (Harms and Chen, 2006). 
As it is the case for p53, there are also different p63 isoforms expressed caused by two 
different promoters and alternative splicing of the C-terminus. 6 distinct p63 isoforms could 
be identified, 3 isoforms that contain the TAD and 3 ∆N variants: TAp63α (full-length), 
TAp63β, TAp63γ, ∆Np63α, ∆Np63β, ∆Np63γ. The promoter upstream of exon one produces 
the TA isoforms containing the TAD. Whereas usage of an alternative promoter located in 
intron 3 leads to N-terminally truncated isoforms (∆Np63) lacking the TAD. Alternative 
splicing at the C-terminus results in 3 different splice variants. The α isoform contains the 
whole C-terminus including the SAM and TID whereas the β isoform lacks exon 13 and the γ 
isoform lacks exons 11 to 14 but contains an additional exon 15 (Figure 10) (Levrero et al., 
2000; Marcel et al., 2011; Murray-Zmijewski et al., 2006; Pietsch et al., 2008).  
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Figure 10: Schematic drawing of human p63 protein isoforms. 
(A) Structure of the human p63 gene consisting of 14 exons. Usage of an alternative promoter in 
intron 3 and alternative splicing at the C-terminus leads to the expression of 6 p63 isoforms. (B) The 6 
different human p63 protein isoforms are depicted. Numbers indicate the exons present in the 
corresponding isoforms. For a detailed explanation of the characteristics of the different isoforms and 
how they are generated see text. Modified from (Bourdon, 2007). 
 
 
The TAp63γ isoform, which lacks the SAM and TID, is most similar to p53 (Deyoung and 
Ellisen, 2007; Petitjean et al., 2008) and is a more potent transactivating isoform than 
TAp63α containing both domains (Danilova et al., 2008a; Serber et al., 2002). Furthermore, 
dominant-negative ∆Np63 isoforms do not contain the TAD but nevertheless they are able to 
transactivate target genes by using an alternative transactivation domain in their N-terminus 
including the PR (Dohn et al., 2001; Helton et al., 2006). ∆Np63α and ∆Np63β contain an 
additional proline-rich domain at the C-terminus that enhances the transcriptional activity of 
these isoforms (Candi et al., 2007; Ghioni et al., 2002; Helton et al., 2006). It has been 
shown that ∆Np63β possesses the strongest transcriptional activity of the ∆Np63 isoforms 
(Helton et al., 2006).(Liefer et al.)demonstrated that dominant-negative ∆Np63 isoforms are 
down-regulated and TAp63 isoforms increase after irradiation with UV light. Thus the ∆Np63 
isoforms are not able to inhibit the apoptotic function of p53. 
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Both TAp63 and ∆Np63 isoforms are necessary for a normal epidermal development 
(Danilova et al., 2008a; Koster et al., 2004). TAp63 isoforms are expressed earlier than 
∆Np63 isoforms but ∆Np63 isoforms are predominantly expressed during development 
(Candi et al., 2007; Koster et al., 2004; Mikkola, 2007). Moreover it was suggested that p63 
plays two distinct roles during development and in the mature epidermis. During 
development it induces epithelial stratification and in the mature epidermis p63 sustains 
proliferation of basal keratinocytes (Koster et al., 2004). Accordingly, p63 is highly expressed 
in proliferating basal cells of several epithelial structures and ∆Np63α is the major isoform 
expressed in the mature epidermis (Liefer et al., 2000; Yang et al., 1998). Though, TAp63 is 
critical for maintaining stem cells of the adult skin and preventing premature aging of tissues 
by regulation of genomic stability and cellular senescence. 
 
 
1.2.2.2 Regulation of p63 
 
Like p53 (see chapter 1.2.1.2), p63 is also regulated by ubiquitin ligases. The HECT E3 
ubiquitin ligase Itch binds to the p63 protein, ubiquitinates p63 and promotes its degradation 
by proteasomes. However until now any negative feedback-loop like between Mdm2 and p53 
has been identified for p63 and an E3 ubiquitin ligase (Rossi et al., 2006; Watson and Irwin, 
2006). Furthermore, p63 induces the expression of Mdm2 but Mdm2 does not target p63 for 
degradation by the proteasome as p53. Though, the effects of the interaction between Mdm2 
and p63 are controversial. It was demonstrated that Mdm2 binds to p63 thereby stabilizing 
p63 and enhancing its transactivation function (Calabro et al., 2002). However, it was also 
reported that Mdm2 does not interact with p63 (Okada et al., 2002), that overexpression of 
Mdm2 inhibits the transcriptional activity of p63 (Kadakia et al., 2001) or that there are no 
effects of Mdm2 on transcriptional activity and stability of p63 (Little and Jochemsen, 2001). 
As p53, p63 is regulated by post-translational modifications, like phosphorylation, as well 
(Danilova et al., 2008a; Okada et al., 2002; Petitjean et al., 2008). Moreover, Ankirin repeats, 
SH3 domain, proline-rich protein (ASPP1) and ASPP2 interact with p63 and enhance its 
apoptotic activity by promoting the induction of Bax and Puma by p63 (Bergamaschi et al., 
2004). Furthermore, ∆Np63 can be positively and negatively regulated by both p53 and 
∆Np63α itself, respectively (Harmes et al., 2003) or by TAp63γ (Li et al., 2006).(Ratovitski et 
al.)demonstrated that p53 binds to ∆Np63 and targets it for degradation by caspases. 
Additionally it was shown that the expression of dominant negative ∆Np73 is induced by 
TAp63 after genotoxic stress which could be a hint for a regulatory loop that controls the 
activity of p63 (Petitjean et al., 2008).  
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1.2.2.3 p63 in zebrafish (Danio rerio) 
 
During early development ∆Np63 is expressed in the somites, eyes, otic vesicle and 
epidermis. Later in development the expression of ∆Np63 is restricted to the eye epithelium 
and epidermis (Lee and Kimelman, 2002). ∆Np63α is the major isoform expressed during 
development and the expression of ∆Np63α in zebrafish is first detected during gastrulation. 
It is needed in non-neural ectoderm for ventral specification where it acts as a transcriptional 
repressor activated by BMP signaling to prevent neural specification. Later in development 
the expression of ∆Np63α can be detected in the epithelium where it is essential for the 
formation of fins and skin. It antagonizes p53 thereby stimulating the proliferation of 
epidermal cells but ∆Np63 seems to be dispensable for epidermal differentiation (Bakkers et 
al., 2002; Lee and Kimelman, 2002). p63-deficient zebrafish show similar developmental 
defects as mice since the fin and skin development is impaired (Lee and Kimelman, 2002). 
Over-expression of ∆Np63 promotes the overgrowth of fins and other non-neural structures 
and inhibits neural structures of zebrafish embryos (Bakkers et al., 2002). 
 
 
1.2.2.4 p63 in the mammalian nervous system 
 
During development p63 is expressed in Cajal-Retzius cells of the cerebral cortex and 
hippocampus and in some SVZ cells. In contrast to p53 the expression of p63 increases 
during development and in the adult brain it is almost ubiquitously expressed. In the adult 
brain expression of both ∆Np63 and TAp63 could be detected in the cortex, cerebellum, SVZ 
and olfactory bulb. p63 is also expressed in neurons and precursor cells of the hippocampus. 
In the adult cortex and hippocampus p63 is expressed in pyramidal neurons for example 
(Hernandez-Acosta et al., 2011; Jacobs et al., 2005). 
TAp63 is the main isoform expressed in the nervous system during development and the 
amount of TAp63 increases in sympathetic neurons during developmental neuronal cell 
death (Jacobs et al., 2005). Over-expression of TAp63 leads to neuronal apoptosis and 
apoptosis of sympathetic neurons was inhibited in vivo by p63 deficiency. TAp63 together 
with p53 and TAp73 may be crucial for elimination of newly born neurons and neural 
progenitors in the nervous system of embryos that failed to differentiate properly (Jacobs et 
al., 2006; Jacobs et al., 2004). Therefore, TAp63 is an important proapoptotic factor that 
induces death of sympathetic neurons during embryonal development (Jacobs et al., 2005). 
The survival of neurons during developmental cell death may depend on the balance 
between pro-survival (∆N) and pro-apoptotic (TA) isoforms of p53, p63 and p73 (Jacobs et 
al., 2004). Furthermore, Bax is necessary for TAp63, as for p53, to induce apoptosis of 
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sympathetic neurons (Jacobs et al., 2005). Additionally, it was shown that p53 requires 
TAp63 to induce neural apoptosis during the development of mouse embryos while TAp63 is 
able to induce apoptosis on its own (Jacobs et al., 2005). 
Furthermore it was demonstrated in vitro and in vivo that ∆Np63 is crucial for the survival of 
newly born neurons and precursor cells in the cerebral cortex of embryos since it 
antagonizes the pro-apoptotic functions of p53 and probably TAp63. It was suggested that 
∆Np63 stimulates survival by impeding the intrinsic cell death pathway (Dugani et al., 2009; 
Jacobs et al., 2005). In contrast to these observations, it was shown in vitro and in vivo using 
p63 knock-out mice by(Holembowski et al.)that p63 is of no importance for the correct 
development of the central nervous system and that it does not play a role in the 
maintenance or differentiation of embryonic neural stem and progenitor cells. This is in line 
with the observation that p63 knock-out mice do not show any obvious malformation of the 
brain (Hernandez-Acosta et al., 2011; Holembowski et al., 2011). It was suggested that p63 
may be more important in the adult brain. Likewise,(Cancino et al.)showed in vitro and in vivo 
that ∆Np63 promotes the survival of adult NPCs and adult newborn neurons in the olfactory 
bulb and in neurogenic regions of the lateral ventricles and hippocampus as well by inhibition 
of p53- and Puma-dependent apoptosis. Loss of ∆Np63 results in increased apoptosis of 
newborn neurons and NPCs. This leads to deficits in hippocampus-dependent memory 
formation (Cancino et al., 2013b). In a recent paper it was shown that both p63 and p73 play 
a role in maintaining NPCs in the adult brain by regulating p53. p63 supports NPC survival 
through antagonizing p53 and p73 controls the self-renewal of NPCs and decides if NPCs 
undergo apoptosis mediated by p53 or senescence. Thus both proteins are crucial for self-
renewal and long-term maintenance of NPCs in the adult forebrain and hippocampus (Fatt et 
al., 2014). In contrast to p53 and p73, p63 seems not to play a role in oligodendrocyte 
development (Billon et al., 2004).  
 
 
 
1.2.3 p73 
 
p73, the third member of the p53 family of transcription factors, is crucial for normal 
development. p73-deficient mice exhibit several defects like hydrocephalus, hippocampal 
dysgenesis, chronic infections and inflammation. In addition they also show problems in 
pheromone sensory pathways, and thus infertility due to abnormal mating. In contrast to p63-
deficient mice (see chapter 1.2.2), p73-deficient mice are more viable and do not die shortly 
after birth. Contrary to p53-deficient mice (see chapter 1.2.1), p73-deficient mice do not 
develop spontaneous tumors (Yang et al., 2000). Compared to p53 and p63, no human 
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disorder has been linked until now to a germ line mutation of the p73 gene (Danilova et al., 
2008a; Murray-Zmijewski et al., 2006). Moreover, it was demonstrated that in most human 
cell lines and tissues the expression level of p73 is very low. 
 
 
1.2.3.1 Structure and isoforms of the p73 protein 
 
The human, mouse and zebrafish p73 gene is composed of 14 exons, which give rise to a 
protein with 636, 631 and 640 amino acids, respectively. Like p53 (see chapter 1.2.1.1), the 
p73 protein contains a N-terminal TAD, a central DBD, a C-terminal OD, and like p63 (see 
chapter 1.2.2.1) several PRs (Irwin and Kaelin, 2001a, b), a SAM (Thanos and Bowie, 1999) 
and a TID (Chi et al., 1999; Danilova et al., 2008a; Kaghad et al., 1997; Murray-Zmijewski et 
al., 2006; Pietsch et al., 2008). p73 possesses also a NLS and a NES (Harms and Chen, 
2006; Inoue et al., 2002).  
There are 7 different C-terminal isoforms expressed due to alternative splicing of the C-
terminus: α, β, γ, δ, ε, ζ and η. Alternative splicing at the N-terminus and usage of different 
promoters leads to the expression of further isoforms. Transcription from the promoter 
upstream of exon 1 produces TAp73 isoforms containing the TAD. Whereas usage of an 
internal promoter located in intron 3 generates ∆Np73 isoforms lacking the TAD. Alternative 
splicing of exon 2 causes Ex2p73 isoforms, which lack a part of the TAD. Ex2/3p73 isoforms 
are generated by alternative splicing of exons 2 and 3. These isoforms lack the entire TAD. 
In addition, the ∆N`p73 isoform could be identified, at least at the mRNA level. The 
corresponding protein could either be a very short protein or an isoform identical to ∆Np73. 
The ∆N`p73 isoform is produced by alternative splicing of exon 3` contained in intron 3. It 
could be transcribed from promoter 1 until a stop codon in exon 3`. Thus it could produce a 
very short protein consisting only of the TAD. Or it could be translated from a third AUG 
present in exon 3` which leads to a p73 protein identical to the ∆Np73 isoform. In all, 29 
different p73 protein isoforms can be generated (Figure 11) (Bourdon, 2007; Murray-
Zmijewski et al., 2006; Pietsch et al., 2008). TAp73α resembles the full-length protein. β 
isoforms lack exon 13, γ isoforms lack exon 11 and in δ isoforms exons 11 to 13 are spliced 
out. Furthermore ε isoforms do not contain exons 11 and 13, ζ isoforms lack exons 11 and 
12 and η isoforms lack exon 14 (Bourdon, 2007; De Laurenzi et al., 1998; Levrero et al., 
2000; Melino et al., 2002). 
The TAp73 isoforms are able to activate the transcription of target genes to induce apoptosis 
and cell cycle arrest. Whereas the ∆Np73 isoforms are able to act in a dominant-negative 
and anti-apoptotic manner to p53, p63 and p73 (Murray-Zmijewski et al., 2006). However, 
since ∆Np73 isoforms contain an alternative TAD including the PR at their N-terminus they 
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are able to transactivate target genes, such as p21, and induce cell cycle arrest or apoptosis 
as well. They are also capable of activating genes that are not induced by TAp73 isoforms 
(Liu et al., 2004; Murray-Zmijewski et al., 2006). 
The distinct C-terminal isoforms differ in their ability to activate target genes (Grob et al., 
2001). The α C-terminal isoforms containing the SAM and TID are less potent to induce the 
transcription of target genes than other isoforms lacking the SAM and TID (Harms and Chen, 
2006; Liu et al., 2004). The SAM and TID block the interaction of p73 with p300/CBP thereby 
inhibiting the transcriptional activity of p73 (see chapter 1.2.3.2) (Liu and Chen, 2005). p73β 
isoforms show a strong transcriptional activity contrary to p73γ isoforms which are less 
efficient in transactivation (De Laurenzi et al., 1998). Moreover, the TAp73δ isoform is most 
similar to p53 (De Laurenzi et al., 1998; Levrero et al., 2000) and the Ex2p73 isoforms is only 
expressed in several types of tumors but not in normal tissues (Melino et al., 2002) . 
The knock-out of either the TA or ∆N isoforms of p73 causes different phenotypes compared 
to the simultaneous knock-out of all isoforms described above (see chapter 1.2.3). It was 
shown that TAp73-null mice are tumor-prone and infertile due to defective oocytes (Tomasini 
et al., 2008). Additionally, they exhibit characteristics of premature aging caused by 
mitochondrial dysfunction (Rufini et al., 2012). Moreover, TAp73 is important for the 
development of the hippocampus and TAp73-deficient mice exhibit hippocampal dysgenesis 
(Tomasini et al., 2008). In contrast to TAp73-deficient mice, cells from ∆Np73-deficient mice 
show enhanced p53-dependent apoptosis and are more sensitive to DNA-damaging agents. 
It was shown that ∆Np73 plays an inhibitory role in the DNA damage response pathway. 
∆Np73 is able to localize to the site of DNA damage and to prevent phosphorylation of p53 
by inhibition of ATM kinase (Wilhelm et al., 2010). During development ∆Np73 isoforms are 
the major isoforms expressed (Danilova et al., 2008a). However, over-expression of ∆Np73 
in embryos is lethal maybe due to dysregulation of p53, p63 and p73 (Erster et al., 2006). 
Furthermore, adult ∆Np73-deficient mice exhibit signs of neurodegeneration since ∆Np73 
plays an anti-apoptotic role in neurons (Pozniak et al., 2000). Additionally it was 
hypothesized, that the hydrocephalus of p73-deficient mice is caused by extensive loss of 
neurons since p73 is necessary for the survival of neurons (see chapter 1.2.3.4). 
Furthermore, in humans TA isoforms are mostly expressed during development and foetal 
tissues express more p73 than the equivalent adult tissue (Grob et al., 2001). 
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Figure 11: Schematic drawing of human p73 protein isoforms. 
(A) Structure of the human p73 gene consisting of 14 exons. Due to usage of an alternative promoter 
located in intron 3 and alternative splicing at the N- and C-terminus 29 different p73 isoforms can be 
generated. (B) The 29 p73 protein isoforms are illustrated. Numbers indicate the exons present in the 
corresponding isoforms. For a detailed explanation of the characteristics of the different isoforms and 
how they are generated see text. Modified from (Bourdon, 2007). 
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1.2.3.2 Regulation of p73 
 
In accordance with p53 (see chapter 1.2.1.2), the level of p73 in a cell is strictly regulated 
(Oberst et al., 2005). Under normal conditions p73 is degraded ubiquitin-independently by 
the 20S proteasome (Asher et al., 2005), by calpains (Munarriz et al., 2005) or by the 26S 
proteasome (Rossi et al., 2005). As p63 (see chapter 1.2.2.2), p73 is also ubiquitinated by 
Itch and thereby targeted for degradation by 26S proteasomes (Rossi et al., 2005). After 
cellular stress like DNA damage, there is a rapid accumulation of p73 but the way how p73 
becomes activated differs from that of p53 (Melino et al., 2002). It was demonstrated that 
after genotoxic stress as DNA-damage or oncogenes or oxidative stress, p73 becomes 
transcriptionally activated by p53 and p73 also up-regulates its own expression (Chen et al., 
2001; Wang et al., 2007a). This leads to the induction of cell cycle arrest or apoptosis. The 
induction of apoptosis by p73 is mediated by transactivation of pro-apoptotic p53-target 
genes like NoxA, Puma and Bax or the death receptor CD95. However, p73 is able to induce 
some of the p53 target genes, like Mdm2, p21 or Bax, but not all (Zhu et al., 1998a). It also 
induces genes that are not target genes of p53 (Harms et al., 2004). Furthermore it was 
demonstrated that p73 is able to induce apoptosis transcription-independently, as p53 (see 
chapter 1.2.1.2). p73 is cleaved by caspases and localizes to mitochondria where it induces 
release of cytochrome c (Sayan et al., 2008). Furthermore p73 is able to induce genes that 
play a role in DNA repair (Lin et al., 2009).  
As it is the case for p53 (see chapter 1.2.1.2), p73 is regulated by interaction with other 
proteins and by post-translational modifications, such as phosphorylation, ubiquitination or 
acetylation, as well (Pietsch et al., 2008). The tyrosine kinase c-Abl phosphorylates and 
stabilizes p73 after DNA damage thereby enhancing the transactivating and apoptotic 
potential of p73 (Agami et al., 1999; Gong et al., 1999; Yuan et al., 1999). Furthermore, the 
activity of p73 is also regulated by transcriptional co-activators like p300 and CBP. It was 
shown in vitro and in vivo that p300/CBP bind to and increase the transcriptional activity of 
p73 (Zeng et al., 2000). In addition p73 becomes acetylated by p300 after DNA damage in a 
c-Abl-dependent manner. Due to acetylation the ability of p73 to induce the transcription of 
pro-apoptotic target genes is increased (Costanzo et al., 2002; Pietsch et al., 2008; Zeng et 
al., 2000). Moreover, the peptidyl-prolyl cis/trans-isomerase Pin1 interacts with p73 in a c-Abl 
dependent manner and stimulates the acetylation of p73 by p300. In general, these events 
lead to the stabilization and an increased apoptotic activity of p73 (Mantovani et al., 2004). It 
was also demonstrated in vitro and in vivo that ASPP1 and ASPP2 bind to p73, as to p53 
and p63, and enhance also the apoptotic potential of p73 (Bergamaschi et al., 2004). 
Moreover, it was shown that some p53 mutants are able to bind to and inactivate the 
transcriptional activity of several p73 isoforms (Strano et al., 2000). 
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Furthermore, p73 is not activated by a variety of DNA damaging agents like p53 but only by a 
subset of agents. Actinomycin D or UV irradiation do not affect p73 for example (Kaghad et 
al., 1997). Additionally, the reaction of p73 to different types of DNA-damaging agents varies 
and accumulation and phosphorylation of p73 occurs only after specific types of cellular 
stress. For example, treatment of cells with cisplatin, which is a cytostatic drug, results in an 
increased half-life of p73 but p73 is not tyrosine-phosphorylated (Gong et al., 1999). 
Whereas ionizing irradiation does not lead to p73 stabilization (Levrero et al., 2000). 
However, ionizing irradiation induces activation of c-Abl by ATM kinase, which leads to the 
phosphorylation of p73 by c-Abl. Therefore it depends both on the cell type and on the DNA-
damaging agent if c-Abl phosphorylates or stabilizes p73 (Davis and Dowdy, 2001; Levrero 
et al., 2000; Yuan et al., 1999). Phosphorylation and/or accumulation of p73 is crucial for 
induction of apoptosis by p73 after DNA-damage (Levrero et al., 2000). Moreover,(Costanzo 
et al.)showed that after treatment with doxorubicin p73 becomes stabilized by acetylation. 
In addition, ∆Np73 is degraded via proteasomes, while TAp73 is up-regulated after DNA 
damage in order to permit apoptosis and cell cycle arrest (Maisse et al., 2004; Oberst et al., 
2005). TAp73 induces the ubiquitin ligase p73-induced Ring finger protein 2 (PIR2), which 
binds to, ubiquitinates and degrades ∆Np73 (Sayan et al., 2010).  
Additionally, feedback-loops could be identified that regulate the activity of p73 and several 
other proteins. p53 and TAp73 are capable of binding to the second promoter of ∆Np73 in 
intron 3 and induce its transcription. ∆Np73 on the other hand impairs the function of TAp73 
and p53, also on its own promoter, via binding the proteins (TAp73) or competing for 
promoter sites (p53) thereby creating a negative feedback loop (Grob et al., 2001; 
Kartasheva et al., 2002; Nakagawa et al., 2002; Stiewe et al., 2002). p73 is also able to 
induce the expression of p21 (Zhu et al., 1998a) and Mmd2. Mdm2 is activated by p73 and in 
turn inhibits the function of p73 but does not affect its stability (Zeng et al., 1999). In contrast 
to p53 (see chapter 1.2.1.2), Mdm2 binds to p73 but does not target it for degradation by 
proteasomes (Rossi et al., 2005; Zeng et al., 1999). It was also shown that p73 binds to 
MdmX (Ongkeko et al., 1999). Mdm2 and MdmX compete with p73 for binding to p300/CBP 
thereby inhibiting its function (Melino et al., 2002; Zeng et al., 1999; Zeng et al., 2000). 
However,(Ongkeko et al.)pointed out that induction of p21 and growth suppression functions 
and induction of apoptosis by p73 were increased in presence of Mdm2. Furthermore they 
also showed that binding of Mdm2 and MdmX to p73 enhances the half-life of p73 (Ongkeko 
et al., 1999). Another feedback-loop has been identified between p73 and TRIM32. TAp73 
induces the expression of TRIM32 and TRIM32 interacts with TAp73 and promotes its 
ubiquitination and degradation. ∆Np73 inhibits the expression of TRIM32 (Gonzalez-Cano et 
al., 2013). 
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1.2.3.3 p73 in zebrafish (Danio rerio) 
 
Zebrafish p73 is 70 to 95% identical to p73 of other vertebrates (Pan et al., 2003). It seems 
to be essential for the first 24 hours during zebrafish development (Davidson et al., 2008). In 
contrast to other observations, where p73 expression was already observed at the one-cell 
stage (Pan et al., 2003), the expression of p73 could not be detected until midgastrulation 
onwards by others. Contrary to p53 (see chapter 1.2.1.3) and according to ∆Np63 (see 
chapter 1.2.2.3), p73 is not expressed during early gastrulation (Rentzsch et al., 2003). In 
contrast to p53 and p63, which are ubiquitously expressed, the expression of p73 is more 
restricted. Compared to mice and in accordance with human embryos, TAp73 isoforms are 
mainly expressed during the development of zebrafish. Their expression is very restricted 
during development and can be detected in specific neurons in the telencephalon, dorsal 
diencephalon, olfactory epithelium, and hypothalamus, in differentiating slow muscle cells of 
the somites, pharyngeal arches, endodermal pouches and in the pronephric ducts (Danilova 
et al., 2008b; Pan et al., 2003; Rentzsch et al., 2003; Satoh et al., 2004). In the adult 
zebrafish p73 is expressed in the brain (telencephalon, hypothalamus, olfactory bulbs and 
optic tectum), skin, kidney, gill, eye and muscles (Pan et al., 2003; Satoh et al., 2004). 
Additionally, expression of p73 could be observed in the ovary, testis and fin (Pan et al., 
2003). Although the expression of p73 in the adult zebrafish was investigated by RT-PCR 
and rough whole-mount ISH, a detailed characterization of p73 expression was not provided 
by these studies. Down-regulation of TAp73 leads to developmental defects of the 
telencephalon, pharyngeal arches and olfactory system. Thus TAp73 is required for a proper 
craniofacial and neuronal development in zebrafish similar to mammals. Whereas, over-
expression of TAp73α does not increase apoptosis in zebrafish embryos, contrary to p53. 
Therefore, in contrast to mammals, TAp73 seems not to induce the same pro-apoptotic 
target genes in zebrafish embryos as p53 (Rentzsch et al., 2003).  
It is not clear if there is a ∆Np73 isoform expressed in zebrafish, which is similar to the 
∆Np73 isoforms in mammals (Rentzsch et al., 2003). However,(Satoh et al.)were able to 
detect ∆Np73 at least in a subset of zebrafish tissues. Furthermore, in zebrafish the p73θ 
isoform could be identified, which has not been detected in mammals. This isoform lacks the 
SAM domain but contains additional 55 amino acids at the C-terminus. p73θ exhibits a 
strong transcriptional activity and over-expression leads to developmental defects (Satoh et 
al., 2004).  
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1.2.3.4 p73 in the mammalian nervous system 
 
p73 is expressed in the embryonic and adult vomeronasal organ, the olfactory epithelium and 
in the preplate layer of the telencephalic ventricle. As p63 (see chapter 1.2.2.4), p73 is 
expressed in Cajal-Retzius neurons in the hippocampus and in the marginal zone of the 
developing cerebral cortex (Hernandez-Acosta et al., 2011; Yang et al., 2000). p73-deficient 
mice show a defective neuronal development caused by loss of Cajal-Retzius cells 
(Hernandez-Acosta et al., 2011). In postnatal mice, p73 is expressed in cells of the SVZ and 
p73 seems to be necessary for the proliferation in the SVZ. During development the 
expression of p73 in the brain is restricted but in the adult brain p73 is almost ubiquitously 
expressed. The expression of p73 can be observed in pyramidal neurons of the adult human 
cortex and hippocampus for example (Hernandez-Acosta et al., 2011).  
The different isoforms of the p73 protein possess distinct functions in the brain and both 
TAp73 and ∆Np73 isoforms are crucial for a normal functional brain. Both TAp73 and ∆Np73 
isoforms are present in neurons in the adult human cerebral cortex and hippocampus. 
∆Np73 is mainly located in the nucleus but it is also present in the cytoplasm whereas TAp73 
is predominantly expressed in the cytoplasm in cortical neurons. The same holds true for 
cortical neurons of mice (Cabrera-Socorro et al., 2006). ∆Np73 isoforms are the predominant 
isoforms present in Cajal-Retzius cells (Hernandez-Acosta et al., 2011) and in the fetal 
human brain ∆Np73α shows a high expression in these cells (Meyer et al., 2002). In the 
developing mouse brain ∆Np73 is predominantly expressed and functions antagonistically to 
p53 and TAp63 thereby preventing neuronal death. Removal of NGF induces p53-mediated 
neuronal cell death (see chapter 1.2.1.4) and a decrease of ∆Np73 expression. Over-
expression of ∆Np73 protects sympathetic neurons from cell death. Therefore ∆Np73 plays a 
crucial pro-survival role in sympathetic neurons during development (Jacobs et al., 2005; 
Jacobs et al., 2006; Jacobs et al., 2004; Pozniak et al., 2000).(Tissir et al.)demonstrated in 
vivo that ∆Np73 is essential for neuronal survival. In postnatal and adult cortical neurons p73 
is crucial for their survival as well but in the survival of embryonic cortical neurons it is not 
involved (Pozniak et al., 2002; Pozniak et al., 2000). Furthermore, ∆Np73 does not control 
the survival of precursor cells in the cortex (Dugani et al., 2009). Therefore, ∆Np73 is 
essential for the survival of neurons in both the central (cortical neurons) and the peripheral 
(sympathetic neurons) nervous system and it is crucial both for the survival of sympathetic 
neurons during developmental neuronal death and for the long-term maintenance of adult 
neurons (Pozniak et al., 2002). Adult neurons are relatively invulnerable after treatment with 
DNA damaging agents or after injury. It was hypothesized that this is achieved by increasing 
the ratio of ∆Np73 to p53 (Jacobs et al., 2004; Walsh et al., 2004). Thus, if a neuron lives or 
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dies depends on the relative levels of pro-survival (∆Np63, ∆Np73) and pro-apoptotic (p53, 
TAp63, TAp73) proteins (Jacobs et al., 2004).  
Furthermore, TAp73 is a crucial regulator of neural stem cell maintenance and self-renewal 
in embryos as well as in adults (Agostini et al., 2010; Fujitani et al., 2010; Talos et al., 2010) 
and as already mentioned above (see chapter 1.2.3), TAp73-deficient mice exhibit 
hippocampal dysgenesis. Neural stem cells express a much higher level of TAp73 compared 
to ∆Np73 (Talos et al., 2010). It was shown in vitro and in vivo that TAp73 is crucial for self-
renewal and long-term maintenance of adult neural precursors in the dentate gyrus of the 
hippocampus and the SVZ via induction of bHLH Hey2 (Sakamoto et al., 2003) and other 
target genes that control asymmetric cell division and proliferation. Hey2 inhibits premature 
differentiation thereby promoting the maintenance of neural precursors (Fujitani et al., 2010; 
Talos et al., 2010). Accordingly, it was demonstrated in vitro that TAp73 positively regulates 
self-renewal of embryonic neural stem cells and that loss of p73 depletes their number due to 
premature neuronal differentiation (Agostini et al., 2010; Gonzalez-Cano et al., 2010). In 
addition, it was reported by(Talos et al.)that p73 promotes proliferation and self-renewal and 
prevents premature senescence of neural stem and progenitor cells. Thus p73 is crucial for 
maintaining a stem cell pool both in adult and in embryonic neurogenesis (Agostini et al., 
2010; Talos et al., 2010).  
Moreover, TAp73 is able to induce neuronal differentiation in vitro in a neuroblastoma cell 
line (De Laurenzi et al., 2000). As p53 (see chapter 1.2.1.4), p73 plays a role in the 
differentiation of OPCs (Billon et al., 2004). Accordingly, it was shown that the expression of 
TAp73 increases and is also required for differentiation of precursor cells into 
oligodendrocytes or neurons (Agostini et al., 2010; Talos et al., 2010). 
As for p53 (see chapter 1.2.1.5), neurodegenerative diseases as Alzheimer´s disease have 
been linked to p73 (Cancino et al., 2013a; Wetzel et al., 2008). In hippocampal pyramidal 
Alzheimer´s disease neurons increased p73 levels show a nuclear localization whereas in a 
healthy brain p73 is located in the cytoplasm (Wilson et al., 2004). However, it was also 
observed that in some cases of Alzheimer´s disease the expression of p73 is decreased (Li 
et al., 2004). Additionally, p73 is involved in responses to cortical ischemia (Bui et al., 2009). 
  
In summary, the transcription factor p73 is crucial for normal development, also of the brain. 
It is involved in survival of embryonic and adult neurons of the central and peripheral nervous 
system. Furthermore, p73 is essential for self-renewal and maintenance of neural stem cells 
both in embryos and in adult mice. Additionally, p73 plays a role in the differentiation of 
precursor cells. 
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1.3 Aims of the project 
 
Both p53 and p73 play crucial roles in mammalian adult neurogenesis. p53 suppresses the 
self-renewal of adult neural stem cells and is involved in apoptotic death of neurons. p73 is 
relevant for the survival of neurons, self-renewal and maintenance of neural stem cells and 
differentiation of precursor cells. Given the high constitutive and regenerative neurogenic 
capacity of the zebrafish, a crucial question is whether the two genes play similar roles 
during these processes in the adult zebrafish brain. This may give insights into the underlying 
mechanisms and how they compare to the mammalian system. Such comparative 
approaches are key to extrapolate the knowledge of mechanisms underlying regeneration in 
the zebrafish to a potential application in humans for development of therapeutic 
approaches.  
One objective of my work was to characterize the overall expression of the two transcription 
factors p53 and p73 in the adult zebrafish brain and to assess whether the expression 
correlates with known neurogenic niches. Moreover by focusing on the adult zebrafish 
telencephalon I asked first whether the expression can be mapped to specific cell types such 
as neurons, OPCs and the different types of stem and progenitor cells in the telencephalon 
and whether the expression pattern is changed in response to injury. Finally, I assessed 
whether the neurogenic properties of the healthy and injured brain is changed in p53 
mutants. The results are discussed in relation to the known functions of p53 and p73 in the 
mammalian systems.   
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Chapter 2 
 
Material and Methods 
2 Material and Methods 
2.1 Consumables and instruments 
 
Borosilicate glass capillary tubes Warner instruments 
Cell culture flasks Greiner 
Compound microscope Leica DM5000 
Confocal microscope Leica TCS2 SP5 
Developing machine Kodak 
Dissecting microscope Nikon 
ECL films GE Healthcare Europe 
Electroporator Bio-Rad GenePulser II 
ELISA reader Biotek instruments 
Gel dryer BioRad 
Incubator cell culture Heraeus 
Incubator fish Binder   
Microinjector Eppendorf Femtojet express 
Micropipette puller Sutter Instrument Company  
PCR machine Perkin Elmer 
PVDF Transfer membrane Imobilon P Millipore 
Spectrometer Thermo Scientific NanoDrop 
Stereo microscope Leica stereo MZ16F 
Vibratome Leica VT1000S 
 
 
2.2 Kits and reagents 
 
DIG-RNA labeling mix Roche 
Gel extraction kit Peqlab 
Maxiprep kit Qiagen 
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2.3 Antibodies 
 
Primary antibodies: 
Anti-p53 zebrafish rabbit, AnaSpec (1:200) 
Anti-GFP chicken, Aves Labs (1:1000) 
Anti-HuC/D mouse, Molecular probes (1:300) 
Anti-BrdU mouse, DAKO (1:400) 
Anti-PCNA mouse, DAKO (1:500) 
Anti-PSA-NCAM mouse, Chemicon (1:500) 
Anti-S100β rabbit, DAKO (1:400) 
AP-anti-DIG Roche (1:4000) 
Anti-DIG-poly-POD Roche (1:1000) 
 
Secondary antibodies: 
Anti-chicken Alexa Fluor 488 Invitrogen (1:500) 
Anti-mouse Alexa Fluor 488 Invitrogen (1:500) 
Anti-rat Alexa Fluor 488 Invitrogen (1:500) 
Anti-mouse Alexa Fluor 680 Invitrogen (1:500) 
Anti-mouse Alexa Fluor 594 IgM Invitrogen (1:500) 
Anti-rabbit Alexa Fluor 546 Invitrogen (1:500) 
Anti-rabbit-HRP DAKO (1:1000) 
Anti-rat-HRP DAKO (1:1000) 
Anti-mouse-HRP DAKO (1:1000) 
 
Tyramide Cy3 solution Perkin Elmer (1:50) 
Tyramide Cy5 solution Perkin Elmer (1:100) 
DRAQ5 Biostatus (1:500) 
 
 
2.4 Buffers, media, solutions, chemicals 
 
Acrylamide solution Roth 
APS Sigma-Aldrich 
BCIP Roche 
Blocking Buffer 1x PBS, 0.1% (v/v) Tween 20, 
 0.2% (w/v) BSA, 1% (v/v) DMSO 
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Blotting Buffer 25 mM Tris, 192 mM Glycin,  
 10% MeOH 
BT-Fix 4% (w/v) PFA, 4% (w/v) sucrose,  
 0.12 mM CaCl2, 0.2 M Na2HPO4,  
 0.2 M NaH2PO4 
Coomassie staining solution 250 ml 150 mg Coomassie Brilliant Blue  
 R-250, 100 ml MeOH, 25 ml 
glacial acetic acid, 125 ml H2O 
Coomassie discolouration solution 500 ml 200 ml MeOH, 250 ml H20, 50 ml 
glacial acetic acid 
DMEM Invitrogen 
Dyalisis tubes G-Biosciences 
Fetal calf serum (FCS) PAA 
Freund´s Adjuvant Complete     Sigma-Aldrich  
Freund´s Adjuvant Incomplete    Sigma-Aldrich 
Glycerol       Roth 
GST-elution buffer 1 M Tris pH 8.0, L-Glutathion  
 reduced 
HBS 280 mM NaCl, 50 mM HEPES,  
 1.5 mM Na2HPO4, pH 7.05 
HYB buffer 50% (v/v) formamide, 5x SSC,  
 500 µg/ml yeast RNA, 50 µg/ml  
 Heparin, 0.1% (v/v) Tween 20 
 9 mM Citric acid  
IPTG Peqlab 
LB medium 10 g/l tryptone, 5 g/l yeast extract, 
 10 g/l NaCl 
Low-fat milk powder Saliter 
NBT Roche 
PBS  Invitrogen 
Penicillin/ Streptomycin Invitrogen 
Proteinase K Sigma-Aldrich 
PTW 1x PBS, 0.1% (v/v) Tween 20 
Running Buffer SDS-PAGE 25 mM Tris, 192 mM Glycin,  
 0.1% SDS 
20x SSC 0.3 M sodium citrate, 3 M NaCl,  
  pH 7,0 
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Staining buffer 100 mM Tris pH 9.5, 50 mM MgCl2 
  100 mM NaCl, 0.1% (v/v) Tween  
  20 
TAE 50x 2 M Tris, 1 M glacial acetic acid,  
  0.05 M EDTA 
TEMED Roth 
Trypsin-EDTA 0.25% Invitrogen  
Wash buffer 1 ISH 50% (v/v) formamide, 1x SSC,  
 0.05% (v/v) Tween 20 
Wash buffer 2 ISH 2x SSC, 0.1% (v/v) Tween 20 
Wash buffer 3 ISH 0.2x SSC, 0.1% (v/v) Tween 20 
Wash buffer 4 ISH 0.1x SSC, 0.05% (v/v) Tween 20, 
 50% (v/v) PTW 
  
 
 
2.5 Molecular biological and microbiological methods 
 
2.5.1 Polymerase chain reaction (PCR) 
 
The PCR was performed according to the protocols of the manufacturers of the reaction 
mixes. Pfu-polymerase (Fermentas) was used when the correct sequence of the amplicon 
was required. The PCR-programm was as follows: a single denaturation step for 5 min at 
95°C, followed by 27 cycles of 95°C for 30 sec, ann ealing temperature according to the 
melting temperature of the primers for 30 sec and 72°C for an extension time according to 
the length of the amplicon, followed by a final extension step at 72°C for 10 min.  
Standard PCR was performed with GoTaq DNA polymerase (Promega). The PCR-programm 
was as follows: a single denaturation step for 2 min at 95°C, followed by 35 cycles of 95°C 
for 30 sec, annealing temperature according to the melting temperature of the primers for 30 
sec and 72°C for an extension time according to the  length of the amplicon, followed by a 
final extension step at 72°C for 15 min. 
Primers (Metabion) used for the cloning of the C-terminus of zfp53 and zfp73 in the pGEX-
4T-2 vector for the production of the polyclonal antibodies: 
BamHI-zfp53_neu_for: 5´-ccgcgtggatccccacaagagaccaaaaccatggcgaaaaccaccact-3´ 
NotI-zfp53-Reverse: 5´-cgatgcggccgctcgttaatcagagtcgcttcttcc-3´ 
BamHI-zfp73_neu_for: 5´-ccgcgtggatccccacagagtgtgtaccaccttcagactcttact-3´ 
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NotI-zfp73-rev2: 5´-cgatgcggccgctcgtcagtgaacgtcgccttc-3´ 
As templates plasmids containing wildtype zfp53 and zfp73, respectively, were used. The 
last 342 base pairs (bp) of zfp53 and the last 363 bp of zfp73 were amplified. 
Primers used for the cloning for in situ probes: 
BamHI-zfp53-Forward: 5´-ccgcgtggatccccaatggcgcaaaacgacagccaagag-3´ 
NotI-zfp53-Reverse: 5´- cgatgcggccgctcgttaatcagagtcgcttcttcc-3´ 
As template cDNA from zebrafish embryos was used. 
Primers used for the cloning of p53 in the pCS2:GFP vector: 
EcoRI-p53-for: 5`-ttcgaattcaagatggcgcaaaacgacagc-3´ 
XhoI-p53-rev: 5´-ggctcgagaggcatcagagtcgcttcttcc-3´ 
As template a pcDNA3 vector with myc-zfp53 was used. 
 
 
2.5.2 Agarose gel electrophoresis and gel extraction 
 
DNA molecules were separated by size via agarose gel electrophoresis. The concentration 
of agarose varied depending on the size of the DNA fragments. For small DNA fragments 
(<500 bp) a 2% (w/v) and for larger fragments (>500 bp) a 1 or 1.5% (w/v) agarose gel was 
used. The agarose was melted in an appropriate amount of 1x TAE buffer. After cooling 
down to 60°C 0.1 µg/ml ethidium bromide (Roth) was added. The samples were 
supplemented with 6x DNA loading dye (Fermentas) and the gel was run in 1x TAE buffer at 
10 V/cm. GeneRuler DNA ladder mix (Fermentas) was used as a size marker. For extracting 
the gels the PeqGOLD gel extraction kit was used according to the manufacturer´s 
instructions. 
 
 
2.5.3 Restriction digest 
 
The restriction digest of DNA was performed by using FastDigest restriction enzymes 
(Fermentas) or HF restriction enzymes (NEB) as recommended by the manufacturers. The 
appropriate amount of DNA (PCR product or plasmid) was mixed with 1x buffer and 1 µl of 
the corresponding enzymes in a total volume of 40 µl. The digestion was carried out at 37°C 
for up to 1h.  
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2.5.4 Ligation 
 
For the ligation of DNA into linearized plasmids 100 ng of the linearized vector was mixed 
with the appropriate amount of insert (1:4 molar ratio vector:insert), 10x ligase buffer and 1µl 
of T4 DNA ligase (Fermentas) in a total volume of 20 µl. The mixture was incubated at room 
temperature for 2 to 3 hours. Afterwards it was directly used for transformation of competent 
bacteria.  
 
 
2.5.5 Transformation of competent bacteria 
 
100 µl of frozen competent Escherichia coli DH5α, BL21 or XL1-Blue were thawed on ice for 
several minutes. After adding the corresponding DNA the mixture was incubated on ice for 
20 min. Subsequently the bacteria were heatshocked for 30 sec at 42°C and incubated 
afterwards for 10 min on ice again. After adding 500 µl of 1x LB medium (without antibiotics) 
the transformation mixture was shaken at 37°C for 3 0 min. 20-200 µl of the bacteria were 
plated on selective plates containing LB medium with 50 µg/ml ampicillin (or other antibiotics 
as required by the plasmids). The plates were incubated overnight at 37°C.  
 
 
2.5.6 Small-scale (Miniprep) and large-scale (Maxiprep) DNA preparation 
 
In order to identify positive clones containing the plasmid of interest 2, 5 ml of 1x LB medium 
with the appropriate antibiotics were inoculated with single colonies picked from the selective 
LB plates. The cultures were shaken overnight at 37°C. On the next day the bacterial culture 
was centrifuged at 13000 rpm for 30 sec at room temperature. The bacterial pellet was 
resuspended in 250 µl of P1 buffer (Buffers P1-3 are from the Maxiprep kit from Qiagen) by 
vortexing. Afterwards 250 µl of P2 buffer were added and the samples were inverted 7 times 
to lyse the bacteria. Adding of P3 buffer and inverting the tubes 7 times stopped the lysis. 
After centrifugation at room temperature at 13000 rpm for 25 min the supernatant containing 
the DNA was transferred into new vials and 800 µl of isopropanol (1 volume) was added to 
precipitate the DNA. The samples were mixed before incubating them at -80°C for 30 min. 
Afterwards they were centrifuged for 25 min at 4°C at 13000 rpm. The supernatant was 
removed and the pellet was washed by adding 500 µl 75% (v/v) EtOH and centrifugation for 
5 min at 4°C at 13000 rpm. The DNA pellet was dried  at room temperature for about 15 min 
and then resuspended into 50 µl of water.    
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The Maxipreps were performed as described in the manufacturer´s protocol (Qiagen). 
 
 
2.5.7 Sequencing 
 
The sequencing was performed by Qiagen Sequencing services and Microsynth AG. 
 
 
 
2.6 Generation of the GST-zfp53-C-terminus and GST-zfp73-C-
terminus proteins 
 
2.6.1 Protein expression in bacteria and purification of GST proteins 
 
After transformation of competent BL21 bacteria with a pGEX-4T-2 vector (GE Healthcare) 
containing the C-terminus of zfp53 and zfp73, respectively, single colonies were used to 
inoculate 100 ml of 1x LB medium with ampicillin (100 µg/ml). The cultures were shaken over 
night at 37°C and at the next day the cultures were  diluted to 1 l and shaken again for 1.5 h 
at 37°C. By adding 1ml of 1 M Isopropylthiogalactop yranosid (IPTG) and shaking for 
additional 6 h at 37°C the expression of zfp53-C-te rminus and zfp73-C-terminus proteins 
fused to glutathione-S-transferase (GST) was induced. Afterwards the bacterial cultures were 
centrifuged for 10 min at 6000 rpm and 4°C and the pellets were resuspended in 25 ml 1x 
PBS. These suspensions were sonicated on ice 2 times for 30 sec. After adding 250 µl of 
PMSF (Sigma-Aldrich) and Triton X-100 (Sigma-Aldrich) the samples were shaken for 30 min 
at 4°C. Then the samples were centrifuged for 30 mi n at 9000 rpm and 4°C. The 
supernatants were incubated overnight at 4°C with 2 00 µl Glutathione Sepharose (GE 
Healthcare), which was washed with PBS before added to the samples. On the next day the 
samples were put on columns for protein purification (BioRad). After washing 2 times with 
PBS the GST-zfp53-C-terminus and GST-zfp73-C-terminus proteins were eluted from the 
Glutathione Sepharose with different amounts of GST-elution buffer.  
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2.6.2 Dialysis of the GST-zfp53-C-terminus and GST-zfp73-C-terminus 
proteins 
 
To further purify the GST-zfp53-C-terminus and GST-zfp73-C-terminus proteins and to 
remove the glutathione from the protein solutions, the solutions were dialysed against PBS 
overnight at 4°C. On the next day the PBS was chang ed and the protein solutions were 
dialysed again for several hours. 
 
 
2.6.3 SDS-PAGE 
 
10% acrylamide gels were prepared (separating gel: 4 ml H2O, 3.3 ml Acrylamide, 2.5 ml 1.5 
M Tris pH 8.8, 100 µl 10% SDS, 100 µl 10% APS, 4µl TEMED; stacking gel: 3.4 ml H2O, 830 
µl Acrylamide, 630 µl 1 M Tris pH 6.8, 50 µl 10% SDS, 50 µl 10% APS, 5 µl TEMED). The 
protein samples were supplemented with 2x loading buffer (160 mM Tris pH 6.8, 4% SDS, 
20% Glycerin, 4% β-mercaptoethanol, 0.02% bromphenolblue) and incubated at 95°C for 5 
min. The protein samples were loaded onto the acrylamide gel. As a standard to determine 
the concentration of the GST-zfp53-C-terminus and GST-zfp73-C-terminus proteins different 
volumes of a BSA solution (1µg/µl) were also loaded onto the gel. For the cell lysates 30 µg 
protein was used, 500 ng of GST protein and 30 µl telencephalon lysate were loaded onto 
the gels. PageRuler Prestained protein ladder (Fermentas) was used as a size marker. The 
gels were run in running buffer at 150 V. 
 
 
2.6.4 Staining, discolouration and drying of polyacrylamide gels 
 
Polyacrylamide gels were stained overnight in a Coomassie-staining solution. On the next 
day the gels were discoloured in a Coomassie-discolouration solution until the protein bands 
were clearly visible. The discolouration solution was changed several times. Afterwards the 
gels were dried for 2 h at 80°C in a gel dryer. 
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2.6.5 Estimation of the protein concentration 
 
To estimate the concentration of the GST-zfp53-C-terminus and GST-zfp73-C-terminus 
proteins the BSA standard was used. Thereby the bands of the produced proteins were 
compared to the bands of the BSA standard. This is an example how the concentration of the 
proteins was estimated: 
30 µl of GST-zfp53-C-terminus or GST-zfp73-C-terminus protein were loaded onto the gel 
and correlate to 1 µl of BSA with a concentration of 1µg/µl. Therefore in 30 µl protein solution 
1 µg protein is contained and thus the protein concentration is 0,033 µg/µl. 
Both the GST-zfp53-C-terminus and the GST-zfp73-C-terminus protein have a size of about 
39 kDa (13 kDa of zfp53-C-terminus or zfp73-C-terminus protein plus 26 kDa GST tag). 
 
 
 
2.7 Generation of polyclonal antibodies 
 
2.7.1 Immunization of rats 
 
For the generation of the polyclonal antibodies against the GST-zfp53-C-terminus and GST-
zfp73-C-terminus proteins 4 female BD10 rats were injected intraperitoneal 6 times (twice a 
week) with 15 µg (ca. 300 µl solution) of GST-zfp53-C-terminus and GST-zfp73-C-terminus 
protein (see chapter 2.6), respectively. The injections were performed according to the 
following scheme: 
 
 
Injection 1 15 µg protein plus Freund´s Adjuvant 
Complete 
Injection 2 15 µg protein plus Freund´s Adjuvant 
Incomplete 
Injection 3 15 µg protein in PBS 
Injection 4 15 µg protein in PBS 
Injection 5 15 µg protein in PBS 
Injection 6 15 µg protein in PBS 
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The Freund´s Adjuvant Complete and Freund´s Adjuvant Incomplete were used as described 
in the manufacturer´s protocol.  
 
 
2.7.2 Extraction of the polyclonal antibodies 
 
After finishing the immunization process the rats were sacrificed by an overdose of CO2. 
Afterwards the blood of the rats was gained by heart puncture. The amount of blood of the 
distinct rats varied between 4 and 8 ml. The blood was incubated at room temperature for 30 
min and then at 4°C for 6 h. To obtain the serum, w hich contained the polyclonal antibodies 
against the GST-zfp53-C-terminus and GST-zfp73-C-terminus proteins, the blood was 
centrifuged at room temperature for 10 min at 3500 g.   
 
 
2.7.3 Affinity purification of the polyclonal antibodies 
 
For the affinity purification pieces of a nitrocellulose membrane (Piercenet) with a size of 9 
cm2 were wetted with PBS and 100 µg of GST-zfp53-C-terminus or GST-zfp73-C-terminus 
protein were added to the membranes. The membranes were incubated at 4°C for 5 h. 
Afterwards 5 ml 100 mM Glycin/HCl pH 2.5 were added for 5 min. Then the membranes 
were washed twice with 5 ml TBS for 2 min. After that the membranes were blocked with 2 
ml 5% (w/v) low-fat milk for 1 h at 4°C. The membra nes were washed 3 times with PBS 
before 200 µl polyclonal antibodies in 2 ml 5% milk were added. The membranes plus the 
antibodies were incubated overnight at 4°C to let t he antibodies bind to the membrane. On 
the next day the membranes were washed 5 times for 5 min with PBS. Then the antibodies 
were eluted with 500 µl elution buffer (0.2 M Glycin pH 2.5, 150 mM NaCl, 0.1% (w/v) BSA) 
and 125 µl Tris HCl pH 7.9 were added to the polyclonal antibodies. Afterwards the 
specificity of the antibodies was tested. 
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2.8 Cell culture methods 
 
2.8.1 Cell line 
 
The H1299 cell line (ATCC no. HTB-96TM) used in all experiments is a p53-negative 
adherent human non-small cell lung carcinoma cell line derived from a lymph node.  
 
 
2.8.2 Cell culture maintenance 
 
H1299 cells were maintained in Dulbeco´s modified eagle medium (DMEM) plus 10% FCS 
and 1% Penicillin/Streptomycin. They were passaged twice a week by trypsinization at a 
ration of 1:8 to 1:10 and were cultivated in 175 cm2 cell culture flasks at 37°C in a 5% CO 2 
humidified incubator.  
 
 
2.8.3 Transient transfections 
 
Transient transfections with myc-zfp53 (in pcDNA3 vector, Invitrogen) were performed with 
calcium-phosphate precipitation. H1299 cells were passaged by trypsinization at a ratio of 
1:8 to 1:10 and incubated in petridishes for 4 to 6 h at 37°C. For immunohistochemistry small 
round coverslips were put into the petridishes. Afterwards the transfection mix was added to 
the cells: 0.125 M CaCl2, 5 µg DNA, 1x HBS in a volume of 1ml. The cells were incubated 
overnight at 37°C. The next day, a glycerol shock w as performed by removing the 
maintenance medium from the cells and adding 5 ml of 15% (v/v) Glycerol for 3 min. After 
washing with PBS the cells were incubated in maintenance medium at 37°C until they were 
harvested 6 h later. 
For transfection of cells with myc-zfp73α (in pcDNA3 vector) Effectene (Qiagen) was used 
according to the manufacturer´s protocol 
 
 
2.8.4 Cell lysis 
 
Attached cells were removed from the bottom of the petridishes by a scraper and transferred 
into vials. After centrifugation at 13000 rpm at 4°C for 1 min the cell pellet was washed with 
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PBS. Then the cells were lysed in 100 µl NP-40 lysis buffer (1% NP-40, 150 mM NaCl, 50 
mM Tris pH 8.0, 5 mM EDTA pH 8.0, 1 mM PMSF) for 20 min on ice. Afterwards the samples 
were centrifuged for 20 min at 13000 rpm and 4°C. T he supernatant containing the proteins 
was transferred into a new vial. 
To determine the protein concentration of the cell lysates a Bradford assay was performed. 
For the standard curve 1 ml Bradford solution (100 mg Coomassie Brilliant Blue, 50 ml EtOH, 
100 ml 85% phosphoric acid in 1l) was mixed with 2 µl lysis buffer and 0, 2, 4, 6, 8 or 10 µl 
BSA (1 µg/µl). 2 µl of the cell lysates were added to 1 ml Bradford solution. 150 µl of these 
samples were transferred into a 96 well plate and measured at the ELISA reader at 595 nm. 
The protein concentration was calculated as follows: 
Protein concentration = x * extinction of the protein 
x = extinction (BSA-standard) / concentration (BSA-standard) 
 
 
 
2.9 Western blot 
 
For the western blot the PVDF membranes were activated in methanol before setting up the 
blot device. The device was set up in a way that the proteins from the polyacrylamide gel 
migrate onto the membrane. The western blot was performed overnight in Blotting buffer at 
30 Volt.  
On the next day the membranes were blocked for 30 min in 5% milk (5% (w/v) milk powder in 
PBS plus 0.2% (v/v) Tween). For the commercially available anti-p53 antibody the 
membranes were blocked in milk without Tween. Afterwards the membranes were incubated 
with the primary antibodies. The primary antibodies were diluted in 5% milk as follows: 
polyclonal antibodies against GST-zfp53-C-terminus or GST-zfp73-C-terminus 1:1000, anti-
myc antibody (supernatant of 9E10 hybridoma cells) 1:50, commercially available anti-p53 
antibody 1:500. The primary antibodies were incubated at room temperature for 1.5 h or 
overnight at 4°C. Then the membranes were washed 3 to 5 times for 10 min in PBS plus 
0.2% (v/v) Tween (PTW) before incubating them for 1.5 h at room temperature with the 
secondary antibodies diluted 1:1000 in 5% milk (polyclonal antibodies: anti-rat-HRP, myc 
antibody: anti-mouse-HRP). For the commercially available anti-p53 antibody an anti-rabbit 
IRDye800 secondary antibody was used diluted 1: 5000 in 5% milk. This antibody was 
incubated for 1.5 h at room temperature in the dark. Afterwards the membranes were 
washed 5 times for 10 min in PTW and 2 times for 10 min in PBS.   
The membranes incubated with the polyclonal or the myc antibodies were incubated with 
ECL solution 1 (100 mM Tris-HCl pH 8.5, 400 µM cumaric acid 2.5 M Luminol) and 2 (100 
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mM Tris-HCl 8.5, 0.02% H2O2) for 2 min. Afterwards the membranes were exposed to an 
ECL-film. The exposure time depended on the intensity of the signals. The films were 
developed in a developing machine. 
The membranes incubated with the commercially available anti-p53 antibody were scanned 
at the Odyssey system. 
 
 
 
2.10 Immunohistochemistry on cells 
 
For the immunohistochemistry on cells, cells cultured on cover slips were used (see chapter 
2.8.3). The coverslips were transferred into a 24-well plate and washed with PBS. The cells 
were fixed on ice for 8 min with 800 µl Aceton/Methanol (1:1) and afterwards the cells were 
dried at room temperature. Then the cells were washed 3 times with PBS and treated with 
PBS with 0.5% (v/v) Triton X-100 for 10 min. Before the cells were blocked in blocking buffer 
(1% BSA and 1% goat serum in PBS) for 30 min they were washed 3 times in PBS. 
Afterwards the cells were washed with PBS and the primary antibodies were added to the 
cells diluted in blocking buffer (polyclonal antibodies 1: 200 and anti-myc antibody 1:50). The 
antibodies were incubated for 1.5 h. Then the cells were washed 3 times with PBS before 
incubated with the secondary antibodies diluted in blocking buffer (Anti-rat Alexa Fluor 488 
and Anti-mouse Alexa Fluor 488 1:1000). To label the nuclei the nuclear marker DRAQ5 was 
also added diluted 1:1000. The cells were incubated for 1.5 h in the dark. Afterwards the 
cells were washed 3 times with PBS, mounted with Hydromount (National diagnostics) on 
glas slides and analysed at the confocal microscope. 
 
 
 
2.11 Histological methods on adult zebrafish brains 
 
2.11.1 Fish strains used 
 
Experiments were performed on adult 6-12 month old wildtype (AB), transgenic 
Tg(olig2:EGFP) (Shin et al., 2003), Tg(gfap:GFP) (Bernardos and Raymond, 2006) and Tg(-
3.9nestin:GFP) (Lam et al., 2009) or tp53M214K mutant (Berghmans et al., 2005) zebrafish 
(Danio rerio). The fish were maintained on a 14 h/ 10 h light-dark cycle at 28.5°C in 
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recirculation systems (Schwarz Ltd Germany, Müller and Pfleger Ltd Germany) and fed 
commercial food and in-house hatched brine shrimp as described (Westerfield, 2007).  
 
 
2.11.2 Dissection and fixation of brains 
 
Fish were anesthetized with 0.02% (w/v) Tricaine (Ethyl 3-aminobenzoate methanesulfonate 
salt, Sigma) before being killed in ice water (Westerfield, 2007). Brains were carefully 
removed and fixed in 4% paraformaldehyde over night at 4°C. They were then step wise 
dehydrated in a methanol/ PBS concentration series and stored at -20°C (Adolf et al., 2006). 
 
 
2.11.3 In situ hybridization (ISH) 
 
Digoxigenin labelled anti-sense riboprobes were used from a repertoire described in (Armant 
et al., 2013). The Digoxigenin labelled p53 anti-sense riboprobe was generated according to 
(Armant et al., 2013; Lam et al., 2009). Digoxigenin labelled sense riboprobes were 
generated with suitable restriction enzymes and RNA polymerases according to (Armant et 
al., 2013; Lam et al., 2009). Briefly, the in situ templates were cloned by performing a PCR 
with the GoTaq polymerase kit (see chapter 2.5.1). The PCR products were subcloned into 
the pGEM-T Easy vector (p53 and p73, Promega) or modified pBluescript II SK(-)vector (p21 
and Mdm2, Invitrogen, Addgene) as described by the manufacturer. The templates for the 
synthesis of DIG-labelled anti-sense and sense riboprobes were linearized plasmids. The 
plasmids were linearized with the following restriction enzymes: p53 anti-sense SalI (T7), p53 
sense SacII (Sp6), p73 anti-sense ApaI (New England Biolabs) (Sp6), p73 sense SacI (T7), 
Mdm2 and p21 anti-sense XhoI (T3). The linearized plasmids were purified by 
phenol/chloroform extraction and precipitated with isopropanol. For the synthesis of 
Digoxigenin labelled anti-sense and sense riboprobes the following mixture was prepared: 1 
µl linearized template, 0.75 µl RNAse inhibitor (Fermentas), 0.75 µl corresponding RNA 
polymerase (Fermentas), 1 µl DIG labeling mix (Roche) and 1x transcription buffer 
(Fermentas) in a total volume of 10 µl. The mixture was incubated at least 3 h at 37°C. The 
transcribed RNA was precipitated by adding sodium acetate and ethanol and incubation at -
80°C for 30 min and centrifugation afterwards at 4° C for 25 min. The Digoxigenin labelled 
riboprobes were stored in HYB buffer at -20°C. 
ISH on adult brains was performed according to (Adolf et al., 2006). Brains stored in 100% 
MeOH were step wise rehydrated in a decreasing methanol/PBS concentration series and 
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washed afterwards 4 times for 5 min in PTW. Then the brains were treated for 30 min with 
ProtK PTW buffer (10 mg/ml Proteinase K in PTW) and fixed again for 20 min in BT-Fix. 
Afterwards the brains were washed 5 times for 5 min in PTW before they were rinsed in HYB 
buffer. Subsequently the brains were prehybridized in HYB buffer at 67°C for at least 3 h. 
Then the brains were hybridized overnight at 67°C w ith the Digoxigenin labelled anti-sense 
and sense riboprobes in HYB buffer. The following day the brains were washed at 67°C 2 
times for 30 min with wash buffer 1, 15 min with wash buffer 2, 2 times for 30 min with wash 
buffer 3 and 5 min with wash buffer 4. Afterwards the brains were washed for 5 min at room 
temperature in blocking buffer before embedding the brains in 2% (w/v) agarose in PBS 
(Schmidt et al., 2014). Using a vibratome 50 µm sections were cut, collected in blocking 
buffer and blocked for at least 1 h at room temperature (Schmidt et al., 2014). The brain 
sections were incubated overnight at 4°C with Anti- DIG-AP diluted 1:4000 in blocking buffer. 
On the next day sections were washed 5 times for 15 min with PTW and 2 times with staining 
buffer. Afterwards the sections were stained in the dark with NBT/ BCIP staining solution. To 
stop the staining, sections were washed at least 3 times with PTW. The experiments with 
sense probes were stopped at the same time as the experiments with the antisense probes. 
The sections were imaged on a compound microscope. 
For fluorescent in situ hybridization (FISH) the following modifications of the ISH protocol 
were performed. Signal amplification was performed by using tyramide amplification (TSA 
plus Cyanine 5 System, Perkin Elmer). After rehydration and washing of the brains, they 
were incubated in 3% (v/v) H2O2 in PBS for 35 min for quenching of endogeneous 
peroxidase. The 50 µm sections were incubated overnight with Anti-DIG-poly-POD antibody 
(Roche) diluted 1:1000 in blocking buffer at 4°C. T he next day, after washing with PTW the 
brain sections were washed 2 times for 10 min in PTW plus 0.002% (v/v) H2O2. Afterwards 
they were stained in the dark with tyramide Cy5 solution 1:100 in PTW plus 0.002% (v/v) 
H2O2 for 2 h. Then the sections were washed 3 times for 5 min in PTW. Afterwards the 
sections were processed for immunohistochemistry using the anti-p53 antibody and tyramide 
Cy3. 
All fluorescent pictures were acquired using a laser scanning confocal microscope (Leica 
TCS2 SP5) and processed using Leica software. Pictures were adjusted for brightnes and 
contrast and panels were created in Adobe Photoshop CS4. 
All brains were oriented as dorsal up, ventral down. In brains with stab wounds, the lesioned 
telencephalic hemisphere was always located to the left. 
 
 
 
Material and Methods 
66 
 
 
2.11.4 Immunohistochemistry 
 
Immunostainings were performed on free-floating vibratome sections as described in (Adolf 
et al., 2006). Brains stored in 100% MeOH were step wise rehydrated in a decreasing 
methanol/PBS concentration series and washed afterwards 4 times for 5 min in PTW. 
Afterwards the brains were embedded in 2% (w/v) agarose in PBS. Sections were cut with a 
vibratome to a thickness of 50 µm (Schmidt et al., 2014). The sections were blocked in 
blocking buffer for at least 2 h at room temperature. The self-made polyclonal antibodies 
were incubated overnight at 4°C diluted 1:10 in blo cking buffer and the rabbit anti-S100β 
antibody was incubated overnight at 4°C diluted 1:4 00 in blocking buffer. Afterwards the 
sections were washed 3 times for 10 min with PTW before they were incubated in the dark 
for 2 h with the secondary antibody from the Alexafluor series (anti-rat Alexa 488 and anti-
rabbit Alexa 546 1:500). Then the sections were washed 3 times for 10 min in PTW and 
mounted on glass slides in Aqua Polymount (Polyscience). 
For the commercially available rabbit anti-p53 antibody a different protocol was used. After 
rehydration, washing and cutting sections with a vibratome the sections were collected in 
PBS. Then an antigen retrieval was performed by incubating the sections for 30 min at 80°C 
in sodium citrate pH 6, 0. Afterwards the sections were washed in PBS for 5 min at room 
temperature before they were incubated for 30 min in PBS plus 3% (v/v) H2O2 for quenching 
of endogeneous peroxidase. Then the brain sections were washed 2 times for 5 min in PBS 
plus 0.2% (v/v) Tween20 and blocked in 5% (w/v) milk in PBS plus 0.2% (v/v) Tween20 for at 
least 45 min. The primary rabbit anti-p53 antibody was incubated overnight at room 
temperature diluted 1: 200 in 5% (w/v) milk in PBS plus 0.2% (v/v) Tween20. The next day, 
sections were washed 2 times for 10 min with PBS plus 0.2% (v/v) Tween20 before they 
were incubated with the secondary antibody (anti-rabbit-HRP 1:1000 in 5% (w/v) milk in PBS 
plus 0.2% (v/v) Tween20). Afterwards the sections were washed 2 times for 10 min with PBS 
plus 0.2% (v/v) Tween20 and then they were incubated for 7 min in the dark with tyramide 
Cy3 solution (1:50 in 1x plus amplification diluent from the TSA plus Cyanine 3 System kit, 
Perkin Elmer). Then the sections were washed 3 times for 5 min with PBS plus 0.2% (v/v) 
Tween20. For co-staining with PSA-NCAM Cy5 instead of Cy3 was used. 
Co-stainings were performed after finishing the staining for p53. Therefore, after removing 
the Cy3 solution and washing, the sections were again incubated for 2 h at room temperature 
in blocking buffer. The primary antibodies were incubated overnight at 4°C. Primary 
antibodies were: chicken anti-GFP (1:1000), mouse anti-HuC/D (1:300), mouse anti-BrdU 
(1:400), mouse anti-PCNA (1:500), mouse anti-PSA-NCAM (IgM, 1:500). Before incubation 
with the anti-BrdU antibody the sections were treated for 30 min with 2 N HCl, washed 
afterwards 2 times for 10 min in 0.1 M Na-tetraborate buffer pH 8.5 and then washed 3 times 
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for 5 min in PTW. The next day, sections were washed 3 times for 10 min in PTW and were 
then incubated with the secondary antibodies from the Alexafluor series (Alexa 488, Alexa 
594 IgM, Alexa 680 1:500). Nuclear staining was performed with DRAQ5 (1:500 in PBS, 
Biostatus). DRAQ5 solution was incubated for 10 min and then the sections were washed 3 
times for 10 min with PTW. The sections were mounted on glass slides in Aqua Polymount.  
 
 
2.11.5 BrdU administration 
 
Intraperitoneal injection of BrdU (5-Bromo-2`deoxyuridine) into Tg(olig2:EGFP) adult 
zebrafish (Shin et al., 2003) was performed as described in (Chapouton et al., 2006) 
cumulatively for 3 days and followed by a chase of 2, 3 and 4 weeks, respectively. For the 
injections fish were anesthetized with 0.02% (w/v) Tricaine and the BrdU solution was mixed 
with methylene blue for injection control. At the corresponding time points fish were sacrificed 
and the brains were processed as described in chapter 2.11.2. 
 
 
2.11.6 Stab wounds 
 
Fish were anesthetized with 0.02% (w/v) Tricaine and placed afterwards into a slit in a block 
of tricaine-soaked foam. Under a dissecting microscope with light from the top a syringe 
needle (30 G) was inserted vertically through the scull into the medial region of the right 
telencephalic hemisphere. The contralateral unlesioned left hemisphere served as the 
control. Afterwards fish were transferred to a tank with fresh fish water and were removed at 
different time points after lesioning (Schmidt et al., 2014). 
 
 
2.11.7 TUNEL staining 
 
For detection of apoptosis via TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end 
labeling) the ApopTag Red in situ apoptosis detection kit (Chemicon) was used according to 
the manufacturer´s instructions. Briefly, brains were step wise rehydrated in a decreasing 
methanol/PBS concentration series and washed afterwards 4 times for 5 min in PTW. Then 
the brains were treated for 30 min with ProtK PTW buffer (10 mg/ml Proteinase K in PTW) 
and fixed again for 20 min in BT-Fix. Afterwards the brains were washed 4 times for 5 min in 
PTW before embedding the brains in 2% (w/v) agarose in PBS. Using a vibratome 50 µm 
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sections were cut. Then the brain sections were washed for 2 min in equilibration buffer and 
incubated for 1 h in working strength TdT enzyme at 37°C. Afterwards the sections were 
treated with working strength stop/wash buffer for 10 min at room temperature. Then the 
sections were washed in PBS 3 times for 1 min and incubated for 30 min in the dark with 
working strength Anti-digoxigenin conjugate. Afterwards the sections were washed 4 times 
for 5 min with PBS and mounted on glass slides in Aqua Polymount.  
 
 
 
2.12 Lysis of adult zebrafish telencephala 
 
Adult wildtype fish were anesthetized with 0.02% (w/v) Tricaine before being killed in ice 
water. Brains were carefully removed and the telencephala were transferred in lysis buffer 
(PBS plus 0.1% (v/v) Triton-X 100, 1 mM DTT, 1 mM PMSF, 1x protease inhibitor mix 
(Roche)) on ice. The telencephala were homogenized and sonicated. Afterwards the solution 
was centrifuged at 13000 rpm for 10 min at 4°C and the supernatant was transferred to a 
new vial. 
 
 
 
2.13 Microinjection  
 
Injection mixes plus 0.1% (w/v) phenol red as an injection control were prepared. Injection 
needles were obtained from borosilicate glass capillary tubes by pulling the heated capillaries 
on a micropipette puller. Wildtype zebrafish eggs were transferred directly after spawning 
into petridishes with fishwater. The injection mixes were loaded into the needles and the tip 
of the needles was opened. The fishwater was completely removed from the eggs and 
approximately 4 nl of the injection mix was injected into one cell stage zebrafish eggs with a 
microinjector as described by (Muller et al., 1999). After injection zebrafish water plus 
methylene blue (1mg/ml) as a fungizide was added to the injected embryos. Unfertilized or 
dead eggs were removed around the sphere stage and the embryos were kept at 28°C until 
the experiments were performed. 
20 ng/µl of p53-GFP RNA was injected. The RNA was produced from the pCS2 vector with 
p53-GFP by using a mMessage mMachine Sp6 Transcription kit (Ambion) according to the 
manufacturer´s protocol.  At 8 hpf GFP-positive embryos were selected and fixed at 4°C over 
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night in BT-Fix. The next day the embryos were dechorionated manually with forceps and 
stored in methanol at -20°C. 
 
 
 
2.14 Immunohistochemistry of embryos 
 
The embryos were step wise rehydrated in a decreasing methanol/PBS concentration series 
and washed afterwards 4 times for 15 min in PTW. Then the embryos were rinsed in water 
and the water was immediately removed. Pre-cooled aceton was added and incubated for 7 
min at -20°C. The aceton was removed and the embryo s were rinsed in water. The water 
was immediately removed and the embryos were washed 5 times for 20 min in PTW. Then 
an antigen retrieval was performed by incubating the embryos for 30 min at 80°C in sodium 
citrate pH 6.0. Afterwards the embryos were washed in PBS for 5 min at room temperature 
before they were incubated for 30 min in PBS plus 3% (v/v) H2O2 for quenching of 
endogeneous peroxidase. Then the embryos were washed 2 times for 5 min in PBS plus 
0.2% (v/v) Tween20 and blocked in 5% (w/v) milk in PBS plus 0.2% (v/v) Tween20 for at 
least 45 min. The primary antibodies were incubated overnight at room temperature (rabbit 
anti-p53 1:200, chicken anti-GFP 1:1000 diluted in 5% (w/v) milk in PBS plus 0.2% (v/v) 
Tween20). The next day, embryos were washed 2 times for 10 min with PBS plus 0.2% (v/v) 
Tween20 before they were incubated with the secondary antibody (anti-rabbit-HRP 1:1000, 
Alexa 488: 1:500 in 5% (w/v) milk in PBS plus 0.2% (v/v) Tween20). Afterwards the embryos 
were washed 2 times for 10 min with PBS plus 0.2% (v/v) Tween20 and then they were 
incubated for 7 min in the dark with tyramide Cy3 solution (1:50 in 1x plus amplification 
diluent from the TSA plus Cyanine 3 System kit, Perkin Elmer). Then the embryos were 
washed 3 times for 5 min with PBS plus 0.2% (v/v) Tween20. The embryos were embedded 
in 0.5% (w/v) agarose for imaging them at the confocal microscope. 
 
 
 
2.15 BAC recombineering  
 
The strategy for modifying a BAC clone for transgenesis is adapted from (Lam et al., 2009; 
Shin et al., 2003). The first exon of the p53 coding region in the BAC clone CHORI CH211-
92I1 and the first exon of the p73 coding region in the BAC clone CHORI CH211-69A12 were 
replaced by EGFP. Furthermore, the p53 and p73 coding regions were fused to GFP. 500 bp 
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of the 5´ and 3´ flanking regions of the first exon and the C-terminus of p53 and p73, 
respectively, were amplified by PCR from the BAC and cloned into pPCR-EGFP. 
The following primers and enzymes were used for cloning: 
Replacing the first exon of p53: 
5´arm forward: 5´-cgcgtcgacttgtgtgttgtattattgtaacaaac-3´ 
5´arm reverse: 5´-gcgaagctttgctgtgaaattataaacacgaaagtc-3´ 
Enzymes: SalI and HindIII 
3´arm forward: 5´-cgcccgcgggtaagttcgcaagggtcgcactcctgatac-3´ 
3´arm reverse: 5´-gcggagctcgcctaaatccatgatcgccgggatagtcgc-3´ 
Enzymes: SacII and SacI 
Fusion construct p53: 
5´arm forward: 5´-cgcgtcgactaccttcagtatttgagatgacctaagaag-3´ 
5´arm reverse: 5´-gcgaagcttgatcagagtcgcttcttccttcgtcctt-3´ 
Enzymes: SalI and HindIII 
3´arm forward: 5´-cgcccgcggttatggattggatgtctaaatatgagc-3´ 
3´arm reverse: 5´-gcggagctcgaacaaataatatgggagtcgttgggataa-3´ 
Enzymes: SacII and SacI 
Replacing the first exon of p73: 
5´arm forward: 5´-cgcgtcgaccatcatatactgtgatgaaaacaagcc-3´ 
5´arm reverse: 5´-gcgaagcttcttggatgttggacaatccaccgc-3´ 
Enzymes: SalI and HindIII 
3´arm forward: 5´-cgcccgcgggtgagttcattcacactcattaaatac-3´ 
3´arm reverse: 5´-gcggagctccattatcgtagtgaaaaatgaattgttgcg-3´ 
Enzymes: SacII and SacI 
Fusion construct p73: 
5´arm forward: 5´-cgcgtcgacaatagtgaagtccactaaaggaggttgagc-3´ 
5´arm reverse: 5´-gcgaagcttggtgaacgtcgccttcggcaaactc-3´ 
Enzymes: SalI and HindIII 
3´arm forward: 5´-cgcgcggccgctttgtgcaattgtgtatgatattg-3´ 
3´arm reverse: 5´-gcggagctcgtagactactttacggattttgcctattgc-3´ 
Enzymes: NotI and SacI 
The BAC clones were electroporated into temperature sensitive EL250 cells. The targeting 
cassettes were cut out of the pPCR vector with SacI and KpnI. Then the targeting cassettes 
were electroporated into the EL250 cells containing the BAC clones followed by a heat-shock 
at 42°C for 15 min to induce the production of reco mbination proteins. After positive selection 
clones that were kanamycin-resistant were further verified by PCR for successful 
recombination. The following primers were used: 
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Replacing the first exon of p53: 
Upstream forward primer: 5´-gcagatttaaatcgtctacgcgacctg-3´ 
Fusion construct p53: 
Upstream forward primer: 5´-gcacatttacagctttgtgcgtacgcaatg-3´ 
Replacing the first exon of p73: 
Upstream forward primer: 5´-caactgaatcgattcacaggtgtgaaagc-3´ 
Fusion construct p73: 
Upstream forward primer: 5´-atacgtagaacttagcaggctacatcactg 
EGFP reverse primer: 5´-ccgtccagctcgaccag-3´ 
Afterwards the kanamycin cassette was removed by induction with 1% arabinose. To allow 
transposon-mediated BAC transgenesis the Tol2 cassette was amplified from the iTol2 
plasmid (Suster et al., 2011) using the following primers: 
Bac-tol2 forward: 5´- gcgtaagcggggcacatttcattacctctttctccgcacccgacatagatccctgctcgagccgggc 
ccaagtg-3` 
Bac-tol2 reverse: 5´-cgcggggcatgactattggcgcgccggatcgatccttaattaagtctactaattatgatcctctagatc 
agatct-3´ 
The Tol2 cassette was electroporated as described for the targeting cassette. Integration of 
the Tol2 cassette was checked by PCR. The following primers were used: 
Outside loxP forward: 5´-tggccaatatggacaacttct-3´ 
Inside Amp reverse: 5´-cacccaactgatcttcagca-3´ 
For stable integration into the genome 30 ng/µl Tol2-BAC DNA and 30 ng/µl transposase 
mRNA were co-injected into one-cell stage zebrafish embryos. Fish were raised and 
outcrossed to identify stable integration of the transgene.  
 
 
 
2.16 Homozygous tp53M214K mutant zebrafish 
 
To obtain homozygous tp53M214K mutant zebrafish (Berghmans et al., 2005), heterozygous 
fish were bred and raised. About 2 months later the raised fish were genotyped by fin 
clipping to identify the homozygous ones. Briefly, fish were anesthetized with 0.02% (w/v) 
Tricaine and a small piece of the tail fin was cut off and put into tail buffer (80 mM Tris-HCl 
pH 8.5, 200 mM NaCl, 5 mM EDTA, 0.2% SDS, 100 µg/ml Proteinase K). The fin clips were 
incubated over night at 63°C. The next day, isoprop anol was added to precipitate genomic 
DNA and the samples were centrifuged at 13000 rpm for 10 min. The pellet was washed with 
70% (v/v) ethanol and centrifuged at 13000 rpm for 10 min. Then the pellet was dried and 
resuspended in water. A PCR was carried out to reveal the genotypes of the fish. 
Material and Methods 
72 
 
 
Primers used for genotyping from (Berghmans et al., 2005): 
p53 genotyping forward: 5´-gatagcctagtgcgagcacactctt-3´ 
p53 genotyping mutant reverse: 5´-agctgcatgggggggaa-3´ 
p53 genotyping wildtype reverse: 5´-agctgcatgggggggat-3´ 
The homozygous fish were further bred and raised. 
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Chapter 3 
 
Results 
3 Results 
3.1 Characterization of the expression of p53 and p73 in the adult 
zebrafish brain 
 
My overall aim was to investigate the role of p53 and p73 in the adult zebrafish brain since it 
was shown that both p53 and p73 play important roles in adult neurogenesis in the 
mammalian brain. p53 suppresses the self-renewal of adult neural stem cells (Meletis et al., 
2006) and is involved in neuronal death following damage (Culmsee and Mattson, 2005; 
Miller et al., 2000; Morrison and Kinoshita, 2000). Furthermore, p73 is essential both for the 
survival of neurons (Pozniak et al., 2002) and for the self-renewal and maintenance of neural 
stem cells (Agostini et al., 2010; Talos et al., 2010) in mammals. 
There are differences between the mammalian and the zebrafish brain regarding the 
capacity of adult neurogenesis and the regeneration of damaged brain areas (Adolf et al., 
2006; Chapouton et al., 2007; Grandel et al., 2006; Kaslin et al., 2008; Zupanc, 2001; 
Zupanc and Zupanc, 2006). Therefore, I intended to examine the expression of p53 and p73 
in the adult zebrafish brain and to detect potential differences to the mammalian brain.  
 
To examine the role of p53 and p73 in the brain of the adult zebrafish I first characterized in 
which regions of the brain p53 and p73 mRNAs are expressed by performing in situ 
hybridizations (ISH). Additionally, I analyzed the expression of the p53 protein in the adult 
zebrafish brain by immunohistochemistry. 
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3.1.1 Analysis of p53 mRNA expression in the adult zebrafish brain 
 
To investigate the expression of p53 mRNA in the adult zebrafish brain, an ISH on cross 
sections through the whole brain with a p53 antisense probe was performed. As a control a 
sense probe for p53 was used. As shown in Figure 12 the p53 mRNA is broadly expressed in 
many parts of the adult zebrafish brain.  
In the telencephalon p53 mRNA expression was observed in the periventricular zone of the 
telencephalic ventricle (TelV) (Figure 12 A-C) as well as in the central (Vc) (Figure 12 B), 
dorsal (Vd) (Figure 12 A-B), ventral (Vv) (Figure 12 B) and postcommissural (Vp) (Figure 12 
C) nuclei of the ventral telencephalic area (V). Furthermore, p53 mRNA was expressed in the 
medial (Dm) (Figure 12 B-C), lateral (Dl) (Figure 12 B-C), dorsal (Dd) (Figure 12 C) and 
posterior (Dp) (Figure 12 B-C) zone of the dorsal telencephalic area (D) and in the sulcus 
ypsiloniformis (SY) (Figure 12 B-C).  
The diencephalon showed an expression of p53 mRNA in the periventricular zone of the 
diencephalic ventricle (DiV) (Figure 12 C-F) and in the anterior (PPa) (Figure 12 C) and 
posterior (PPp) (Figure 12 D) part of the parvocellular preoptic nucleus. p53 mRNA was also 
expressed in the dorsal (ENd) (Figure 12 C) and ventral (ENv) (Figure 12 C) part of the 
entopeduncular nucleus, in the anterior (PGa) (Figure 12 E) and lateral (PGl) (Figure 12 E) 
preglomerular nucleus and in the ventromedial (VM) (Figure 12 D-E) and anterior (A) (Figure 
12 E) thalamic nucleus. Additionally, p53 expression was detectable in the caudal (Hc) 
(Figure 12 G), dorsal (Hd) (Figure 12 F-G) and ventral (Hv) (Figure 12 E-F) zone of the 
periventricular hypothalamus and in the corpus mamillare (CM) (Figure 12 F-G). Moreover, 
p53 mRNA could be detected in the ventral habenular nucleus (Hav) (Figure 12 D-E) and in 
the periventricular nucleus of the posterior tuberculum (TPp) (Figure 12 E). 
In the mesencephalon an expression of p53 mRNA could be observed in the periventricular 
zone of the tectal ventricle (TeV) (Figure 12 F-G), in the periventricular grey zone of the optic 
tectum (PGZ) (Figure 12 E-G) and in the torus longitudinalis (TL) (Figure 12 F-G).  
In the hindbrain p53 mRNA was expressed in the periventricular zone of the 
rhombencephalic ventricle (RV) (Figure 12 H), in the lateral division of the valvula cerebelli 
(Val) (Figure 12 F-G), in the corpus cerebelli (CCe) (Figure 12 H), in the crista cerebellaris 
(CC) (Figure 12 H) and in the eminentia granularis (EG) (Figure 12 H). 
Figure 13 shows an ISH with a p53 sense probe as a negative control. As there is no staining 
visible in the brain regions that showed an obvious staining with the p53 antisense probe, the 
staining for p53 is specific and p53 mRNA is expressed in the regions described above. 
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Figure 12: p53 mRNA is expressed in many regions of the adult zebrafish brain. 
(A-H) In situ hybridization with a p53 antisense probe on cross sections through the whole adult 
zebrafish brain to investigate the expression of p53 mRNA. The schematics on the left side (modified 
from Wullimann et al., 1996) show the anatomical subdomains of the examined cross sections. Grey 
dots indicate areas of p53 mRNA expression. The small inserts on the right side indicate the anterior-
posterior levels of the sections. The p53 mRNA is broadly expressed in many parts of the adult 
zebrafish brain. 
Expression of p53 mRNA in (A) Vd, D, periventricular zone of the TelV; (B) Vv, Vd, Vc, Dm, Dl, Dp, 
SY, periventricular zone of the TelV; (C) PPa, Vp, SY, Dm, Dd, Dl, Dp, ENd, ENv, periventricular zone 
of the TelV and DiV; (D) PPp, VM, Hav, periventricular zone of the DiV; (E) PGZ, Hv, TPp, VM, A, PGl, 
PGa, periventricular zone of the DiV; (F) PGZ, TL, Val, Hv, Hd, CM, periventricular zone of the DiV 
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and TeV; (G) PGZ, TL, Val, Hd, Hc, CM, periventricular zone of the TeV; (H) CCe, EG, CC, 
periventricular zone of the RV. 
Abbrevations: A: anterior thalamic nucleus; CC: crista cerebellaris; CCe: corpus cerebelli; CM: corpus 
mamillare; D: dorsal telencephalic area; Dd: dorsal zone of D; DiV: diencephalic ventricle; Dl: lateral 
zone of D; Dm: medial zone of D; Dp: posterior zone of D; EG: eminentia granularis; ENd: 
entopeduncular nucleus, dorsal part; ENv: entopeduncular nucleus, ventral part; Hav: ventral 
habenular nucleus; Hc: caudal zone of periventricular hypothalamus; Hd: dorsal zone of periventricular 
hypothalamus; Hv: ventral zone of periventricular hypothalamus; PGa: anterior preglomerular nucleus; 
PGl: lateral preglomerular nucleus; PGZ: periventricular grey zone of optic tectum; PPa: parvocellular 
preoptic nucleus, anterior part; PPp: parvocellular preoptic nucleus, posterior part; RV: 
rhombencephalic ventricle; SY: sulcus ypsiloniformis; TeV: tectal ventricle; TelV: telencephalic 
ventricle; TL: torus longitudinalis; TPp: periventricular nucleus of posterior tuberculum; V: ventral 
telencephalic area; Val: lateral division of valvula cerebelli; Vc: central nucleus of V; Vd: dorsal 
nucleus of V; VM: ventromedial thalamic nucleus; Vp: postcommisural nucleus of V; Vv: ventral 
nucleus of V. Scale bar: 100 µm. 
 
 
 
Figure 13: No staining with the p53 sense probe. 
(A-H) In situ hybridization with a p53 sense probe on cross sections through the whole adult zebrafish 
brain as a negative control. The small inserts indicate the anterior-posterior levels of the sections. No 
staining could be observed with the p53 sense probe in all sections examined. Scale bar: 100 µm 
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3.1.2 Analysis of p73 mRNA expression in the adult zebrafish brain 
 
In order to analyze the expression of p73 mRNA in the adult zebrafish brain an ISH on cross 
sections through the whole brain with a p73 antisense probe was performed. A sense probe 
for p73 was used as a control. The p73 mRNA is broadly expressed in many parts of the 
adult zebrafish brain (Figure 14).  
p73 mRNA expression could be observed in the telencephalon in the periventricular zone of 
the telencephalic ventricle (TelV) (Figure 14 A-C) as well as in the central (Vc) (Figure 14 B), 
dorsal (Vd) (Figure 14 A-B), ventral (Vv) (Figure 14 B) and postcommissural (Vp) (Figure 14 
C) nuclei of the ventral telencephalic area (V). Furthermore p73 mRNA was expressed in the 
medial (Dm) (Figure 14 B-C), lateral (Dl) (Figure 14 B-C), dorsal (Dd) (Figure 14 C) and 
posterior (Dp) (Figure 14 B-C) zone of the dorsal telencephalic area (D) and in the sulcus 
ypsiloniformis (SY) (Figure 14 B).  
In the diencephalon p73 mRNA was expressed in the periventricular zone of the diencephalic 
ventricle (DiV) (Figure 14 C-F) and in the anterior (PPa) (Figure 14 C) and posterior (PPp) 
(Figure 14 D) part of the parvocellular preoptic nucleus. p73 mRNA could also be detected in 
the dorsal (ENd) (Figure 14 C) and ventral (ENv) (Figure 14 C) part of the entopeduncular 
nucleus, in the torus lateralis (TLa) (Figure 14 F-G) and in the ventromedial (VM) (Figure 14 
D-E) and anterior (A) (Figure 14 E) thalamic nucleus. Moreover, p73 was expressed in the 
caudal (Hc) (Figure 14 G), dorsal (Hd) (Figure 14 F-G) and ventral (Hv) (Figure 14 E-F) zone 
of the periventricular hypothalamus and in the corpus mamillare (CM) (Figure 14 F-G). 
Furthermore, p73 mRNA was detected in the ventral habenular nucleus (Hav) (Figure 14 D) 
and in the periventricular nucleus of the posterior tuberculum (TPp) (Figure 14 E). 
In the mesencephalon an expression of p73 mRNA was observed in the periventricular zone 
of the tectal ventricle (TeV) (Figure 14 F-G), in the periventricular grey zone of the optic 
tectum (PGZ) (Figure 14 E-G) and in the torus longitudinalis (TL) (Figure 14 F-G).  
In the hindbrain p73 mRNA was expressed in the periventricular zone of the 
rhombencephalic ventricle (RV) (Figure 14 H), in the lateral division of the valvula cerebelli 
(Val) (Figure 14 F-G), in the corpus cerebelli (CCe) (Figure 14 H), in the crista cerebellaris 
(CC) (Figure 14 H) and in the eminentia granularis (EG) (Figure 14 H). 
In Figure 15 an ISH with a p73 sense probe as a negative control is shown. There is no 
staining detectable in the brain regions that showed a clear staining with the p73 antisense 
probe. Thus, the staining for p73 is specific. 
When the expression patterns of p53 (Figure 12) and p73 (Figure 14) mRNA are compared, 
it is obvious that both are expressed in a similar manner with few exceptions. In the 
diencephalon p53 but not p73 mRNA was expressed in the anterior (PGa) and lateral (PGl) 
preglomerular nucleus and in the torus lateralis (TLa) p73 but not p53 mRNA was expressed. 
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In mammals p53 and p73 were shown to interact (Chen et al., 2001; Grob et al., 2001; 
Kartasheva et al., 2002; Wang et al., 2007a) and p73 is able to transactivate the same target 
genes as p53 (see chapter 1.2.3.2) (Kaghad et al., 1997; Levrero et al., 2000; Murray-
Zmijewski et al., 2006; Zhu et al., 1998a). The co-expression seen in many tissues of the 
adult zebrafish brain indicates that the two proteins may similarly interact in this context. 
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Figure 14: p73 mRNA is expressed in many regions of the adult zebrafish brain. 
(A-H) In situ hybridization with a p73 antisense probe on cross sections through the whole adult 
zebrafish brain to analyze the expression of p73 mRNA. The schematics on the left side (modified 
from Wullimann et al., 1996) show the anatomical subdomains of the examined cross sections. Grey 
dots indicate areas of p73 mRNA expression. The small inserts on the right side indicate the anterior-
posterior levels of the sections. The p73 mRNA is expressed in many parts of the adult zebrafish 
brain. 
Expression of p73 mRNA in (A) Vd, D, periventricular zone of the TelV; (B) Vv, Vd, Vc, Dm, Dl, Dp, 
SY, periventricular zone of the TelV; (C) PPa, Vp, Dm, Dd, Dl, Dp, ENd, ENv, periventricular zone of 
the TelV and DiV; (D) PPp, VM, Hav, periventricular zone of the DiV; (E) PGZ, Hv, TPp, VM, A, 
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periventricular zone of the DiV; (F) PGZ, TL, Val, Hv, Hd, CM, TLa, periventricular zone of the DiV and 
TeV; (G) PGZ, TL, Val, Hd, Hc, CM, TLa, periventricular zone of the TeV; (H) CCe, EG, CC, 
periventricular zone of the RV. 
Abbrevations: A: anterior thalamic nucleus; CC: crista cerebellaris; CCe: corpus cerebelli; CM: corpus 
mamillare; D: dorsal telencephalic area; Dd: dorsal zone of D; DiV: diencephalic ventricle; Dl: lateral 
zone of D; Dm: medial zone of D; Dp: posterior zone of D; EG: eminentia granularis; ENd: 
entopeduncular nucleus, dorsal part; ENv: entopeduncular nucleus, ventral part; Hav: ventral 
habenular nucleus; Hc: caudal zone of periventricular hypothalamus; Hd: dorsal zone of periventricular 
hypothalamus; Hv: ventral zone of periventricular hypothalamus; PGZ: periventricular grey zone of 
optic tectum; PPa: parvocellular preoptic nucleus, anterior part; PPp: parvocellular preoptic nucleus, 
posterior part; RV: rhombencephalic ventricle; SY: sulcus ypsiloniformis; TeV: tectal ventricle; TelV: 
telencephalic ventricle; TL: torus longitudinalis; TLa: torus lateralis; TPp: periventricular nucleus of 
posterior tuberculum; V: ventral telencephalic area; Val: lateral division of valvula cerebelli; Vc: central 
nucleus of V; Vd: dorsal nucleus of V; VM: ventromedial thalamic nucleus; Vp: postcommisural 
nucleus of V; Vv: ventral nucleus of V. Scale bar: 100 µm. 
 
 
 
Figure 15: No staining with the p73 sense probe. 
(A-H) In situ hybridization with a p73 sense probe on cross sections through the whole adult zebrafish 
brain as a negative control. The small inserts indicate the anterior-posterior levels of the sections. No 
staining could be detected with the p73 sense probe in all sections examined. Scale bar: 100 µm. 
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3.1.3 Generation of polyclonal antibodies against the C-terminus of the 
zebrafish p53 and p73 protein and testing of a new antibody against the 
zebrafish p53 protein 
 
Specific antibodies are important tools for characterizing the expression of proteins and to 
compare their expression to the expression of the mRNA. When I started to work on 
zebrafish p53 and p73 there were no antibodies against the two proteins available. 
Therefore, I first generated polyclonal antibodies against the zebrafish p53 and p73 protein.    
Since p53 (see chapter 1.2.1) and p73 (see chapter 1.2.3) have very similar sequences, 
especially in the DNA binding domain (Danilova et al., 2008a; De Laurenzi and Melino, 2000; 
Levrero et al., 2000; Murray-Zmijewski et al., 2006), I produced polyclonal antibodies only 
against the variable C-terminus of these proteins to avoid cross reactivity of the antibodies. 
For producing the polyclonal antibodies I cloned the C-terminus of zebrafish p53 and p73, 
respectively, in a vector (pGEX-4T-2) for expression of the proteins fused to Glutathion-S-
Transferase (GST) in bacteria. Afterwards the purified p53 and p73 proteins were used to 
immunize rats in order to produce the polyclonal antibodies. At the end, the serum of the 
immunized rats was recovered which contained the polyclonal antibodies against the C-
terminus of the zebrafish p53 or p73 protein. Subsequently, the specificity of the polyclonal 
antibodies was tested by western blot and immunohistochemistry. 
 
 
3.1.3.1 The polyclonal antibodies are functional in western blot 
 
After producing, extracting and purifying the polyclonal antibodies against the GST-zfp53-C-
terminus and GST-zfp73-C-terminus protein they were first tested by western blot if they are 
able to detect the zebrafish p53 and p73 protein. Therefore, H1299 cells, a p53 negative cell 
line, were transfected with a pcDNA3 vector that contained either full-length zebrafish p53 or 
p73α plus a myc tag (myc-zfp53 and myc-zfp73α). The myc tag was used to confirm that the 
transfection was successful. As negative controls H1299 cells were transfected with an 
empty pcDNA3 vector or they stayed untransfected. Subsequently the cells were lysed and 
the cell lysates were loaded onto a polyacrylamide gel. For the following western blot the 
self-made polyclonal antibodies against the GST-zfp53-C-terminus and GST-zfp73-C-
terminus protein or an anti-myc antibody were used. 
In Figure 16 A a band of 53 kDa (black arrow) can be observed for the cells transfected with 
myc-zfp53. This suggests that the polyclonal antibodies against the GST-zfp53-C-terminus 
protein are able to recognize the zebrafish p53 protein in western blot. As expected, there 
are any bands visible for the untransfected cells and for the cells transfected with an empty 
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vector since these cell lysates should not contain any zebrafish p53 protein. But there are 
unspecific bands present in all three different cell lysates with a size of about 72 kDa.  
Figure 16 B shows the western blot with an antibody against the myc tag for the cell lysates 
of untransfected cells and cells transfected with myc-zfp53. These lysates are the same 
lysates than the ones that were used in Figure 16 A. The band at 53 kDa (red arrow) for the 
cells transfected with myc-zfp53 indicates that the transfection was successful. There is any 
band present for the untransfected cells because these cells do not contain a p53 protein 
with a myc tag. There are also several unspecific bands visible. 
Figure 16 C shows that the polyclonal antibodies against the GST-zfp73-C-terminus protein 
are capable of detecting the zebrafish p73α protein in western blot (black arrow). As for p53, 
there are also unspecific bands visible and there is only a band for p73 at ca. 73 kDa 
detectable in the lysate of cells that were transfected with myc-zfp73α. Moreover, the 
transfection with myc-zfp73α also worked since there is a band present at 73 kDa in the 
lysate of cells transfected with myc-zfp73α (Figure 16 D). 
In summary, the self-made polyclonal antibodies against the GST-zfp53-C-terminus and 
GST-zfp73-C-terminus protein are both able to detect the zebrafish p53 and p73α protein, 
respectively, demonstrating that they work in western blot. 
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Figure 16: The self-made polyclonal antibodies against the GST-zfp53-C-terminus and the GST-
zfp73-C-terminus protein are functional in western blot. 
(A-D) To investigate if the polyclonal antibodies against the GST-zfp53-C-terminus and the GST-
zfp73-C-terminus protein are working, H1299 cells were transfected with a pcDNA3 vector containing 
either full length zebrafish p53 (A, B) or p73α (C, D) plus a myc tag (myc-zfp53 and myc-zfp73α). As 
negative controls cells were transfected with an empty pcDNA3 vector or they stayed untransfected. 
The myc tag was used to proof that the transfection was successful (B, D). Cells were lysed and the 
lysates were separated by a polyacrylamide gel. For the western blot the polyclonal antibodies against 
the GST-zfp53-C-terminus (A) and the GST-zfp73-C-terminus (C) protein or an antibody against the 
myc tag (B, D) were used. The polyclonal antibodies are able to detect zebrafish p53 (A, black arrow) 
and p73 (C, black arrow) protein in western blot. Furthermore, the myc control shows that the 
transfection was successful (B, D; red arrows). 
 
 
Additionally, it was tested by western blot if the polyclonal antibodies are also able to detect 
the GST protein since the GST tag was not cleaved off from the p53 and p73 protein before 
they were injected into rats to produce the antibodies. Thus, there is the possibility that the 
rats produced not only antibodies against zebrafish p53 and p73 but also against GST. To 
test this option, also cell lysate of H1299 cells either transfected with a pcDNA3 vector that 
contained full length zebrafish p53 or p73α plus a myc tag (myc-zfp53 and myc-zfp73α) as a 
positive control and additionally GST protein was loaded onto a polyacrylamide gel. For the 
following western blot the polyclonal antibodies against the GST-zfp53-C-terminus or GST-
zfp73-C-terminus protein were used. 
Figure 17 A and B show that, as already observed before, the polyclonal antibodies detect 
the zebrafish p53 and p73 protein (black arrows). But in addition they also recognize the 
GST protein (red arrows) which is indicated by the band at 26 kDa. Since the antibodies 
detect not only the zebrafish p53 and p73 protein but additionally also the GST protein this 
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could lead to problems in further experiments because the antibodies are not exclusively 
specialized to the proteins of interest. This could lead to false positive results. 
 
 
 
Figure 17: The self-made polyclonal antibodies against the GST-zfp53-C-terminus and the GST-
zfp73-C-terminus protein also recognize the GST protein. 
(A and B) To investigate if the polyclonal antibodies against the GST-zfp53-C-terminus and the GST-
zfp73-C-terminus protein are also able to detect GST protein, cell lysate from H1299 cells transfected 
with a pcDNA3 vector containing either full length zebrafish p53 (A) or p73α (B) plus a myc tag (myc-
zfp53 and myc-zfp73α) as a positive control and GST protein were loaded onto a polyacrylamide gel. 
For the western blot the polyclonal antibodies against the GST-zfp53-C-terminus (A) and the GST-
zfp73-C-terminus (B) protein were used. The polyclonal antibodies detect the zebrafish p53 (A, black 
arrow) and the zebrafish p73 (B, black arrow) protein. But they are also able to detect the GST protein 
(A, B; red arrows). 
 
 
3.1.3.2 The polyclonal antibodies are functional in Immunohistochemistry on cells 
 
The self-made polyclonal antibodies against the GST-zfp53-C-terminus and GST-zfp73-C-
terminus protein were also tested whether they worked in immunohistochemistry. Therefore, 
as for the western blot, H1299 cells were transfected with a pcDNA3 vector that contained 
either full length zebrafish p53 or p73α plus a myc tag (myc-zfp53 and myc-zfp73α). As 
negative controls H1299 cells were transfected with an empty pcDNA3 vector or they stayed 
untransfected. The cells were cultured on coverslips to perform the immunostaining with the 
polyclonal antibodies or with an antibody against the myc tag to ensure that the transfection 
was successful. Moreover, the nuclei were stained with the nuclear marker DRAQ5. 
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Figure 18 shows that the polyclonal antibodies against the GST-zfp53-C-terminus and GST-
zfp73-C-terminus protein do not only detect the zebrafish p53 and p73 protein in western blot 
but also in immunohistochemistry. The nuclei stained with DRAQ5 are depicted in red and 
the p53 or p73 protein is shown in green.  
Figure 18 A suggests that the polyclonal antibodies against the GST-zfp53-C-terminus 
protein detect the p53 protein in immunohistochemistry (white arrows). Additionally, the 
polyclonal antibodies against the GST-zfp73-C-terminus protein are able to recognize the 
p73 protein (Figure 18 C, white arrows). Furthermore, this figure shows that the transfection 
of the cells was effective indicated by the positive staining with the antibody against the myc 
tag (Figure 18 B and D, yellow arrows). However, not all cells are positive for myc. This 
indicates that not all of the cells were transfected effectively and therefore not all of the cells 
could be positive for p53 or p73. 
Of course also some negative controls were performed where H1299 cells were transfected 
with an empty pcDNA3 vector or they stayed untransfected. There was any staining visible 
for the negative controls neither with the polyclonal antibodies nor with the antibody against 
the myc tag (data not shown). 
These results suggest that the self-made polyclonal antibodies against the GST-zfp53-C-
terminus and GST-zfp73-C-terminus protein are functional both in western blot and 
immunohistochemistry when the experiments were performed with cells. 
 
 
 
Figure 18: The self-made polyclonal antibodies against the GST-zfp53-C-terminus and the GST-
zfp73-C-terminus protein are functional in immunohistochemistry on cells. 
(A-D) To examine if the polyclonal antibodies against the GST-zfp53-C-terminus and the GST-zfp73-
C-terminus protein are working in immunohistochemistry, H1299 cells were transfected with a pcDNA3 
vector containing either full length zebrafish p53 (A, B) or p73α (C, D) plus a myc tag (myc-zfp53 and 
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myc-zfp73α). The myc tag was used to proof that the transfection was successful (B, D). Cells were 
seeded on coverslips to perform the immunostainings with the antibodies against the GST-zfp53-C-
terminus (A) and the GST-zfp73-C-terminus (C) protein or with an antibody against the myc tag (B, D). 
Additionally, the nuclei of the cells were stained with the nuclear marker DRAQ5. The myc control 
shows that the transfection was effective (B, D; yellow arrows). Furthermore, the polyclonal antibodies 
are able to detect zebrafish p53 (A, white arrows) and p73 (C, white arrows) protein in 
immunohistochemistry. 
 
 
3.1.3.3 The polyclonal antibodies are not functional in Immunohistochemistry on 
brain sections 
 
Since I was interested in the expression of p53 and p73 in the adult zebrafish brain, the 
polyclonal antibodies were tested if they also specifically detect the p53 and p73 protein, 
respectively, in immunohistochemistry on sections of the adult zebrafish brain. To address 
this, cross sections through the telencephalon of adult zebrafish were stained with the 
polyclonal antibodies. 
Figure 19 A shows a section of a zebrafish telencephalon stained with the antibodies against 
p53. Since there is any staining visible for p53 this demonstrates that the self-made 
antibodies did not work in the immunostaining and they did not detect the p53 protein. The 
same holds true for the antibodies against p73. In Figure 19 B there is also any staining 
present for p73. Thus, the polyclonal antibodies against the GST-zfp53-C-terminus and GST-
zfp73-C-terminus protein do not work in immunohistochemistry on brain sections. 
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Figure 19: The self-made polyclonal antibodies against the GST-zfp53-C-terminus and the GST-
zfp73-C-terminus protein are not functional in immunohistochemistry on brain sections. 
(A-B) To find out if the polyclonal antibodies against the GST-zfp53-C-terminus and the GST-zfp73-C-
terminus protein are working in immunohistochemistry on adult zebrafish brain sections, an 
immunostaining of cross sections through the telencephalon of adult wildtype zebrafish with the 
antibodies against the p53 (A) or p73 (B) protein was performed. The inserts indicate the anterior-
posterior positions. The absent staining for both p53 (A) and p73 (B) denotes that the polyclonal 
antibodies against the GST-zfp53-C-terminus and the GST-zfp73-C-terminus protein are not working 
in immunohistochemistry on brain sections. Scale bars: 100 µm in A and B. 
 
 
In summary, the self-made polyclonal antibodies against the GST-zfp53-C-terminus and 
GST-zfp73-C-terminus protein are working in western blot and in immunohistochemistry 
when the experiments were performed with cells. However, they are not working in 
immunohistochemistry on zebrafish brain sections. Furthermore, the antisera are not only 
specific to p53 and p73 because they also detect GST. For this reason I decided not to use 
the self-made polyclonal antibodies for the following experiments. 
 
 
3.1.3.4  A commercially available antibody against the zebrafish p53 protein detects 
p53 in Immunohistochemistry and western blot 
 
As the self-made polyclonal antibodies against the GST-zfp53-C-terminus protein are not 
working properly (see chapter 3.1.3.3), an antibody against the zebrafish p53 protein, which 
was launched in the meantime, was tested. This antibody is a rabbit polyclonal antibody 
called “Anti-Tp53, ZFishTM“ (further referred to as anti-p53 antibody). It is available from 
AnaSpec and is directed against the full length p53 protein. I investigated if this antibody is 
able to detect the p53 protein and if this antibody is specific. 
First, the anti-p53 antibody was tested if it works in western blot. Telencephala of adult 
wildtype zebrafish were lysed and the lysate was loaded, together with lysate from H1299 
cells transfected with a pcDNA3 vector that contained full length zebrafish p53 plus a myc 
tag (myc-zfp53) (see chapter 3.1.3.1) as a positive control, onto a polyacrylamide gel. For the 
following western blot the anti-p53 antibody was used.  
As shown in Figure 20 there are bands visible at around 53 kDa which suggests that the anti-
p53 antibody is able to detect the p53 protein both in the cell lysate and in the telencephalon 
lysate (Figure 20, red box). There are also unspecific bands visible for the telencephalon 
lysate. This result indicates that on the one hand the antibody works in western blot and on 
the other hand that the p53 protein is present in the telencephalon of adult zebrafish. 
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Figure 20: The new anti-p53 antibody detects the p53 protein in telencephalon-lysate. 
To investigate if the new anti-p53 antibody is working in western blot, telencephala of adult zebrafish 
were lysed and the lysate was loaded onto a polyacrylamide gel together with lysate of H1299 cells 
transfected with myc-zfp53 as a positive control. For the western blot the new anti-p53 antibody was 
used. This antibody is able to detect the p53 protein in the positive control as well as in the 
telencephalon lysate (red box). 
 
 
Furthermore, cross sections through the telencephalon of adult zebrafish were stained with 
the anti-p53 antibody to find out if this antibody is working in immunohistochemistry on brain 
sections. The nuclei were stained with the nuclear marker DRAQ5.  
As shown in Figure 21, in contrast to the self-made polyclonal antibodies, the new anti-p53 
antibody is able to detect the p53 protein on brain sections. The p53 protein is expressed 
along the ventricular zone (Figure 21 C’, white arrow) and in the parenchyma (Figure 21 C’’, 
white arrow) of the adult zebrafish telencephalon. Furthermore, p53 shows a nuclear 
expression. As a negative control brain sections were stained only with the secondary 
antibody. There was no staining present without the first anti-p53 antibody (data not shown), 
which suggests that the staining is specific. 
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Figure 21: The new anti-p53 antibody detects the p53 protein in immunohistochemistry on 
brain sections. 
(A-C’’) To examine if the new anti-p53 antibody is working in immunohistochemistry on adult zebrafish 
brain sections cross sections through the telencephalon of adult wildtype zebrafish were 
immunostained with this antibody (A-A’’), the nuclei were stained with the nuclear marker DRAQ5 (B-
B’’). (C-C’’) show the merged panels. These pictures display a representative vibratome section 
through the medial telencephalon. The insert in (A) indicates the anterior-posterior position and the 
boxes in (A) show the regions depicted in higher magnification in (A’-C’, right box) and (A’’-C’’, left 
box). The new anti-p53 antibody detects the p53 protein in a brain section of the adult zebrafish 
telencephalon. p53 is expressed along the ventricular zone (C’, white arrow) and in the parenchyma 
(C’’, white arrow) of the telencephalon and it shows a nuclear expression. Scale bars: 100 µm in C; 20 
µm in C’ and C’’. 
 
 
To further verify that the observed staining is specific and that the detected protein is p53, I 
performed a fluorescent in situ hybridization (FISH). A p53 antisense probe and the anti-p53 
antibody were used to compare the expression of p53 mRNA with the expression of the 
protein detected by the anti-p53 antibody in the adult zebrafish telencephalon. If the detected 
protein is p53, there should be an overlap in the expression of p53 mRNA and 
immunostaining.  
In Figure 22 it is shown that the p53 mRNA is expressed in almost the same areas of the 
section of the telencephalon as the protein which is detected by the anti-p53 antibody. The 
p53 mRNA is also expressed along the ventricular zone and partially in the parenchyma. 
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This suggests that there is an overlap in the expression of p53 mRNA and detected protein 
(Figure 22 C’, white arrows). Thus it is most likely that the protein detected by the antibody is 
p53. There are also some regions where the protein is present but the mRNA is not, as in the 
ventral telencephalic area. This is most likely a technical problem of the probe.  
 
 
 
Figure 22: The expression of p53 mRNA overlaps with the immunostaining for p53. 
(A-C’) Fluorescent in situ hybridization (FISH) with a p53 antisense probe (B-B’) and the anti-p53 
antibody (A-A’) was performed on cross sections through the telencephalon of adult wildtype zebrafish 
in order to investigate if there is an overlap in the expression of p53 mRNA with the protein detected 
by the new antibody. The merged panels are shown in (C-C’). These pictures display a representative 
vibratome section through the medial telencephalon. The insert in (A) indicates the anterior-posterior 
position and the box in (A) shows the region depicted in higher magnification in (A’-C’). There is an 
overlap in the expression of p53 mRNA and the potential p53 protein which is detected by the anti-p53 
antibody (C’, white arrows). Scale bars: 100 µm in C; 20 µm in C’. 
 
 
Another proof that the commercially available anti-p53 antibody specifically detects the p53 
protein was provided by immunostaining embryos. Therefore p53-GFP RNA was injected 
into one-cell stage wildtype zebrafish embryos. p53-GFP positive embryos were fixed at 8 
hours post fertilization (hpf) and afterwards the embryos were co-immunostained with the 
anti-p53 antibody and an antibody against GFP. Since a p53-GFP fusion construct was 
injected, p53 expression should be detected everywhere where GFP expression can be 
observed.  
Figure 23 indicates that this is the case because the representative embryo shows 
expression of the injected p53-GFP construct and all cells that are positive for GFP show 
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also a staining for p53 (Figure 23 C, white arrows). Consequently, this experiment supports 
the assumption that the staining with the new anti-p53 antibody is specific. 
 
 
 
Figure 23: The staining with an anti-GFP antibody overlaps with the staining for p53 in the 
embryo. 
(A-C) p53-GFP RNA was injected into one-cell stage wildtype zebrafish embryos. p53-GFP positive 
embryos were fixed at 8 hpf and were co-immunostained afterwards with an anti-GFP and the anti-p53 
antibody. This figure shows a representative embryo stained with an anti-GFP (A) and the anti-p53 
antibody (B). (C) shows the merged view of the staining. All cells of the embryo that are positive for 
GFP are also positive for p53 (C, white arrows). Scale bar: 50 µm. 
 
 
In summary these results suggest that the new anti-p53 antibody was working very well. It 
detected the p53 protein both in western blot and, in contrast to the self-made polyclonal 
antibodies, also in immunohistochemistry on brain sections. Moreover, the staining with the 
antibody is specific. Furthermore, these results lead to the assumption that the p53 protein is 
expressed in the adult zebrafish brain which will be further investigated in the following 
paragraphs. Since the new antibody was working properly I used it for the following 
experiments.  
Unfortunately there is no antibody against the zebrafish p73 protein commercially available 
and therefore I could not investigate the expression of the p73 protein.  
 
 
 
3.1.4 Analysis of p53 protein expression in the adult zebrafish brain 
 
With this new p53 antibody as tool, I wanted to investigate the expression of the p53 protein 
not only in the telencephalon but also in the other parts of the adult zebrafish brain. In 
addition, I intended to find out if the p53 protein is expressed in the same areas of the adult 
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zebrafish brain as the mRNA (see chapter 3.1.1). The p53 protein is tightly regulated by 
Mdm2 and other components (Boehme and Blattner, 2009; Levine et al., 2006) (see chapter 
1.2.1.2). Therefore it could be possible that the mRNA of p53 is expressed in a region of the 
brain but the protein is not present in this region. To examine the expression of the p53 
protein in the adult zebrafish brain, cross sections through the whole brain were 
immunostained with the anti-p53 antibody. The nuclei were stained with the nuclear marker 
DRAQ5. In Figure 24 it is shown that the p53 protein is broadly expressed in many parts of 
the adult zebrafish brain, like the p53 mRNA. 
In the telencephalon the p53 protein was expressed in the periventricular zone of the 
telencephalic ventricle (TelV) (Figure 24 A-C) and in the central (Vc) (Figure 24 B), dorsal 
(Vd) (Figure 24 A-B), ventral (Vv) (Figure 24 B) and postcommisural (Vp) (Figure 24 C) 
nuclei of the ventral telencephalic area (V). Furthermore, the p53 protein was expressed in 
the medial (Dm) (Figure 24 B-C), lateral (Dl) (Figure 24 B-C), dorsal (Dd) (Figure 24 C) and 
posterior (Dp) (Figure 24 B-C) zone of the dorsal telencephalic area (D). Unlike the mRNA, 
the p53 protein could not be detected in the sulcus ypsiloniformis (SY). 
In the diencephalon p53 protein expression was observed in the periventricular zone of the 
diencephalic ventricle (DiV) (Figure 24 C-F) and in the anterior (PPa) (Figure 24 C) and 
posterior (PPp) (Figure 24 D) part of the parvocellular preoptic nucleus. Moreover, the p53 
protein was also expressed in the dorsal (ENd) (Figure 24 C) and ventral (ENv) (Figure 24 C) 
part of the entopeduncular nucleus, in the anterior (PGa) (Figure 24 E) and lateral (PGl) 
(Figure 24 E) preglomerular nucleus and in the ventromedial (VM) (Figure 24 D-E) and 
anterior (A) (Figure 24 E) thalamic nucleus. p53 could also be detected in the caudal (Hc) 
(Figure 24 G), dorsal (Hd) (Figure 24 F-G) and ventral (Hv) (Figure 24 E-F) zone of the 
periventricular hypothalamus and in the corpus mamillare (CM) (Figure 24 G). Additionally, 
the p53 protein was expressed in the ventral habenular nucleus (Hav) (Figure 24 D) and in 
the periventricular nucleus of the posterior tuberculum (TPp) (Figure 24 E-F). 
In the mesencephalon an expression of p53 protein was observed in the periventricular zone 
of the tectal ventricle (TeV) (Figure 24 F-G), in the periventricular grey zone of the optic 
tectum (PGZ) (Figure 24 E-G) and in the torus longitudinalis (TL) (Figure 24 F-G).  
In the hindbrain the p53 protein was expressed in the periventricular zone of the 
rhombencephalic ventricle (RV) (Figure 24 H), in the corpus cerebelli (CCe) (Figure 24 H), in 
the crista cerebellaris (CC) (Figure 24 H) and in the eminentia granularis (EG) (Figure 24 H). 
In contrast to p53 mRNA, the p53 protein was not expressed in the lateral division of the 
valvula cerebelli (Val). 
When the expression of p53 mRNA (Figure 12) and p53 protein (Figure 24) are compared it 
is obvious that both are expressed in the same regions of the adult zebrafish brain, with few 
exceptions. There are some small differences in the expression pattern but nevertheless it is 
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evident that the p53 mRNA and protein are broadly expressed in many regions of the adult 
zebrafish brain and the p53 protein is expressed in most of the regions where an expression 
of p53 mRNA was observed. 
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Figure 24: The p53 protein is broadly expressed in many regions of the adult zebrafish brain. 
(A-H) Immunohistochemistry on cross sections through the whole adult zebrafish brain with the anti-
p53 antibody to examine the expression of the p53 protein. The nuclei were stained with the nuclear 
marker DRAQ5. The schematics on the left side (modified from Wullimann et al., 1996) show the 
anatomical subdomains of the examined cross sections. Grey dots indicate areas of p53 protein 
expression. The small inserts on the right side indicate the anterior-posterior levels of the sections. 
Like the p53 mRNA, the p53 protein is broadly expressed in many parts of the adult zebrafish brain. 
Expression of the p53 protein in (A) Vd, D, periventricular zone of the TelV; (B) Vv, Vd, Vc, Dm, Dl, 
Dp, periventricular zone of the TelV; (C) PPa, Vp, Dm, Dd, Dl, Dp, ENd, ENv, periventricular zone of 
the TelV and DiV; (D) PPp, VM, Hav, periventricular zone of the DiV; (E) PGZ, Hv, TPp, VM, A, PGl, 
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PGa, periventricular zone of the DiV; (F) PGZ, TL, Hv, Hd, TPp, periventricular zone of the DiV and 
TeV; (G) PGZ, TL, Hd, Hc, CM, periventricular zone of the TeV; (H) CCe, EG, CC, periventricular zone 
of the RV. Abbreviations: see Figure 12 and Figure 14. Scale bar: 100 µm. 
 
 
 
3.1.5 Generation of p53 and p73 transgenic lines  
 
Since any antibody against the zebrafish p73 protein was available it was not possible to 
perform any experiments regarding the expression of the p73 protein. But as I wanted to 
examine the expression of the p73 protein as well, I started to generate transgenic lines for 
p73. At the same time I also tried to generate transgenic lines for p53. I attempted to 
generate two different transgenic lines for p53 and p73, respectively. On the one hand I tried 
to generate the transgenic lines Tg(p53:EGFP) and Tg(p73:EGFP) by using a BAC clone of 
the zebrafish p53 or p73 locus to drive the expression of enhanced green fluorescent protein 
(EGFP). On the other hand, Tg(p53-EGFP) and Tg(p73-EGFP) fusion lines should be 
generated by using BAC clones harboring the zebrafish p53 or p73 locus. After injection of 
the different constructs into one-cell stage zebrafish embryos, the fish were raised to 
adulthood and outcrossed to identify a stable integration of the transgene. Unfortunately, any 
positive founder has been found for the different lines. 
 
 
In summary, it was shown in this chapter that both p53 mRNA and p53 protein are broadly 
expressed in many regions of the adult zebrafish telencephalon, as well as p73 mRNA. 
Furthermore, it turned out that the self-made polyclonal antibodies against the GST-zfp53-C-
terminus and GST-zfp73-C-terminus protein are not functional in immunohistochemistry on 
zebrafish brain sections but the commercially available anti-p53 antibody detects specifically 
the p53 protein both in western blot and immunohistochemistry.  
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3.2 The p53 protein is expressed in different cell types in the 
adult zebrafish telencephalon  
 
After mapping the overall expression of p53 protein in the various subdivisions of the adult 
zebrafish brain (see chapter 3.1.4). I focus in this chapter on the results of the high resolution 
mapping of expression of p53 to determine in which cell types exactly the p53 protein is 
expressed. I performed co-immunostainings with specific markers for the different cell types 
that are present in the adult zebrafish brain to further characterize the expression of p53 in 
these cell types. I focused my work in this and the following chapters on the telencephalon. 
The telencephalon, like the rest of the zebrafish CNS, shows a very high proliferative and 
regenerative capacity in comparison to the mammalian brain (Adolf et al., 2006; Chapouton 
et al., 2007; Grandel et al., 2006; Kaslin et al., 2008; Zupanc, 2001; Zupanc and Zupanc, 
2006) In addition it was shown that the adult zebrafish telencephalon harbours homologs of 
the SVZ and SGZ, the two mammalian neurogenic regions (Adolf et al., 2006; Grandel et al., 
2006; März et al., 2010a). To know in which cell types p53 is expressed could be a first hint 
to its role in the adult zebrafish telencephalon in general and to its potential role in 
constitutive neurogenesis.  
 
 
 
3.2.1 p53 expression in cells located in the parenchyma of the adult zebrafish 
telencephalon 
 
3.2.1.1 The p53 protein is not expressed in Tg(olig2:EGFP)- positive cells 
 
As shown in chapter 3.1.4, the p53 protein is expressed in the parenchyma of the adult 
zebrafish telencephalon (Figure 24 A-C). Therefore I investigated whether p53 is expressed 
in cells of the oligodendrocyte lineage, which are located in the parenchyma of the adult 
zebrafish telencephalon and express the basic helix-loop-helix (bHLH) transcription factor 
Olig2 (März et al., 2010b). I made use of the Tg(olig2:EGFP) line (Shin et al., 2003) that 
faithfully marks these cell types (März et al., 2010b). Cross sections through the 
telencephalon of Tg(olig2:EGFP) fish were co-immunostained with an anti-GFP and the anti-
p53 antibody. The nuclei were stained with the nuclear marker DRAQ5.  
The p53 protein is not expressed in Tg(olig2:EGFP)-positive cells (Figure 25). Instead p53 is 
expressed in cells that are located next to Tg(olig2:EGFP)-positive cells (Figure 25 D’ and 
D’’, white arrows). It was shown that Tg(olig2:EGFP)-positive cells can often be found in 
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close association with cells that express the neuronal marker HuC/D (März et al., 2010b). 
Therefore, the p53 expressing cells residing next to the Tg(olig2:EGFP)-positive cells could 
be neurons. 
 
 
 
Figure 25: The p53 protein is not expressed in Tg(olig2:EGFP)-positive cells in the adult 
zebrafish telencephalon. 
(A-D’’) To investigate if the p53 protein is expressed in cells of the oligodendrocyte lineage, cross 
sections through the telencephalon of adult Tg(olig2:EGFP) zebrafish were co-immunostained with the 
anti-p53 antibody (A-A’’) and with an anti-GFP antibody (B-B’’). The nuclei were stained with the 
nuclear marker DRAQ5 (C-C’’). (D-D’’) show the merged panels. These pictures display a 
representative vibratome section through the medial telencephalon. The insert in (A) indicates the 
anterior-posterior position and the boxes in (A) show the regions depicted in higher magnification in 
(A’-D’, left box) and (A’’-D’’, right box). Tg(olig2:EGFP)-positive cells in the parenchyma do not express 
p53, p53- positive cells are located next to Tg(olig2:EGFP)-positive cells ((D’) and (D’’), white arrows). 
The boxes in (D’) and (D’’) show magnified p53 positive cells next to Tg(olig2:EGFP)-positive cells. 
Scale bars: 100 µm in D; 20 µm in D’ and D’’. 
 
 
3.2.1.2 The p53 protein is expressed in HuC/D-positive neurons 
 
The result of the immunostaining performed in chapter 3.2.1.1 led to the assumption that the 
p53 protein could be expressed in neurons. In order to prove if this hypothesis is correct, I 
performed co-immunostainings of cross sections through the telencephalon of adult wildtype 
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zebrafish with antibodies against p53 and HuC/D, which is a RNA binding protein and labels 
cells that show a neuronal differentiation state (Mueller and Wullimann, 2002). The nuclei 
were stained with the nuclear marker DRAQ5. 
The p53 protein is indeed expressed in cells of the neuronal lineage in the adult zebrafish 
telencephalon (Figure 26). There are many p53-positive cells that co-express the neuronal 
marker HuC/D (Figure 26 D’ and D’’, white arrows). In mammals p53 preserves the post-
mitotic character of neurons (see chapter 1.2.1.5) (Miller et al., 2003). Thus, p53 could have 
the same anti-proliferative role in the adult zebrafish brain. However, HuC/D does not 
discriminate between mature neurons and neuroblasts/immature neurons since it is 
expressed from early stages of neuronal differentiation onwards (Kroehne et al., 2011).  
 
 
 
Figure 26: The p53 protein is expressed in neurons in the adult zebrafish telencephalon. 
(A-D’’) Co-immunostainings of cross sections through the telencephalon of adult wildtype zebrafish 
with antibodies against p53 (A-A’’) and the neuronal marker HuC/D (B-B’’) were performed to examine 
if the p53 protein is expressed in neurons. The nuclei were stained with the nuclear marker DRAQ5 
(C-C’’). (D-D’’) show the merged panels. These pictures display a representative vibratome section 
through the medial telencephalon. The insert in (A) indicates the anterior-posterior position and the 
boxes in (A) show the regions depicted in higher magnification in (A’-D’, upper box) and (A’’-D’’, lower 
box). p53- positive cells co-express the neuronal marker HuC/D ((D’) and (D’’), white arrows) which 
indicates that the p53 protein is expressed in neurons. The boxes in (D’) and (D’’) show magnified 
triple-positive cells for p53, HuC/D and DRAQ5. Scale bars: 100 µm in D; 20 µm in D’ and D’’. 
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3.2.1.3 The p53 protein is expressed in HuC/D-positive neurons located next to 
Tg(olig2:EGFP)-positive cells 
 
In chapter 3.2.1.2 it was shown that the p53 protein is expressed in HuC/D-positive neurons 
in the adult zebrafish telencephalon. Therefore, the cells located next to Tg(olig2:EGFP)-
positive cells could be p53-positive neurons (see chapter 3.2.1.1). To verify this speculation I 
co-immunostained cross sections through the telencephalon of Tg(olig2:EGFP) zebrafish 
with an anti-GFP, an anti-HuC/D and with the anti-p53 antibody. 
The p53-positive cells residing next to the Tg(olig2:EGFP)-positive cells are also HuC/D-
positive (Figure 27). These results suggest that in the adult zebrafish telencephalon there are 
p53-positive neurons present that are located close to cells that belong to the 
oligodendrocyte lineage (Figure 27 D’ and H’, white arrows). As already mentioned in chapter 
3.2.1.2, the p53-positive neurons could be early neurons since oligodendrocytes are 
myelinating new-born neurons (März et al., 2010b). This could be the reason why these 
neurons are located next to cells of the oligodendrocyte lineage. 
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Figure 27: The p53 protein is expressed in neurons located next to Tg(olig2:EGFP)-positive 
cells in the adult zebrafish telencephalon. 
(A-H’) To investigate if the p53 protein is expressed in HuC/D-positive neurons that are located next to 
Tg(olig2:EGFP)-positive cells in the parenchyma of the adult zebrafish telencephalon, cross sections 
through the telencephalon of adult Tg(olig2:EGFP) zebrafish were co-immunostained with the anti-p53 
antibody (A-A’ and E-E’), an anti-GFP antibody (B-B’ and F-F’) and with an anti-HuC/D antibody (C-C’ 
and G-G’). (D-D’ and H-H’) show the merged panels. These pictures display representative vibratome 
sections through the medial telencephalon. The inserts in (A) and (E) indicate the anterior-posterior 
positions and the boxes in (A) and (E) show the regions depicted in higher magnification in (A’-D’) and 
(E’-H’), respectively. HuC/D-positive cells co-express p53 and are located next to Tg(olig2:EGFP)-
positive cells ((D’) and (H’), white arrows). This denotes that the p53 protein is expressed in neurons 
which are residing next to Tg(olig2:EGFP)-positive cells in the adult zebrafish telencephalon. The 
boxes in (D’) and (H’) show magnified p53-positive neurons next to Tg(olig2:EGFP)-positive cells. 
Scale bars: 100 µm in D and H; 20 µm in D’ and H’. 
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3.2.1.4 The p53-positive neurons located next to Tg(olig2:EGFP)-positive cells are not 
positive for BrdU 
 
In order to investigate if the p53-positive neurons located next to Tg(olig2:EGFP)-positive 
cells are new-born neurons (see chapter 3.2.1.3) I injected the thymidine analogue BrdU 
intraperitoneally on 3 consecutive days into Tg(olig2:EGFP) zebrafish to label the DNA of 
proliferating cells. This was followed by a chase of 2, 3 and 4 weeks, respectively. Afterwards 
a triple staining of cross sections through the telencephalon of BrdU injected Tg(olig2:EGFP) 
zebrafish was performed with an anti-GFP, an anti-BrdU and with the anti-p53 antibody.  
Two weeks after a BrdU pulse, BrdU-positive cells have migrated from the ventricular zone 
into the adjacent parenchyma. Furthermore, 74% of the BrdU-positive cells are also positive 
for the neuronal marker Hu (Adolf et al., 2006) which demonstrates that these cells are new-
born neurons. These data indicate that new neurons are generated at the ventricular zone by 
neural stem cells and these new-born neurons then migrate into the parenchyma. However, 
in constitutive neurogenesis new-born neurons settle mainly at the subventricular zone or in 
the adjacent parenchyma. Whereas in regenerative neurogenesis newborn neurons migrate 
longer distances into the injured parenchyma (Baumgart et al., 2012; Kroehne et al., 2011).  
If the p53-positive neurons located next to Tg(olig2:EGFP)-positive cells are new-born 
neurons that become myelinated they should be labeled by BrdU. 
For all three time points there are no p53 and BrdU double-positive cells present that are 
located next to Tg(olig2:EGFP)-positive cells in the parenchyma of the adult zebrafish 
telencephalon (Figure 28). Whereas at the ventricular zone BrdU and p53 double-positive 
cells could be observed next to Tg(olig2:EGFP)-positive cells (Figure 28 H’, yellow arrow). 
This result leads to the assumption that the p53-positive neurons located next to 
Tg(olig2:EGFP)-positive cells in the parenchyma are not new-born but already differentiated 
neurons. This is in accordance with the assumption that p53 expression retains the post-
mitotic character of neurons in the adult zebrafish brain (see chapter 3.2.1.2). These data are 
also in agreement with the findings that new-born neurons settle mainly at the subventricular 
zone or in the adjacent parenchyma and do not migrate deep into the parenchyma under 
normal conditions. 
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Figure 28: The p53-positive neurons located next to Tg(olig2:EGFP)-positive cells are not BrdU-
positive in the adult zebrafish telencephalon. 
(A-L’) To examine if the p53-positive neurons located next to Tg(olig2:EGFP)-positive cells are early 
neurons,  BrdU was injected on 3 consecutive days into Tg(olig2:EGFP) zebrafish followed by a chase 
of 2, 3 and 4 weeks, respectively. Subsequently a triple immunostaining was performed on cross 
sections through the telencephalon of BrdU-injected Tg(olig2:EGFP) zebrafish with antibodies against 
p53 (A-A’,E-E’ and I-I’), GFP (B-B’, F-F’ and J-J’) and BrdU (C-C’, G-G’ and K-K’). (D-D’, H-H’ and L-
L’) show the merged panels. The inserts in (A), (E) and (I) indicate the anterior-posterior positions and 
the boxes in (A), (E) and (I) show the regions depicted in higher magnification in (A’-D’), (E’-H’) and (I’-
L’), respectively. No p53 and BrdU double-positive cells located next to Tg(olig2:EGFP)-positive cells 
in the parenchyma could be observed. But at the ventricle a p53 and BrdU double-positive cell located 
next to a Tg(olig2:EGFP)-positive cell could be detected ((H’), yellow arrow). The box in (H’) shows a 
magnification of these cells. This indicates that the p53-positive neurons located next to 
Tg(olig2:EGFP)-positive cells in the parenchyma are not new-born neurons. In the parenchyma p53-
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positive but BrdU-negative cells were located next to Tg(olig2:EGFP)- positive cells ((D’), (H’) and (L’), 
white arrows). Also some p53 and BrdU double-positive cells located at the ventricular zone could be 
observed ((D’) and (L’), white arrowheads). A Tg(olig2:EGFP)-positive cell interfered with a p53-
positive cell which looked like as if they were one double-positive cell ((H’), yellow arrowhead). Scale 
bars: 100 µm in D, H and L; 20 µm in D’, H’ and L’. 
 
 
 
3.2.2 p53 expression in cells located at the ventricular zone of the adult 
zebrafish telencephalon 
 
3.2.2.1 The p53 protein is expressed in Tg(gfap:GFP)-positive cells 
 
As shown above, the p53 protein is not only expressed in the parenchyma of the adult 
zebrafish telencephalon but also along the ventricular zone (see chapter 3.1.4 and Figure 24 
A-C).(März et al.)showed that there are distinct progenitor cell types present at the 
ventricular zone of the adult zebrafish telencephalon which are heterogenic in terms of their 
proliferation rate (see chapter 1.1.2.1). The different cell types are characterized by the 
expression of a specific set of markers, which classifies them into at least four cell types. 
Type I cells, which are non-dividing RGCs, and Type II cells, which are dividing RGCs, 
express radial glial markers like S100β and GFAP and the progenitor marker Nestin. 
Additionally, the dividing Type II cells express the proliferation marker PCNA. Type IIIa cells 
are characterized by a low expression of glial markers and they also express PCNA. 
Moreover, they express PSA-NCAM which is a neuronal progenitor marker. Type IIIb cells 
are neuroblasts and lack expression of all glial markers but they are positive for PCNA and 
PSA-NCAM (März et al., 2010a).  
In order to investigate if p53 is expressed in the different cell types located at the ventricular 
zone in the adult zebrafish telencephalon I first examined if p53 is expressed in GFAP-
positive cells. Cross sections through the telencephalon of Tg(gfap:GFP) fish (Bernardos and 
Raymond, 2006) were co-immunostained with an anti-GFP and the anti-p53 antibody. The 
nuclei were stained with the nuclear marker DRAQ5.  
The p53 protein is expressed in Tg(gfap:GFP)-positive cells (Figure 29). Only a very low 
number of Tg(gfap:GFP)-positive cells show co-expression with p53 (Figure 29 D’ and D’’, 
white arrows). These p53 and Tg(gfap:GFP) double-positive cells are most likely either Type 
I or Type II cells (RGCs). But since also Type IIIa cells show a low expression of glial 
markers they could also be neural progenitors. 
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Figure 29: The p53 protein is expressed in Tg(gfap:GFP)-positive cells in the adult zebrafish 
telencephalon. 
(A-D’’) Co-immunostaining of cross sections through the telencephalon of adult Tg(gfap:GFP) 
zebrafish with antibodies against p53 (A-A’’) and GFP (B-B’’) was performed to investigate if the p53 
protein is expressed in Tg(gfap:GFP)-positive cells. The nuclei were stained with the nuclear marker 
DRAQ5 (C-C’’). (D-D’’) show the merged panels. These pictures display a representative vibratome 
section through the anterior telencephalon. The insert in (A) indicates the anterior-posterior position 
and the boxes in (A) show the regions depicted in higher magnification in (A’-D’, upper box) and (A’’- 
D’’, lower box). The p53 protein is expressed in some Tg(gfap:GFP)-positive cells ((D’) and (D’’), white 
arrows). The boxes in (D’) and (D’’) show magnified triple-positive cells for p53, GFP and DRAQ5. 
Scale bars: 100 µm in D; 20 µm in D’ and D’’. 
 
 
3.2.2.2 The p53 protein is expressed in Type I but not in Type II cells 
 
The p53 protein is expressed in Tg(gfap:GFP)-positive cells (see chapter 3.2.2.1 and Figure 
29), which could be Type I (non-dividing RGCs) or Type II (dividing RGCs) cells. In order to 
investigate in which of these two cell types p53 is expressed, a triple immunostaining of 
cross sections through the telencephalon of Tg(gfap:GFP) fish with antibodies against GFP 
and p53 and against the proliferation marker PCNA was performed.  
The p53 protein is expressed in Tg(gfap:GFP)-positive and PCNA-negative cells (Figure 30 
D’’ and H’, white arrows). These cells are Type I cells. Furthermore, it is expressed in PCNA-
positive and Tg(gfap:GFP)-negative cells (Figure 30 D’, D’’ and H’, white arrowheads), which 
could be Type IIIb cells. There are also Tg(gfap:GFP)-positive cells present that are negative 
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for p53 and PCNA (Figure 30 D’ and H’, yellow arrows). Thus, p53 seems not to be 
expressed in all Type I cells. Since p53 is not expressed in PCNA- and Tg(gfap:GFP)-
positive cells it is not expressed in proliferating Type II but only in quiescent Type I cells. In 
the mouse brain p53 is expressed in neural stem and progenitor cells as well and 
suppresses the self-renewal of adult neural stem cells. (Gil-Perotin et al., 2006; Li et al., 
2008). It was suggested that it could be crucial to suppress the self-renewal of stem cells by 
p53 for long-term maintenance of the stem cell population (Meletis et al., 2006). The 
expression of the p53 protein in quiescent Type I cells in the adult zebrafish telencephalon is 
in accordance with the antiproliferative capacities of p53. 
 
 
 
Figure 30: The p53 protein is expressed in Type I cells in the adult zebrafish telencephalon. 
(A-H’) To investigate if the p53 protein is expressed in Type I and/or Type II cells a triple 
immunostaining of cross sections through the telencephalon of adult Tg(gfap:GFP) zebrafish with 
antibodies against p53 (A-A’’ and E-E’), GFP (B-B’’ and F-F’) and the proliferation marker PCNA (C-C’’ 
and G-G’) was performed. (D-D’’ and H-H’) show the merged panels. The inserts in (A) and (E) 
indicate the anterior-posterior positions and the boxes in (A) and (E) show the regions depicted in 
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higher magnification in (A’-D’), (A’’-D’’) and (E’-H’), respectively. The p53 protein is expressed in 
PCNA-positive and Tg(gfap:GFP)-negative cells (D’, D’’ and H’, white arrowheads), which could be 
Type IIIb cells. It is also expressed in Tg(gfap:GFP)-positive and PCNA-negative cells (D’’ and H’, 
white arrows), which are Type I cells. Since it is not expressed in PCNA- and Tg(gfap:GFP)-positive 
cells, p53 seems not to be expressed in Type II cells. There are also Tg(gfap:GFP)- positive cells that 
do not co-express p53 (D’ and H’, yellow arrows). The boxes in (D’) and (D’’) show magnified double-
positive cells either for p53 and PCNA (D’) or p53 and Tg(gfap:GFP) (D’’). Scale bars: 100 µm in D 
and H; 20 µm in D’, D’’ and H’. 
 
 
3.2.2.3 The p53 protein is expressed in Type IIIa and Type IIIb cells 
 
The p53 protein is expressed in Tg(gfap:GFP)-positive and PCNA-negative cells, which are 
Type I cells, at the ventricular zone of the adult zebrafish telencephalon (see chapter 3.2.2.1 
and 3.2.2.2; see Figure 29 and Figure 30). Furthermore, p53 is expressed in PCNA-positive 
and Tg(gfap:GFP)-negative cells which could be Type IIIb cells (see chapter 3.2.2.2 and 
Figure 30). To further investigate if p53 is expressed in Type IIIb cells a triple immunostaining 
of cross sections from Tg(-3.9nestin:GFP) fish, which mark progenitor cells, (Lam et al., 
2009) with antibodies against GFP, p53 and PSA-NCAM, a marker for early neuronal 
precursors (Type III cells), was performed.  
The p53 protein is expressed in Type IIIa (Tg(-3.9nestin:GFP)- and PSA-NCAM-positive) 
(Figure 31 D’, white arrow) and in Type IIIb cells (Tg(-3.9nestin:GFP)-negative and PSA-
NCAM-positive) (Figure 31 D’, white arrowhead) in the area of the RMS, where Type III cells 
are predominantly located (März et al., 2010a). As demonstrated before (see chapter 
3.2.1.4), p53 is expressed in mature neurons in the adult zebrafish telencephalon. Therefore, 
p53 seems to be expressed both in mature neurons in the parenchyma and in neural 
progenitor cells at the ventricular zone of the adult zebrafish telencephalon. 
Normally, Type IIIa cells show also a weak expression of Tg(gfap:GFP) and they are also 
PCNA-positive. But p53 is not expressed in PCNA- and Tg(gfap:GFP)-positive cells, which 
could lead to the assumption that p53 is not expressed in Type IIIa cells. The staining for 
Tg(-3.9nestin:GFP), p53 and PSA-NCAM shows, that this assumption is wrong. It is possible 
that the Tg(gfap:GFP)-expression was too weak to be detected and that the PCNA-positive 
cells in Figure 30 represent both Type IIIa and IIIb cells. 
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Figure 31: The p53 protein is expressed in Type IIIa and IIIb cells in the adult zebrafish 
telencephalon. 
(A-D’) A triple immunostaining of cross sections through the telencephalon of adult Tg(-3.9nestin:GFP) 
zebrafish with antibodies against p53 (A-A’), GFP (B-B’) and PSA-NCAM (C-C’) was performed to 
examine if the p53 protein is expressed in Type III cells. (D-D’) show the merged panels. These 
pictures display a representative vibratome section through the medial telencephalon. The insert in (A) 
indicates the anterior-posterior position and the box in (A) shows the region of the RMS depicted in 
higher magnification in (A’-D’). The p53 protein is expressed both in Type IIIa cells, which are Tg(-
3.9nestin:GFP)-positive and PSA-NCAM-positive ((D’), white arrow), and in Type IIIb cells, which are 
Tg(-3.9nestin:GFP)-negative and PSA-NCAM-positive ((D’), white arrowhead). Scale bars: 100 µm in 
D; 20 µm in D’. 
 
 
In summary, it was demonstrated in this chapter that p53 is not expressed in 
Tg(olig2:EGFP)-positive cells but in HuC/D-positive mature neurons, some of which are 
located next to Tg(olig2:EGFP)-positive cells in the parenchyma of the adult zebrafish 
telencephalon. Moreover, it was shown that p53 expression was detected at the ventricular 
zone of the adult zebrafish telencephalon in Type I, Type IIIa and Type IIIb cells but not in 
Type II cells. 
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3.3 Expression of p53 and p73 in the adult zebrafish 
telencephalon following injury  
 
Zebrafish exhibit a remarkable regenerative potential to repair lesions of the CNS (see 
chapter 1.1.2.2) (Adolf et al., 2006; Chapouton et al., 2007; Grandel et al., 2006; Kaslin et al., 
2008; Zupanc, 2001; Zupanc and Zupanc, 2006). After inflicting a stab wound on the 
zebrafish telencephalon several processes are started to repair the tissue damage. There is 
an increase in the expression of GFAP and also in proliferation. Moreover, OPCs accumulate 
at the site of the lesion. However, this accumulation is, contrary to mammals, only transient. 
Additionally, also the number of microglia cells at the lesion is increased (März et al., 
2011).(Kyritsis et al.)showed that after a brain injury an active inflammatory response, which 
is characterized by the activation of leukocytes and microglia, takes place. This inflammation 
persists only a few days and does not lead to a chronic inflammation. Another early response 
to injury is cell death (see chapter 1.1.2.2) (Kroehne et al., 2011).         
In this chapter I investigated how the expression of p53 and p73 changes in response to a 
stab wound of the adult zebrafish telencephalon. Therefore in situ hybridizations and 
immunohistochemistry were performed to examine if there is a difference in the expression of 
p53 and p73, respectively, in an injured brain compared to an intact brain. An altered 
expression of p53 and p73 as a reaction to an injured telencephalon could be a hint to a 
potential role for p53 and p73 in regenerative neurogenesis. 
 
 
 
3.3.1 The p53 mRNA is up-regulated in response to stab injury 
 
The p53 mRNA is broadly expressed in many regions of the adult zebrafish telencephalon 
(see chapter 3.1.1 and Figure 12). In order to investigate the expression of p53 mRNA after 
brain injury an ISH with a p53 antisense probe on cross sections through the lesioned 
telencephalon at different time points after injury was performed. 
There is an up-regulation of p53 mRNA in the injured telencephalic hemisphere in 
comparison to the uninjured site after brain injury at all time points investigated (Figure 32). 
From 1 to 9 dpl an enhanced expression of p53 mRNA could be observed at the ventricular 
zone (black arrowheads) as well as in the region of the lesion canal (black arrows). 
Especially at 5 dpl the up-regulation of p53 mRNA at the site of the lesion is very pronounced 
(Figure 32 C, black arrows). At 1 dpl the up-regulation is not as intense as at the other time 
points (Figure 32 A). And also at 9 dpl an increased expression of p53 mRNA was still 
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observed (Figure 32 E). Therefore, p53 seems to play a role after injury of the brain. In the 
mammalian brain p53 induces neuronal apoptosis following damage (Miller et al., 2000; 
Morrison and Kinoshita, 2000). Thus, it could be suggested that p53 induces apoptosis in the 
damaged brain area around the lesion. Moreover, p53 may prevent over-proliferation of stem 
cells as a reaction to the injury.  
 
 
 
Figure 32: The p53 mRNA is up-regulated upon stab injury of the adult zebrafish telencephalon. 
(A-E) In situ hybridization with a p53 antisense probe on cross sections through the telencephalon of 
adult zebrafish at different time points after inflicting a stab wound to investigate the expression of p53 
mRNA after brain injury. The hemispheres containing the lesion are always depicted on the left side. 
The right uninjured hemispheres serve as the control. The inserts indicate the anterior-posterior 
positions of the sections. For all time points investigated (1-9 dpl) an up-regulation of p53 mRNA both 
at the site of the lesion ((A-E), black arrows) and at the ventricular zone of the hemisphere containing 
the lesion ((A-E), black arrowheads) was observed. Scale bar: 100 µm. 
 
 
3.3.2 The p73 mRNA is up-regulated in response to stab injury 
 
Like p53 mRNA, the p73 mRNA is broadly expressed in many regions of the adult zebrafish 
telencephalon (see chapter 3.1.2 and Figure 14). Hence, ISH with a p73 antisense probe on 
cross sections through the injured telencephalon at different time points after inflicting a stab 
wound was performed.  
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There is, in contrast to the control hemisphere, an up-regulation of p73 mRNA on the 
telencephalic hemisphere containing the lesion at all time points examined (Figure 33). For 1 
to 7 dpl an elevated expression of p73 mRNA could be observed at the ventricular zone 
(Figure 33 A-D, black arrowheads) and for 3 to 7dpl there was additionally an increase of p73 
mRNA expression in the region of the lesion canal (Figure 33 B-D, black arrows). At 9 dpl an 
up-regulation of p73 mRNA could only be observed at the area of the lesion (Figure 33 E, 
black arrow). Hence, the p73 mRNA reacts in a similar way to brain injury as the p53 mRNA 
and thus seems to play a role in the response to brain damage as well. In mammals p73 is 
able to support survival of neurons (∆Np73 isoforms) or to induce apoptosis (TAp73 
isoforms) (see chapter 1.2.3.4) (Pozniak et al., 2002; Pozniak et al., 2000). Thus it could be 
suggested that in zebrafish p73 acts synergistically to p53 and induces apoptosis and 
prevents the cells from over-proliferation. And/or p73 acts antagonistically to p53 and inhibits 
the death of cells thereby preventing a severe damage of the brain due to loss of a high 
number of cells. 
 
 
 
Figure 33: The p73 mRNA is up-regulated upon stab injury of the adult zebrafish telencephalon. 
(A-E) In situ hybridization with a p73 antisense probe on cross sections through the telencephalon of 
adult zebrafish at different time points after stab injury was performed in order to examine the 
expression of p73 mRNA in injured brains. The hemispheres containing the lesion are always depicted 
on the left side. The right uninjured hemispheres serve as the control. The inserts indicate the anterior-
posterior positions of the sections. An up-regulation of p73 mRNA could be observed at the ventricular 
zone of the injured hemisphere ((A-D), black arrowheads) and/or at the site of the lesion ((B-E), black 
arrows) at 1 to 9 dpl. Scale bar: 100 µm. 
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3.3.3 The p53 protein is up-regulated in response to stab injury 
 
p53 is known to be regulated at the protein level (see chapter 1.2.1.2) (Haupt et al., 1997; 
Honda et al., 1997; Kubbutat et al., 1997). To investigate if the expression of the p53 protein 
is also up-regulated after brain injury, an immunostaining of cross sections through the 
injured telencephalon with the anti-p53 antibody at different time points after inflicting a stab 
wound was performed. The nuclei were stained with the nuclear marker DRAQ5. 
There is an up-regulation of p53 protein on the injured telencephalic hemisphere in 
comparison to the uninjured site at all time points investigated (Figure 34). For 1 to 9 dpl an 
elevated expression of p53 protein could be observed at the ventricular zone (Figure 34 A-E, 
white arrowheads). In contrast to the p53 mRNA, which shows an up-regulation both at the 
ventricular zone and at the site of the lesion, there is no overall increase in p53 protein 
expression in the region of the lesion. Normally, when the mRNA is present also the protein 
should be detectable. In the region of the lesions at 1, 3 and 5 dpl only an intense DRAQ5 
staining was observed (Figure 34 A-C, white arrows). Except the region of the lesion canal, 
the p53 protein shows almost the same up-regulation following stab injury as the mRNA. At 
the site of the lesion p53 mRNA and p53 protein are regulated differentially. Thus, p53 may 
not play a role at the lesion site following brain injury. However, it cannot be excluded that 
there are changes in p53 protein expression in individual cells. 
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Figure 34: The p53 protein is up-regulated upon stab injury of the adult zebrafish 
telencephalon. 
(A-E) Immunohistochemistry with the anti-p53 antibody on cross sections through the telencephalon of 
adult zebrafish at different time points after inflicting a stab wound to investigate if the expression of 
the p53 protein is up-regulated after brain injury. The nuclei were stained with the nuclear marker 
DRAQ5. The hemispheres containing the lesion are always depicted on the left side. The right 
uninjured hemispheres serve as the control. The inserts indicate the anterior-posterior positions of the 
sections. For 1 to 9 dpl an up-regulation of the p53 protein at the ventricular zone of the injured 
hemisphere could be observed (white arrowheads). In contrast to the p53 mRNA, no up-regulation of 
the p53 protein at the site of the lesion was detected. The regions of the lesions show an intense 
DRAQ5 staining at 1, 3 and 5 dpl (A-C, white arrows). Scale bar: 100 µm. 
 
 
 
3.3.4 Expression of the p53 protein in different cell types after stab injury 
 
As shown in chapter 3.2, the p53 protein is expressed in mature neurons, in Type I and Type 
III cells in the adult zebrafish telencephalon. Moreover, in chapter 3.3.3 it is shown that there 
is an increase in the expression of p53 following stab injury of the telencephalon. In this 
chapter I wanted to investigate in which cell types p53 is expressed or up-regulated, 
respectively, after brain injury and if the expression in different cell types changes after a 
telencephalic lesion. 
 
 
3.3.4.1 The expression of p53 in PCNA-positive cells is not changed after stab injury 
 
I showed before that the p53 protein is expressed in PCNA-positive Type III cells and in Type 
I cells, which are PCNA-negative. It is not expressed in PCNA-positive Type II cells (see 
chapter 3.2.2.2 and 3.2.2.3; see Figure 30 and Figure 31). Additionally, I could show that the 
p53 protein is up-regulated at the ventricular zone of the lesioned hemisphere (see chapter 
3.3.3 and Figure 34). PCNA is up-regulated after stab injury of the adult zebrafish 
telencephalon at the ventricle of the injured hemisphere from 3 dpl until at least 14 dpl (März 
et al., 2011). In order to investigate if the expression of p53 in PCNA-positive cells changes 
in response to stab injury and if the cells that up-regulate PCNA also show an elevated 
expression of p53, a co-immunostaining of cross sections through the injured telencephalon 
at 5 dpl with the anti-p53 and with an anti-PCNA antibody was performed. The nuclei were 
stained with the nuclear marker DRAQ5. Since at 5 dpl a strong up-regulation of both p53 
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(see chapter 3.3.3 and Figure 34) and PCNA (März et al., 2011) could be observed, this time 
point was chosen for the following experiments. 
Both p53 and PCNA are up-regulated at the ventricular zone of the lesioned hemisphere in 
comparison to the control side after stab injury of the adult zebrafish telencephalon (Figure 
35). p53 is expressed in a few PCNA-positive cells, which are most likely Type III cells 
(Figure 35 D’ and D’’, white arrows), but the majority of PCNA-positive cells is p53-negative 
(Figure 35 D’ and D’’, yellow arrows). This indicates that the expression of p53 is not up-
regulated in PCNA-positive cells but in a different cell type and that the expression of p53 in 
PCNA-positive cells is not changed after brain injury. I showed before that p53 is expressed 
in Type I cells. It is likely that the cells in which p53 is up-regulated after stab injury are Type 
I cells. The PCNA-positive cells could be Type II cells since these cells show an increased 
proliferation after brain injury (März et al., 2011). Therefore, p53 is not expressed in Type II 
cells both in the uninjured telencephalon and in a telencephalon containing a lesion. It could 
by hypothesized that the up-regulation of p53 in Type I cells prevents an exceeding 
proliferation of stem cells and thus depletion of the stem cell pool. Thus p53 could ensure the 
maintenance of the stem cell pool in the adult zebrafish telencephalon after injury. 
 
 
 
Figure 35: The p53 protein is not up-regulated in PCNA-positive cells after stab injury. 
(A-D’’) Co-immunostaining with the anti-p53 (A-A’’) and with an anti-PCNA (B-B’’) antibody of cross 
sections through the telencephalon of adult zebrafish 5 days post lesion to investigate the expression 
of p53 and PCNA following brain injury. The nuclei were stained with the nuclear marker DRAQ5 (C-
C’’). (D-D’’) show the merged panels. The hemisphere containing the lesion is oriented to the left side. 
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The right uninjured hemisphere serves as the control. The insert in (A) indicates the anterior-posterior 
position of the section and the boxes in (A) show the regions depicted in higher magnification in (A’-D’, 
right box) and (A’’-D’’, left box). Both the p53 protein (D’, white arrowheads) and PCNA are up-
regulated in response to brain injury. p53 is expressed in a few PCNA-positive cells (D’ and D’’, white 
arrows) but the majority of PCNA-positive cells is negative for p53 (D’ and D’’, yellow arrows). The box 
in (D’) shows a magnified double-positive cell for p53 and PCNA. Thus the p53 protein is not up-
regulated in PCNA-positive cells and therefore the expression of p53 in PCNA-positive cells is not 
changed after stab injury of the telencephalon. The yellow arrowhead in (D’’) points to the region of the 
lesion. Scale bars: 100 µm in D; 20 µm in D’ and D’’. 
 
 
3.3.4.2 The expression of p53 in HuC/D-positive neurons is not changed after stab 
injury 
 
As demonstrated in chapter 3.2.1.2, the p53 protein is expressed in mature HuC/D-positive 
neurons in the adult uninjured zebrafish telencephalon (see also Figure 26). Moreover, I 
showed that p53 is up-regulated at the ventricular zone following brain injury (see chapter 
3.3.3 and Figure 34). To analyze if the expression of p53 changes in neurons after inflicting a 
stab injury, a co-immunostaining of cross sections through the telencephalon at 5 dpl with the 
anti-p53 antibody and an antibody against the neuronal marker HuC/D was conducted. The 
nuclei were stained with the nuclear marker DRAQ5. 
There is no difference between the uninjured and the injured hemisphere concerning the 
expression of p53 in HuC/D-positive neurons 5 dpl (Figure 36). Both in the control (Figure 36 
D’, white arrowheads) and in the injured hemisphere (Figure 36 D’’, white arrowheads) p53 is 
expressed in HuC/D-positive neurons. Furthermore, also in the region of the lesion p53 
remains expressed in HuC/D-positive neurons (Figure 36 D’’’, white arrowheads). This 
indicates that there is no overall change in the expression of p53 in neurons following stab 
injury of the telencephalon.  
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Figure 36: The expression of p53 in neurons is not changed after stab injury. 
(A-D’’’) Co-immunostainig of cross sections through the telencephalon of adult zebrafish 5 dpl with the 
anti-p53 (A-A’’’) and with an anti-HuC/D (B-B’’’) antibody to examine if the expression of p53 in HuC/D-
positive neurons changes after brain injury. The nuclei were stained with the nuclear marker DRAQ5 
(C-C’’’). (D-D’’’) show the merged panels. The hemisphere containing the lesion is depicted on the left 
side. The right uninjured hemisphere serves as the control. The insert in (A) indicates the anterior-
posterior position of the section and the boxes in (A) show the regions depicted in higher magnification 
in (A’-D’, right box), (A’’-D’’, left box) and (A’’’-D’’’, lower box). The p53 protein is up-regulated following 
stab injury (A, white arrows). p53 is still expressed in HuC/D-positive neurons (D’-D’’’, white 
arrowheads) after brain injury. Both in the uninjured control (D’, white arrowheads) and in the injured 
(D’’, white arrowheads) hemisphere there are a lot of p53- and HuC/D- double-positive neurons visible. 
At the site of the lesion p53-positive neurons were also observed (D’’’, white arrowheads). Thus, the 
expression of p53 in neurons is not changed 5 days after a stab injury. Scale bars: 100 µm in D; 20 
µm in D’, D’’, and D’’’. 
 
 
3.3.4.3 The p53 protein is expressed in Tg(olig2:EGFP)-positive cells after stab injury 
 
In chapter 3.2.1.1 and 3.2.1.3 I showed, that in an uninjured telencephalon the p53 protein is 
not expressed in Tg(olig2:EGFP)-positive cells but in HuC/D-positive neurons located next to 
Tg(olig2:EGFP)-positive cells (see also Figure 25 and Figure 27). In addition, it was shown 
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that Tg(olig2:EGFP)-positive OPCs accumulate at the site of the lesion after stab injury. 
However, this accumulation is only transient (März et al., 2011), which is in contrast to the 
situation in mammals (Burns et al., 2009; Dimou et al., 2008; Hampton et al., 2004; Magnus 
et al., 2007). To study the expression of p53 in Tg(olig2:EGFP)-positive cells after inflicting a 
stab injury on the adult zebrafish telencephalon, a triple immunostaining of cross sections 
through the telencephalon of Tg(olig2:EGFP) fish with antibodies against p53, HuC/D and 
GFP was performed 5 days after brain injury. This time point was chosen since at 5 dpl p53 
shows a strong up-regulation and also the accumulation of OPCs is detectable (März et al., 
2011).  
The expression of p53 in Tg(olig2:EGFP)-positive cells changes after inflicting a stab injury 
on the adult zebrafish telencephalon (Figure 37). The expression of p53 is up-regulated at 
the ventricular zone of the injured hemispheres compared to the control hemispheres (Figure 
37 A and E, white arrows) and Tg(olig2:EGFP)-positive cells accumulate at the site of the 
lesions (Figure 37 B and F, yellow arrows). Under normal conditions p53 is not expressed in 
Tg(olig2:EGFP)-positive cells but in HuC/D-positive neurons residing next to them. After stab 
injury there were also p53- and HuC/D-double-positive cells located next to Tg(olig2:EGFP)-
positive cells detectable in the uninjured hemisphere (Figure 37 D’ and H’, yellow 
arrowheads). In contrast to the uninjured brain, there were p53- and Tg(olig2:EGFP)-double-
positive cells present as well in the injured telencephalic hemisphere close to the lesion 
(Figure 37 D’’ and H’’, white arrowheads). But also in the control hemisphere single p53- and 
Tg(olig2:EGFP)-double-positive were observed (Figure 37 D’, white asterisk). These results 
indicate that the expression of p53 in Tg(olig2:EGFP)-positive cells is changed 5 days after 
brain injury as p53 is expressed in Tg(olig2:EGFP)-positive cells that accumulate at the 
lesion. Probably p53 prevents OPCs to proliferate at the site of the lesion. 
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Figure 37: p53 is expressed in Tg(olig2:EGFP)-positive cells after brain injury. 
(A-H’’) A triple immunostaining of cross sections through the telencephalon of adult Tg(olig2:EGFP) 
fish 5 dpl with antibodies against p53 (A-A’’ and E-E’’), GFP (B-B’’ and F-F’’) and the neuronal marker 
HuC/D (C-C’’ and G-G’’) was performed to analyze the expression of p53 in Tg(olig2:EGFP)-positive 
cells after stab injury. (D-D’’ and H-H’’) show the merged panels. The inserts in (A) and (E) indicate the 
anterior-posterior positions and the boxes in (A) and (E) show the regions depicted in higher 
magnification in (A’-D’, right box), (A’’-D’’, left box), (E’-H’, right box) and (E’’-H’’, left box), respectively. 
The hemispheres containing the lesion are oriented to the left. The right uninjured hemispheres serve 
as the controls. The p53 protein is up-regulated at the ventricular zone of the injured hemisphere (A 
and E, white arrows) and Tg(olig2:EGFP)-positive cells accumulate at the site of the lesion (B and F, 
yellow arrows) after stab injury. In the control hemispheres p53- and HuC/D-double-positive cells are 
located next to Tg(olig2:EGFP)-positive cells (D’ and H’, yellow arrowheads). In the injured 
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hemispheres Tg(olig2:EGFP)- and p53-double-positive cells could be observed near the lesion (D’’ 
and H’’, white arrowheads). The boxes in (D’’) and (H’’) show magnified double-positive cells for p53 
and Tg(olig2:EGFP). Also in the uninjured hemisphere single Tg(olig2:EGFP)- and p53-double-
positive cells could be detected (D’, white asterisk). Thus, the expression of p53 in Tg(olig2:EGFP)-
positive cells is changed 5 days after stab injury since in an uninjured telencephalon p53 is not 
expressed in Tg(olig2:EGFP)-positive cells. Scale bars: 100 µm in D and H; 20 µm in D’, D’’, H’ and 
H’’. 
 
 
 
3.3.5 Expression of p53 target genes after stab injury 
 
As shown before, the expression of p53 is up-regulated after stab injury of the adult zebrafish 
telencephalon (see chapter 3.3.1 and 3.3.3; see Figure 32 and Figure 34). p53 is a 
transcription factor that transactivates target genes upon activation by cellular stress, which 
results in apoptosis, cell cycle arrest or senescence (reviewed in(Boehme and Blattner, 
2009) (see chapter 1.2.1). Therefore, I intended to find out if there is also an up-regulation of 
the two best-studied target genes of p53, Mdm2 (Barak et al., 1993; Juven et al., 1993; 
Kubbutat et al., 1997) and p21 (el-Deiry, 1998; Wang et al., 2007b), after brain injury. If p53 
plays a role in regenerative neurogenesis, as apoptosis or inhibition of proliferation, the 
target genes of p53 should also show a response to stab injury.  
 
 
3.3.5.1 Mdm2 mRNA is up-regulated after stab injury 
 
The ubiquitin ligase Mdm2 is a target gene of p53 and the main regulator of p53. Both are 
linked in an autoregulatory feedback loop (Wu et al., 1993). Under normal conditions p53 is 
rapidly degraded since Mdm2 ubiquitinates p53 and therefore targets it for degradation by 
the proteasome. After cellular stress p53 becomes activated and is thereby protected from 
degradation, which leads to an accumulation of p53 protein. Consequently, p53 is able to 
induce apoptosis, senescence or cell cycle arrest and also the transcription of Mdm2 (see 
chapter 1.2.1.2) (Barak et al., 1993; Juven et al., 1993; Kubbutat et al., 1997); reviewed 
in(Boehme and Blattner, 2009). To investigate the expression of Mdm2 mRNA and to find out 
if Mdm2 mRNA is up-regulated after stab injury, an ISH with a Mdm2 antisense probe on 
cross sections through the uninjured and through the lesioned telencephalon at 4 hours post 
lesion (hpl) and 1 dpl was performed. The time-points 4 hpl and 1 dpl were chosen because 
the activation of p53 after cellular stress and thus the activation of target genes of p53 is a 
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very rapid process (Boehme and Blattner, 2009). Like that, an up-regulation of p53 mRNA 
was observed at 1 dpl (Figure 32 A). 
Mdm2 mRNA is expressed in several regions of the adult unlesioned zebrafish telencephalon 
(Figure 38 A-C). The expression of Mdm2 mRNA was detected in the periventricular zone of 
the telencephalic ventricle (TelV) (Figure 38 A-C) and the diencephalic ventricle (DiV) (Figure 
38 C) as well as in the central (Vc) Figure 38 B), dorsal (Vd) (Figure 38 A-B), ventral (Vv) 
(Figure 38 B) and postcommisural (Vp) (Figure 38 C) nuclei of the ventral telencephalic area 
(V). Furthermore, Mdm2 mRNA was expressed in the central (Dc) zone (Figure 38 B-C) of 
the dorsal telencephalic area (D), in the anterior (PPa) (Figure 38 C) part of the parvocellular 
preoptic nucleus and in the sulcus ypsiloniformis (SY) (Figure 38 B). In comparison to the 
expression of p53 mRNA (see Figure 12), Mdm2 mRNA is also expressed in regions where 
p53 expression could not be detected, like the central zone of the dorsal telencephalic area, 
and it is not expressed in regions where p53 is expressed, like the medial, lateral, dorsal and 
posterior zone of the dorsal telencephalic area.  
In comparison to the control hemisphere, Mdm2 mRNA is up-regulated at 4 hpl and 1 dpl in 
the parenchyma of the lesioned hemisphere at the site of the lesion (Figure 38 D-E, black 
arrowheads). In contrast to p53, up-regulation at the ventricular zone of the injured 
hemisphere was not observed. p53 and Mdm2 are co-expressed in several regions of the 
uninjured adult zebrafish telencephalon and both are up-regulated at the site of the lesion. 
The up-regulation of Mdm2 at the lesion site may lead to degradation of p53 protein. 
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Figure 38: The Mdm2 mRNA is up-regulated after stab injury of the adult zebrafish 
telencephalon. 
(A-E) In situ hybridization with a Mdm2 antisense probe on cross sections through the unlesioned (A-
C) and the lesioned telencephalon of adult zebrafish 4 hpl (D) and 1 dpl (E) to investigate the 
expression of Mdm2 mRNA under normal conditions and after stab injury. The hemispheres containing 
the lesion are oriented to the left side, the right uninjured hemispheres serve as the control (D and E). 
The inserts indicate the anterior-posterior positions of the sections. Mdm2 mRNA is expressed in (A) 
periventricular zone of the TelV, D and Vd; (B) periventricular zone of the TelV, Vv, Vd, Vc, Dc and 
SY; (C) periventricular zone of the TelV and DiV, PPa, Vp and Dc.  
Both at 4 hpl (D) and at 1 dpl (E) an up-regulation of Mdm2 mRNA in the parenchyma at the site of the 
lesion was observed (D and E, black arrowheads). 
D: dorsal telencephalic area; Dc: central zone of D; DiV: diencephalic ventricle; PPa: parvocellular 
preoptic nucleus, anterior part; SY: sulcus ypsiloniformis; TelV: telencephalic ventricle; V: ventral 
telencephalic area; Vc: central nucleus of V; Vd: dorsal nucleus of V; Vp: postcommisural nucleus of 
V; Vv: ventral nucleus of V. Scale bar: 100µm. 
 
 
3.3.5.2 p21 mRNA is only slightly up-regulated after stab injury 
 
p21/CDKN1A (cyclin-dependent kinase inhibitor 1a)/Waf1/Cip1 (further referred to as p21) is 
an important regulator of the cell cycle. As a target gene of p53 it becomes activated by p53 
after cellular stress. p21 is an inhibitor of cyclin-dependent kinases (CDKs) and inactivates 
cyclin-CDK complexes. This results in the repression of genes that are necessary for 
proceeding the cell cycle. Therefore, an activation of p53 leads to the activation of p21, which 
results in cell cycle arrest (see chapter 1.2.1.2) (el-Deiry et al., 1993; Harper et al., 1993; 
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Jackson et al., 2004). In order to investigate if there is an up-regulation of p21 mRNA after 
brain injury and to examine the expression of p21 mRNA in an uninjured brain, ISH with a 
p21 antisense probe on cross sections through the uninjured and through the lesioned 
telencephalon at 4 hpl and 1 dpl was conducted. Since the activation of p53 target genes 
takes place very rapidly after activation of p53 by cellular stress, the time-points 4 hpl and 1 
dpl were chosen (Boehme and Blattner, 2009).  
Expression of p21 mRNA was detected in several regions of the adult uninjured 
telencephalon (Figure 39 A-B). p21 mRNA expression was observed in the periventricular 
zone of the telencephalic ventricle (TelV) (Figure 39 A-B) and the diencephalic ventricle (DiV) 
(Figure 39 B) as well as in the central (Vc) (Figure 39 A), dorsal (Vd) (Figure 39 A), ventral 
(Vv) (Figure 39 A) and postcommisural (Vp) nuclei (Figure 39 B) of the ventral telencephalic 
area (V). Moreover, p21 mRNA was expressed in the central (Dc) zone (Figure 39 A-B) of 
the dorsal telencephalic area (D) and in the anterior (PPa) part of the parvocellular preoptic 
nucleus (Figure 39 B). p21 shows a similar expression pattern as Mdm2. It is also expressed 
in regions without p53 expression, like the central zone of the dorsal telencephalic area, and 
it is not expressed in regions where p53 expression is observed, like the medial, lateral, 
dorsal and posterior zone of the dorsal telencephalic area (see also Figure 12).  
p21 mRNA is slightly up-regulated in the parenchyma of the lesioned hemisphere at the site 
of the lesion both at 4 hpl and at 1 dpl (Figure 39 C and D, black arrowheads). However, this 
up-regulation is very faint and can only be observed in some single cells near the lesion. 
Compared to p53, up-regulation at the ventricular zone of the lesioned hemisphere was not 
detected.  
It was shown that Mdm2 and p21 are also target genes of p73 (Zhu et al., 1998a). p53, p73, 
Mdm2 and p21 are co-expressed in several regions of the uninjured adult zebrafish 
telencephalon and all four genes are up-regulated at the site of the lesion. These results 
indicate that p53 and/or p73 may regulate Mdm2 and p21 in the regions showing co-
expression of the genes. 
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Figure 39: The p21 mRNA is slightly up-regulated after stab injury of the adult zebrafish 
telencephalon. 
(A-D) In situ hybridization with a p21 antisense probe on cross sections through the unlesioned (A and 
B) and the lesioned telencephalon of adult zebrafish 4 hpl (C) and 1 dpl (D) to examine if the 
expression of p21 mRNA is changed following brain injury and to investigate the expression of p21 
under normal conditions. The hemispheres containing the lesion are oriented to the left side, the right 
uninjured hemispheres serve as the control (C and D). The inserts indicate the anterior-posterior 
positions of the sections. p21 mRNA is expressed in (A) periventricular zone of the TelV, Vv, Vd, Vc 
and Dc; (B) periventricular zone of the TelV and DiV, PPa, Vp and Dc.  
A very slight up-regulation of p21 mRNA in single cells in the parenchyma at the site of the lesion 
could be detected at 4 hpl (C, black arrowheads) as well as at 1 dpl (D, black arrowheads).  
D: dorsal telencephalic area; Dc: central zone of D; DiV: diencephalic ventricle; PPa: parvocellular 
preoptic nucleus, anterior part; TelV: telencephalic ventricle; V: ventral telencephalic area; Vc: central 
nucleus of V; Vd: dorsal nucleus of V; Vp: postcommisural nucleus of V; Vv: ventral nucleus of V. 
Scale bar: 100 µm. 
 
 
 
3.3.6 Induction of Apoptosis after stab injury 
 
The transcription factor p53 is able to induce apoptosis. Under normal conditions p53 is 
rapidly degraded but after DNA damage or other cellular stress it becomes activated and 
accumulates. This permits p53 to activate its target genes which results in cell cycle arrest, 
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senescence or apoptosis to avoid that cells with DNA damage continue to proliferate 
(reviewed in(Boehme and Blattner, 2009).(Kroehne et al.)showed that cell death occurs early 
after brain injury of zebrafish. I showed before that p53 is up-regulated at the ventricular zone 
of the lesioned hemisphere and at the site of the lesion in response to stab injury of the adult 
zebrafish telencephalon (see chapter 3.3.1 and 3.3.3; see Figure 32 and Figure 34). 
Therefore, a Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay 
on cross sections through the lesioned telencephalon was performed in order to investigate if 
the up-regulation of p53 is correlated with the induction of apoptosis after stab injury. The 
nuclei were stained with the nuclear marker DRAQ5. Since cell death is an early response to 
brain injury, the time points 4 hpl and 1 dpl were chosen. 
After stab injury there is an induction of apoptosis in the lesioned hemisphere near the site of 
the lesion at 4 hpl as well as at 1 dpl (Figure 40 A and D, white arrows). For both time points 
TUNEL-positive cells were observed (see Figure 40 C’ and F’, white arrowheads). In contrast 
to the injured hemispheres, no TUNEL-positive cells were detected in the uninjured 
hemispheres.  
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Figure 40: Apoptosis is induced after stab injury of the adult zebrafish telencephalon. 
(A-F’) TUNEL assay (A-A’ and D-D’) on cross sections through the lesioned telencephalon of adult 
zebrafish to investigate if apoptosis is induced at 4 hpl (A-C’) and 1 dpl  (D-F’). The nuclei were 
stained with the nuclear marker DRAQ5 (B-B’ and E-E’). (C-C’ and F-F’) show the merged panels. The 
hemispheres containing the lesion are oriented to the left, the right uninjured hemispheres serve as 
the control. The inserts in (A) and (D) indicate the anterior-posterior positions of the sections and the 
boxes in (A) and (D) show the regions depicted in higher magnification in (A’-C’) and (D’-F’), 
respectively. Both at 4 hpl and at 1 dpl TUNEL-positive cells and therefore an induction of apoptosis 
could be observed in the lesioned hemisphere near the site of the lesion (A and D, white arrows; C’ 
and F’, white arrowheads). Scale bars: 100 µm in C and F; 20 µm in C’ and F’. 
 
 
To sum up the results of this chapter, it was shown that p53 mRNA, p53 protein as well as 
p73 mRNA are up-regulated after stab injury of the adult zebrafish telencephalon. In addition 
it was demonstrated that p53 is not up-regulated in PCNA-positive but in Type I cells 
following brain injury and that the expression of p53 in HuC/D-positive neurons is not 
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changed after stab injury. However, after stab injury an expression of p53 was observed in 
Tg(olig2:EGFP)-positive cells, which do not express p53 in an uninjured telencephalon. 
Furthermore, it was shown that two target genes of p53 and p73, Mdm2 and p21, were up-
regulated and that apoptosis was induced following stab injury.  
 
 
 
3.3.7 Reactions of tp53M214K mutant zebrafish to stab injury 
 
I demonstrated before that wildtype p53 is up-regulated after stab injury of the adult zebrafish 
telencephalon (see chapter 3.3.1 and 3.3.3; see Figure 32 and Figure 34). Furthermore, I 
could show that two target genes of p53, Mdm2 and p21, are also up-regulated after brain 
injury (see chapter 3.3.5.1 and 3.3.5.2; see Figure 38 and Figure 39) and that apoptosis is 
induced after inflicting a stab wound to the telencephalon (see chapter 3.3.6 and Figure 40). 
For the following experiments homozygous tp53M214K mutant zebrafish (Berghmans et al., 
2005), that contain a point mutation where methionin is changed to lysine, were used in order 
to investigate the reactions following stab injury without a functional p53 protein. This 
tp53M214K mutation is a DNA contact mutation, which is located in the DNA-binding domain. 
Thus, the mutant p53 transcription factor is not able to bind to p53-specific consensus 
sequences and therefore an activation of target genes is prevented (Berghmans et al., 2005). 
It was shown by(Berghmans et al.)that apoptosis was not induced and that Mdm2 and p21 
were not up-regulated in homozygous tp53M214K mutant zebrafish embryos after γ-irradiation 
compared to wildtype embryos.    
 
 
3.3.7.1 The tp53M214K mutant zebrafish show the same p53 expression pattern in the 
telencephalon like wildtype fish 
 
As shown before, the wildtype p53 protein is broadly expressed in many regions of the 
uninjured adult zebrafish telencephalon (see chapter 3.1.4 and Figure 24). To analyze the 
expression of tp53M214K mutant protein in the adult zebrafish telencephalon and to compare it 
to wildtype p53 protein, an immunostaining of cross sections through the uninjured 
telencephalon of tp53M214K mutant zebrafish and wildtype fish with the anti-p53 antibody was 
performed. The nuclei were stained with the nuclear marker DRAQ5. 
The tp53M214K mutant protein (Figure 41 B) is expressed in the same regions of the uninjured 
adult zebrafish telencephalon as the wildtype p53 protein (Figure 41 A). For a detailed 
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description in which regions of the telencephalon p53 is expressed, see chapter 3.1.4 and 
Figure 24 A-C.  
 
 
 
Figure 41: The tp53M214K mutant protein shows the same expression pattern than wildtype p53 
protein. 
(A-B) Immunohistochemistry on cross sections through the telencephalon of adult wildtype (A) or 
tp53M214K mutant (B) zebrafish with the anti-p53 antibody to compare the expression of wildtype and 
mutant p53 protein. The nuclei were stained with the nuclear marker DRAQ5. The inserts indicate the 
anterior-posterior positions of the sections. The tp53M214K mutant protein is expressed in the same 
regions as the wildtype p53 protein. For a detailed description of p53 expression see also Figure 24. 
Scale bar: 100 µm. 
 
 
3.3.7.2 The tp53M214K mutant protein is up-regulated in response to stab injury 
 
The wildtype p53 protein is up-regulated after brain injury (see Figure 34). Furthermore, the 
tp53M214K mutant protein shows the same expression pattern as wildtype p53 protein (see 
Figure 41). To find out if the expression of the tp53M214K mutant protein is also up-regulated 
after stab injury of the telencephalon, an immunostaining of cross sections through the 
injured telencephalon with the anti-p53 antibody 5 days after inflicting a stab wound was 
performed. The nuclei were stained with the nuclear marker DRAQ5. 
As already demonstrated, there is an up-regulation of wildtype p53 protein at 5 dpl at the 
ventricular zone of the lesioned hemisphere (Figure 42 A, white arrowheads). In comparison 
to the uninjured hemisphere, the expression of the tp53M214K mutant protein is also up-
regulated at the ventricular zone of the injured hemisphere after stab injury (Figure 42 B, 
yellow arrowheads). Thus, there is no difference between the reaction of the wildtype and the 
mutant p53 protein 5 days after stab injury. Interestingly,(Berghmans et al.)did not observe 
an up-regulation of mutant p53 mRNA in homozygous tp53M214K mutant embryos after 
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cellular stress in terms of γ-irradiation. On the contrary,(Guo et al.)showed that mutant p53 
protein accumulated in tp53M214K mutant embryos after ionizing radiation. In the adult 
zebrafish telencephalon the amount of tp53M214K mutant protein is increased after injury 
although the protein is presumably not functional and is not able to induce the transcription of 
target genes. 
 
 
 
Figure 42: The tp53M214K mutant protein is up-regulated upon stab injury of the adult zebrafish 
telencephalon. 
(A-B) Immunohistochemistry on cross sections through the telencephalon of adult wildtype (A) or 
tp53M214K mutant (B)  zebrafish 5 dpl with the anti-p53 antibody to examine if the mutant p53 protein is 
also up-regulated after brain injury. The nuclei were stained with the nuclear marker DRAQ5. The 
hemispheres containing the lesion are oriented to the left side, the right uninjured hemispheres serve 
as the control. The inserts indicate the anterior-posterior positions of the sections. Like the wildtype 
p53 protein (A, white arrowheads), the tp53M214K mutant protein (B, yellow arrowheads) is up-
regulated 5 days after stab injury at the ventricular zone of the lesioned hemisphere compared to the 
control hemisphere. Scale bar: 100 µm. 
 
 
3.3.7.3 Mdm2 mRNA is slightly up-regulated in the telencephalon of tp53M214K mutant 
zebrafish after stab injury 
 
Mdm2 mRNA is up-regulated in the parenchyma of the injured telencephalic hemisphere 
near the lesion in wildtype zebrafish following brain injury (see chapter 3.3.5.1 and Figure 
38). Mdm2 is the main regulator and a target gene of p53 (see chapter 3.3.5.1; reviewed 
in(Boehme and Blattner, 2009; Wu et al., 1993). It was demonstrated by(Berghmans et 
al.)that in homozygous tp53M214K mutant embryos Mdm2 was not up-regulated after γ-
irradiation compared to wildtype embryos because the mutant p53 transcription factor is not 
capable of activating its target genes. In order to study the expression of Mdm2 mRNA in 
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tp53M214K mutant zebrafish after stab injury, an ISH with a Mdm2 antisense probe on cross 
sections through the lesioned telencephalon of homozygous tp53M214K mutant zebrafish at 4 
hpl and 1 dpl was performed. The time-points 4 hpl and 1 dpl were chosen because p53 
becomes rapidly activated after cellular stress and thus an effect on the target genes of p53 
should be detectable at these time points (Boehme and Blattner, 2009). Like that, an up-
regulation of Mdm2 mRNA was observed at 4 hpl and 1 dpl in wildtype zebrafish (see Figure 
38). 
There is, like in the wildtype fish, an up-regulation of Mdm2 mRNA in the lesioned 
hemisphere near the lesion (Figure 43 A and B, black arrowheads) compared to the 
unlesioned control hemisphere. However, this up-regulation is very weak in comparison to 
the situation in wildtype zebrafish (compare Figure 43 with Figure 38). An up-regulation of 
Mdm2 mRNA was observed in tp53M214K mutant zebrafish although there is supposedly no 
functional p53 protein present that could induce the expression of Mdm2. This result 
suggests that it is either possible that Mdm2 is activated by another protein than p53 in 
response to stab injury or that the mutant p53 protein is not completely inoperable. It was 
shown that p73 is able to induce the expression of Mdm2 (Zeng et al., 1999). Thus, since 
p73 is also up-regulated after stab injury of the adult zebrafish telencephalon, it is likely that 
p73 replaces the inoperable p53 protein and activates p53 target genes. 
 
 
 
Figure 43: The Mdm2 mRNA is slightly up-regulated in tp53M214K mutant zebrafish after stab 
injury of the adult zebrafish telencephalon. 
(A-B) In situ hybridization with a Mdm2 antisense probe on cross sections through the lesioned 
telencephalon of adult tp53M214K mutant  zebrafish 4 hpl (A) and 1 dpl (B) to investigate the expression 
of Mdm2 mRNA after stab injury. The hemispheres containing the lesion are oriented to the left side, 
the right uninjured hemispheres serve as the control. The inserts indicate the anterior-posterior 
positions of the sections. Both at 4 hpl (A) and at 1 dpl (B) a very weak up-regulation of Mdm2 mRNA 
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in the parenchyma at the site of the lesion could be observed (A and B, black arrowheads). Scale bar: 
100 µm. 
 
 
3.3.7.4 p21 mRNA is slightly up-regulated in the telencephalon of tp53M214K mutant 
zebrafish after stab injury 
 
p21 mRNA is slightly up-regulated in the parenchyma of the adult wildtype zebrafish 
telencephalon near the lesion in response to stab injury (see Figure 39). Furthermore, I 
showed that the tp53M214K mutant protein is up-regulated after brain injury (see chapter 
3.3.7.2 and Figure 42) and that the p53 target gene Mdm2 is slightly up-regulated as well in 
the telencephalon of tp53M214K mutant zebrafish after stab injury (see chapter 3.3.7.3 and 
Figure 43). p21 is one of the target genes of p53 and becomes activated by p53 after cellular 
stress which results in cell cycle arrest (see chapter 3.3.5.2;(el-Deiry et al., 1993; Harper et 
al., 1993; Jackson et al., 2004). It was shown by(Berghmans et al.)that p21 was not up-
regulated in homozygous tp53M214K mutant embryos after γ-irradiation compared to wildtype 
embryos. To investigate if there is an up-regulation of p21 mRNA in tp53M214K mutant 
zebrafish after stab injury, an ISH with a p21 antisense probe on cross sections through the 
lesioned telencephalon of homozygous tp53M214K mutant zebrafish at 4 hpl and 1 dpl was 
performed. Since an up-regulation of p21 mRNA could be detected at 4 hpl and 1 dpl in 
wildtype zebrafish (see Figure 39) and p53 becomes rapidly activated after cellular stress 
(Boehme and Blattner, 2009) the time-points 4 hpl and 1 dpl were chosen.  
p21 mRNA is up-regulated in the lesioned hemisphere of tp53M214K mutant zebrafish near the 
lesion (Figure 44 A and B, black arrowheads) compared to the unlesioned control 
hemisphere. Like in wildtype fish, this up-regulation is very weak (see also Figure 39). As for 
Mdm2, an up-regulation of p21 mRNA was observed in tp53M214K mutant zebrafish in which 
any functional p53 should be present. This result indicates that p21 could be activated by 
another protein. p73 is capable of transactivating some p53 target genes like p21 (Zhu et al., 
1998a).  
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Figure 44: The p21 mRNA is slightly up-regulated in tp53M214K mutant zebrafish after stab injury 
of the adult zebrafish telencephalon. 
(A-B) In situ hybridization with a p21 antisense probe on cross sections through the lesioned 
telencephalon of adult tp53M214K mutant  zebrafish 4 hpl (A) and 1 dpl (B) to analyze the expression of 
p21 mRNA after stab injury. The hemispheres containing the lesion are oriented to the left side, the 
right uninjured hemispheres serve as the control. The inserts indicate the anterior-posterior positions 
of the sections. At 4 hpl (A) as well as at 1 dpl (B) a very faint up-regulation of p21 mRNA in the 
parenchyma at the site of the lesion could be observed (A and B, black arrowheads). Scale bar: 100 
µm. 
 
 
3.3.7.5 Induction of apoptosis after stab injury in tp53M214K mutant zebrafish 
 
Apoptosis is induced in wildtype zebrafish following stab injury of the telencephalon (see 
Figure 40). Moreover, I showed that the tp53M214K mutant protein is up-regulated at the 
ventricular zone of the lesioned hemisphere (see chapter 3.3.7.2 and Figure 42) and that two 
target genes of p53, Mdm2 (see chapter 3.3.7.3 and Figure 43) and p21 (see chapter 3.3.7.4 
and Figure 44), are up-regulated at the site of the lesion after brain injury. The transcription 
factor p53 becomes activated after cellular stress and transactivates target genes. 
Subsequently, this leads to the induction of apoptosis amongst others (reviewed in(Boehme 
and Blattner, 2009).(Kroehne et al.)demonstrated that cell death occurs early after brain 
injury of zebrafish. Furthermore, it was figured out that in homozygous tp53M214K mutant 
embryos the induction of apoptosis after γ-irradiation is suppressed compared to wildtype 
embryos (Berghmans et al., 2005). In order to examine if apoptosis is induced after stab 
injury in tp53M214K mutant zebrafish a TUNEL assay on cross sections through the lesioned 
telencephalon of adult tp53M214K mutant zebrafish was performed. The nuclei were stained 
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with the nuclear marker DRAQ5. Because an induction of apoptosis could be observed in 
wildtype zebrafish at 4 hpl and at 1 dpl (see Figure 40) and since cell death is an early 
response to brain injury, the time points 4 hpl and 1 dpl were chosen. 
Like in wildtype fish, there is an induction of apoptosis in the lesioned hemisphere near the 
site of the lesion both at 4 hpl (Figure 45 A, white arrowheads) and at 1 dpl (Figure 45 B, 
white arrowhead). In the uninjured hemispheres TUNEL-positive cells were not observed. 
This result indicates that apoptosis is induced after stab injury of tp53M214K mutant zebrafish 
in cells residing near the lesion although any functional p53 protein is present. But apoptosis 
can also be induced independently of p53 transcription via the mitochondria (Galluzzi et al., 
2008) or by p73 (Levrero et al., 2000; Murray-Zmijewski et al., 2006).  
 
 
 
Figure 45: Apoptosis is induced after stab injury of the telencephalon of adult tp53M214K mutant 
zebrafish. 
(A-B) TUNEL assay on cross sections through the lesioned telencephalon of adult tp53M214K mutant 
zebrafish to investigate if apoptosis is induced 4 hpl (A) and 1 dpl (B). The nuclei were stained with the 
nuclear marker DRAQ5. The hemispheres containing the lesion are oriented to the left, the right 
uninjured hemispheres serve as the control. The inserts in (A) and (B) indicate the anterior-posterior 
positions of the sections. At 4 hpl (A, white arrowheads) and at 1 dpl (B, white arrowhead) TUNEL-
positive cells were observed in the lesioned hemisphere near the site of the lesion. This means that 
there is an induction of apoptosis following stab injury. Scale bar: 100 µm.  
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3.3.7.6 No difference in proliferation between tp53M214K mutant and wildtype zebrafish 
after stab injury 
 
Both p53 and PCNA are up-regulated 5 dpl at the ventricular zone of the lesioned 
hemisphere in response to stab injury though p53 is not up-regulated in PCNA-positive cells 
but in another cell type, most likely in Type I cells (see also Figure 35). Furthermore, I found 
out that the tp53M214K mutant protein is up-regulated as well after brain injury (see chapter 
3.3.7.2 and Figure 42).(März et al.)demonstrated that the radial glial marker S100β and the 
proliferation marker PCNA are up-regulated following brain injury since radial glial cells show 
a strong increase in proliferation after inflicting a stab wound on the telencephalon. After 
cellular stress p53 becomes activated and induces the expression of p21, which leads to cell 
cycle arrest (el-Deiry et al., 1993; Harper et al., 1993). Hence, p53 exhibits anti-proliferative 
capacities. In order to analyze if proliferation is increased in radial glial cells in tp53M214K 
mutant zebrafish, a co-immunostaining on cross sections through the lesioned telencephalon 
of adult tp53M214K mutant and wildtype zebrafish with antibodies against PCNA and S100β 
was performed 5 days after stab injury. The nuclei were stained with the nuclear marker 
DRAQ5.    
Both PCNA and S100β, are up-regulated at the ventricular zone of the injured hemisphere in 
wildtype (Figure 46 A, white arrowheads; Figure 46 B, yellow arrowheads) as well as in 
tp53M214K mutant (Figure 46 E, white arrowheads; Figure 46 F, yellow arrowheads) zebrafish. 
However, there is no difference in the intensity of the up-regulation visible. This result 
suggests that proliferation is not increased in radial glial cells in tp53M214K mutant zebrafish 
relative to wildtype fish after stab injury. Therefore, mutant p53 does not lead to an enhanced 
proliferation. As shown before, there is also an induction of Mdm2 (see chapter 3.3.7.3 and 
Figure 43) and more weakly of p21 (see chapter 3.3.7.4 and Figure 44) following stab injury 
in tp53M214K mutant zebrafish. The induction of p21 after stab injury could still be sufficient to 
control cell proliferation in tp53M214K mutant zebrafish. 
Thus even though any functional p53 is present in the telencephalon, the reactions after stab 
injury are almost the same as in wildtype brains. These results suggest that some other 
mechanisms are activated in response to brain injury to ensure a proper repair of the caused 
damage also in the absence of p53. Probably p73 could play a role in these processes. 
 
Results 
136 
 
 
 
Figure 46: No difference in proliferation after stab injury of the telencephalon of adult tp53M214K 
mutant and wildtype zebrafish. 
(A-H) Co-immunostaining of cross sections through the telencephalon of adult wildtype (A-D) and 
tp53M214K mutant (E-H) zebrafish 5 dpl with antibodies against PCNA (A and E) and S100β (B and F) 
to investigate if proliferation is increased in radial glial cells in tp53M214K mutant zebrafish after stab 
injury. The nuclei were stained with the nuclear marker DRAQ5 (C and G). (D and H) show the 
merged panels. The hemispheres containing the lesion are oriented to the left side, the right uninjured 
hemispheres serve as the controls. The inserts in (A and E) indicate the anterior-posterior positions of 
the sections. Both PCNA (A and E, white arrowheads) and S100β (B and F, yellow arrowheads) are 
up-regulated at the ventricular zone of the lesioned hemisphere in comparison to the uninjured control 
hemisphere in wildtype and in tp53M214K mutant zebrafish. But there is any difference visible 
concerning the intensity of the up-regulation of PCNA and S100β between wildtype and tp53M214K 
mutant zebrafish (D and H). This indicates that the mutant p53 protein does not influence the 
proliferative reactions after brain injury. Scale bar: 100 µm in A and E.     
 
 
In summary, the tp53M214K mutant protein shows the same expression pattern as wildtype 
p53 and it is also up-regulated after stab injury. Interestingly, Mdm2 and p21 are up-
regulated as well and apoptosis occurs in the mutant. Furthermore, there is no difference 
regarding proliferation after stab injury between wildtype and tp53M214K mutant zebrafish. 
Thus, p53 may either not play a role in adult neurogenesis in zebrafish or there may be 
redundancy between p53 and p73. The related p73 shows the same expression pattern as 
p53 in the adult uninjured and injured zebrafish brain.  
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Discussion 
4 Discussion 
 
The adult zebrafish brain exhibits a very high proliferative and neurogenic potential, contrary 
to the adult mammalian brain. In addition, zebrafish show an extraordinary regenerative 
potential after lesions of the central nervous system (Adolf et al., 2006; Chapouton et al., 
2007; Grandel et al., 2006; Kaslin et al., 2008; Zupanc, 2001; Zupanc and Zupanc, 2006). 
The two transcription factors p53 and p73 were shown to play crucial roles in the adult 
mammalian brain. p53 suppresses the self-renewal of adult neural stem cells (Meletis et al., 
2006), may preserve the post-mitotic character of differentiated neurons (Miller et al., 2003) 
and is involved in apoptotic death of neurons following damage (Culmsee and Mattson, 
2005; Miller et al., 2000; Morrison and Kinoshita, 2000; Morrison et al., 2003; Napieralski et 
al., 1999; Xiang et al., 1998; Yonekura et al., 2006). p73 is relevant for the survival of 
neurons (Jacobs et al., 2004; Pozniak et al., 2002; Pozniak et al., 2000; Tissir et al., 2009), 
self-renewal and maintenance of neural stem cells (Agostini et al., 2010; Fujitani et al., 2010; 
Talos et al., 2010) as well as differentiation of precursor cells (Agostini et al., 2010; Billon et 
al., 2004; De Laurenzi et al., 2000; Talos et al., 2010). In order to assess a possible role of 
p53 and p73 in neurogenesis in the zebrafish brain I investigated the expression of p53 and 
p73 mRNA and p53 protein in the adult zebrafish brain. Specific emphasis was given to 
expression in regions known for their constitutive neurogenic potential and during 
regeneration of injuries focusing on the adult telencephalon as a well-characterized model of 
both constitutive (Adolf et al., 2006; Grandel et al., 2006; Kaslin et al., 2008; Lam et al., 2009; 
März et al., 2010a) and regenerative (Baumgart et al., 2012; Kizil et al., 2012a; Kizil et al., 
2012b; Kroehne et al., 2011; Kyritsis et al., 2012; März et al., 2011) adult neurogenesis.  
 
 
4.1 p53 and p73 are expressed in many regions of the adult 
zebrafish brain in an overlapping pattern 
 
I have first characterized the expression of p53 and p73 in the entire adult zebrafish brain. A 
detailed mRNA expression map of the entire brain was established (Table 1). p53 and p73 
mRNAs are expressed in overlapping patterns in most regions in the telencephalon, 
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mesencephalon and hindbrain. For example in the telencephalon, the two genes are 
expressed in the parenchyma and more specifically in the ventral nucleus of the ventral 
telencephalic area (Vv) and in the lateral (Dl) and posterior (Dp) zone of the dorsal 
telencephalic area. Similarly in the diencephalon, the expression of p53 and p73 mRNA 
overlaps in most of the regions. Exceptions in the diencephalon are the PGa and PGl that 
express only p53 and the TLa that expresses only p73. This mostly overlapping pattern of 
expression of the two genes in most regions suggests that the two genes are subject to 
similar regulatory control. It was shown before that p73 is expressed in the telencephalon, 
hypothalamus, olfactory bulbs and in the optic tectum of the adult zebrafish brain (Pan et al., 
2003). However, in this study the expression of p73 mRNA was investigated with whole-
mount ISH and not with brain sections. Thus, they did not provide a detailed expression map 
of p73 mRNA. Accordingly to(Pan et al.)I observed p73 mRNA expression in the 
telencephalon, hypothalamus and optic tectum. However, I did not detect p73 mRNA in the 
olfactory bulbs (Table 1). 
In the adult mammalian brain, p53 is expressed in the SVZ (Jori et al., 2003; van Lookeren 
Campagne and Gill, 1998), in the RMS, in the DG (Medrano and Scrable, 2005) and in the 
cerebellum (Wood and Youle, 1995) while p73 is almost ubiquitously expressed in the adult 
mammalian brain (Hernandez-Acosta et al., 2011). Thus, the expression of p53 and p73 in 
the adult mammalian brain seems to be less co-regulated than in the adult zebrafish brain. In 
mammals, the p53 and p73 proteins are known to interact (Chen et al., 2001; Grob et al., 
2001; Kartasheva et al., 2002; Wang et al., 2007a). The observed co-expression of p53 and 
p73 mRNA in many tissues may reflect similar functional interactions of p53 and p73 in the 
zebrafish brain.  
 
 
 p53 mRNA p73 mRNA p53 protein 
Olfactory bulbs 
   
ECL    
GL    
POF    
ICL    
LOT    
MOT    
Telencephalon   
 
Periventricular zone 
of TelV 
   
Vd    
Vc    
Vl    
Vv    
Vs    
Vp    
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D    
Dm    
Dl    
Dp    
Dc    
Dd    
Cantd    
Cantv    
SY    
LFB    
MFB    
NT    
Diencephalon 
  
 
Periventricular zone 
of DiV 
   
End    
ENv    
PPa    
PPp    
PMg    
PM    
SC    
VM    
VL    
I    
A    
CP    
DP    
P    
Hav    
Had    
Chab    
PSp    
PSm    
SD    
R    
CPN    
DAO    
FR    
Hv    
Hd    
Hc    
APN    
ATN    
E    
PGa    
PGl    
PGm    
PGc    
PO    
TPM    
TPp    
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VAO    
ZL    
Cpost    
Ctec    
Ctub    
DIL    
CIL    
LH    
LR    
PCN    
PPd    
PPv    
PTN    
SCO    
TLa    
Pit    
PVO    
RT    
TGN    
SG    
CM    
PR    
CO    
ON    
OT    
Chor    
Cpop    
DOT    
VOT    
Mesencephalon 
  
 
Periventricular zone 
of TeV 
   
TeO    
PGZ    
TL    
TS    
TSc    
TSvl    
LLF    
MLF    
NMLF    
NR    
Vas    
DTN    
EW    
TTB    
TTBc    
TTBr    
Cans    
NLL    
MN V    
N III    
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III    
N IV    
IV    
D IV    
V    
V s    
N V md    
N V mv    
N V s    
ND V    
V md    
V mv    
D V    
VI r    
N VI c    
VI c    
VII    
VII s    
N VII m    
L VII    
VIII    
IX    
L IX    
X    
L X    
N X m    
PL    
TMCa    
TMCp    
Nln    
NLV    
GC    
SRF    
SR    
NI    
LC    
Hindbrain 
  
 
Periventricular zone 
of RV 
   
Val    
Vam    
AC    
Cven    
CCe    
Ccer    
Cgus    
CC    
SGN    
SGT    
ALLN    
EG    
PC    
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AON    
IMRF    
LCa    
MAC    
MA    
MaON    
MON    
DON    
CON    
IAF    
SO    
T    
PLLN    
TBS    
TVS    
IO    
IR    
IRF    
LRN    
PON    
DV    
Flv    
Fv    
Fd    
Fld    
MFN    
C    
Cinf    
NC    
DH    
DR    
VH    
 
Table 1: The table lists the different domains of the adult zebrafish brain. Domains showing 
expression of p53 and p73 mRNA and p53 protein are indicated by a check. 
Abbreviations: III: oculomotor nerve; IV: trochlear nerve; V: trigeminal nerve; V md: dorsal motor root 
of the trigeminal nerve; V mv: ventral motor root of the trigeminal nerve; V s: sensory root of the 
trigeminal nerve; VI r: rostral root of the abducens nerve; VI c: caudal root of the abducens nerve; VII: 
facial nerve; VII s: sensory root of the facial nerve; VIII: octaval nerve; IX: glossopharyngeal nerve; X: 
vagal nerve; A: anterior thalamic nucleus; AC: anterior cerebellar tract; ALLN: anterior lateral line 
nerves; AON: anterior octaval nucleus; APN: accessory pretectal nucleus; ATN: anterior tuberal 
nucleus; C: central canal; Cans: commissural ansulata; Cantd: commissural anterior, pars dorsalis; 
Cantv: commissural anterior, pars ventralis; CC: crista cerebellaris; CCe: corpus cerebelli; Ccer: 
commissural cerebella; Cgus: commissure of the secondary gustatory nuclei; Chab: commissural 
habenularum; Chor: commissura horizontalis; CIL: central nucleus of the inferior lobe; Cinf: 
commissural infima of Haller; CM: corpus mamillare; CO: chiasma opticum; CON: caudal 
octavolateralis nucleus; CP: central posterior thalamic nucleus; CPN: central  pretectal nucleus; Cpop: 
commissura postoptica; Cpost: commissural posterior; Ctec: commissary tecti; Ctub: commissure of 
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the posterior tuberculum; Cven: commissural ventralis rhombencephali; D: dorsal telencephalic area; 
D IV: trochlear decussation; D V: descending trigeminal root; DAO: dorsal accessory optic nucleus; 
Dc: central zone of D; Dd: dorsal zone of D; DH: dorsal horn; DIL: diffuse nucleus of the inferior lobe; 
DiV: diencephalic ventricle; Dl: lateral zone of D; Dm: medial zone of D; DON: descending octaval 
nucleus; DOT: dorsomedial optic tract; Dp: posterior zone of D; DP: dorsal posterior thalamic nucleus; 
DR: dorsal root; DTN: dorsal tegmental nucleus; DV: descending trigeminal root; E: epiphysis; ECL: 
external cellular layer of olfactory bulb including mitral cells; EG: eminentia granularis; ENd: 
entopeduncular nucleus, dorsal part; ENv: entopeduncular nucleus, ventral part; EW: Edinger-
Westphal nucleus; Fd: funiculus dorsalis; Fld: funiculus lateralis pars dorsalis; Flv: funiculus lateralis 
pars ventralis; FR: fasciculus retroflexus; Fv: funiculus ventralis; GC: griseum centrale; GL: glomerular 
layer of olfactory bulb; Had: dorsal habenular nucleus; Hav: ventral habenular nucleus; Hc: caudal 
zone of periventricular hypothalamus; Hd: dorsal zone of periventricular hypothalamus; Hv: ventral 
zone of periventricular hypothalamus; I: intermediate thalamic nucleus; IAF: inner arcuate fibers; ICL: 
internal cellular layer of olfactory bulb; IMRF: intermediate reticular formation; IO: oliva inferior; IR: 
interior raphe; IRF: inferior reticular formation; L VII: lobus facialis; L IX: lobus glossopharyngeus; L X: 
lobus vagus; LC: locus coeruleus; LCa: lobus caudalis cerebella; LFB: lateral forebrain bundle; LH: 
lateral hypothalamic nucleus; LLF: lateral longitudinal fascicle; LOT: lateral olfactory tract; LR: lateral 
recess of diencephalic ventricle; LRN: lateral reticular nucleus; MA: Mauthner axon; MAC: Mauthner 
cell; MaON: magnocellular octaval nucleus; MFB: medial forebrain bundle; MFN: medial funicular 
nucleus; MLF: medial longitudinal fascicle; MN V: mesencephalic nucleus of trigeminal nerve; MON: 
medial octavolateralis nucleus; MOT: medial olfactory tract; N III: oculomotor nucleus; N IV: trochlear 
nucleus; N V md: trigeminal motor nucleus, dorsal part; N V mv: trigeminal motor nucleus, ventral part; 
N V s: primary sensory trigeminal nucleus; N VI c: abducens nucleus, caudal part; N VII m: facial 
motor nucleus; N X m: vagal motor nucleus; NC: commissural nucleus of Cajal; ND V: nucleus of the 
descending trigeminal root; NI: nucleus istmi; NLL: nu cleus of the lateral lemniscus; NLV: nucleus 
lateralis valvulae; NMLF: nucleus of MLF; Nln: nucleus interpeduncularis; NT: nucleus taeniae; NR: 
nucleus ruber; ON: optic nerve; OT: optic tract; P: posterior thalamic nucleus; PC: posterior cerebellar 
tract; PCN: paracommissural nucleus; PGa: anterior preglomerular nucleus; PGc: caudal 
preglomerular nucleus; PGl: lateral preglomerular nucleus; PGm: medial preglomerular nucleus; PGZ: 
periventricular grey zone of optic tectum; Pit: pituitary; PL: perilemniscal nucleus; PLLN: posterior 
lateral line nerve; PM: magnocellular preoptic nucleus; PMg: gigantocellular part of magnocellular 
preoptic nucleus; PO: posterior pretectal nucleus; POF: primary olfactory fiber layer; PON: posterior 
octaval nucleus; PPa: parvocellular preoptic nucleus, anterior part; PPd: periventricular pretectal 
nucleus; dorsal part; PPp: parvocellular preoptic nucleus, posterior part; PPv: periventricular pretectal 
nucleus; ventral part; PR: posterior recess of diencephalic ventricle; PSm: magnocellular superficial 
pretectal nucleus; PSp: parvocellular superficial pretectal nucleus; PTN: posterior tuberal nucleus; 
PVO: paraventricular organ; R: rostrolateral nucleus; RT: rostral tegmental nucleus; RV: 
rhombencephalic ventricle; SC: suprachiasmatic nucleus; SCO: subcommissural organ; SD: saccus 
dorsalis; SG: subglomerular nucleus; SGN: secondary gustatory nucleus; SGT: secondary gustatory 
tract; SO: secondary octaval population; SR: superior raphe; SRF: superior reticular formation; SY: 
sulcus ypsiloniformis; T: tangential nucleus; TBS: tractus bulbospinalis; TeV: tectal ventricle; TelV: 
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telencephalic ventricle; TeO: tectum opticum; TL: torus longitudinalis; TLa: torus lateralis; TGN: tertiary 
gustatory nucleus; TMCa: tractus mesencephalocerebellaris anterior; TMCp: tractus 
mesencephalocerebellaris posterior; TPM: tractus pretectomamillaris; TPp: periventricular nucleus of 
posterior tuberculum; TS: torus semicircularis; TSc: central nucleus of torus semicircularis; TSvl: 
ventrolateral nucleus of torus semicircularis; TTB: tractus tectobulbaris; TTBc: tractus tectobulbaris 
cruciatus; TTBr: tractus tectobulbaris rectus; TVS: tractus vestibulospinalis; V: ventral telencephalic 
area; Val: lateral division of valvula cerebelli; Vam: medial division of valvula cerebelli; VAO: ventral 
accessory optic nucleus; Vas: vascular lacuna of area postrema; Vc: central nucleus of V; Vd: dorsal 
nucleus of V; VH: ventral horn; Vl: lateral nucleus of V; VL: ventrolateral thalamic nucleus; VM: 
ventromedial thalamic nucleus; VOT: ventrolateral optic tract; Vp: postcommissural nucleus of V; Vs: 
supracommissural nucleus of V; Vv: ventral nucleus of V; ZL: zona limitans. 
 
 
p53 and p73 are involved in regulation of neural stem cells in the two neurogenic regions of 
the adult mammalian telencephalon. p53 negatively regulates the self-renewal of adult neural 
stem cells and may thereby maintain the stem cell population since enhanced proliferation 
could lead to premature senescence (Meletis et al., 2006). Thus, p53 may be important for 
maintaining neurogenesis in the adult mammalian brain because it controls the proliferation 
of stem and progenitor cells (Gil-Perotin et al., 2006; Medrano et al., 2009). p73 is also a 
regulator of neural stem cell self-renewal and long-term maintenance. However, p73 
positively regulates self-renewal and promotes proliferation, in contrast to p53. Thereby p73 
prevents premature differentiation and facilitates the maintenance of stem cells (Agostini et 
al., 2010; Fujitani et al., 2010; Talos et al., 2010). Although p53 and p73 function in an 
antagonistic manner, the result of their activity is the same, namely maintenance of the stem 
cell pool. p53 and p73 may complement and/or regulate one another, depending on whether 
proliferation or quiescence is required, to ensure proper maintenance of the stem cell pool. In 
fact, it was recently shown that p73 together with p63, the third member of the p53 family of 
transcription factors, regulates p53 function to maintain the adult NPC pool (Fatt et al., 2014). 
In the telencephalon of the adult zebrafish, p53 and p73 expression can be observed in 
regions along the ventricular zone where adult neural stem cells, RGCs, are located (Adolf et 
al., 2006; Lam et al., 2009; März et al., 2010a). These regions include the homologs of the 
SVZ and the SGZ of the DG, respectively, the two stem cell niches in the mammalian 
telencephalon. In addition to the proliferative ventricular zone of the zebrafish telencephalon, 
p53 and p73 mRNAs are also detectable in other neurogenic sites of the adult zebrafish 
brain (Table 2). Thus p53 and p73 expression appear to be closely linked to regions of 
neurogenesis suggesting similar roles in zebrafish as in mammalian stem cell niches. 
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 p53 mRNA p73 mRNA p53 protein 
Olfactory bulbs 
   
 
   
Telencephalon 
   
Vv    
Vd    
Ventricular zone of D    
 
   
Diencephalon 
   
PPa (only ventral part)    
Hav    
PP not determined not determined not determined 
DT not determined not determined not determined 
VM    
TPp    
Hd    
Hv    
Hc    
PTN    
Pit not determined not determined not determined 
 
   
Mesencephalon 
   
PGZ    
TL    
 
   
Hindbrain    
Val    
CCe    
LCa    
 
Table 2: The table lists the different proliferation zones in distinct domains of the adult zebrafish brain 
(Grandel et al., 2006). Proliferative domains showing expression of p53 and p73 mRNA and p53 
protein are indicated by a check. 
Abbreviations: CCe: corpus cerebelli; D: dorsal telencephalic area; DT: dorsal thalamus; Hav: ventral 
habenular nucleus; Hc: caudal zone of periventricular hypothalamus; Hd: dorsal zone of periventricular 
hypothalamus; Hv: ventral zone of periventricular hypothalamus; LCa: lobus caudalis cerebelli; PTN: 
posterior tuberal nucleus; Pit: pituitary; PP: periventricular pretectal nucleus; PPa: parvocellular 
preoptic nucleus, anterior part; TeO: tectum opticum; TL: torus longitudinalis; TPp: periventricular 
nucleus of posterior tuberculum; V: ventral telencephalic area; Val: lateral division of valvula cerebelli; 
Vd: dorsal nucleus of V; VM: ventromedial thalamic nucleus Vv: ventral nucleus of V. 
 
 
In mammals p53 protein is subject to regulated protein degradation. Since p53 possesses an 
anti-proliferative capacity and is able to induce apoptosis, the activity of p53 has to be strictly 
regulated. Therefore, in normal unstressed cells, where p53 is not required, its level is kept 
low because it is rapidly degraded. The p53 protein becomes ubiquitinated by its main 
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regulator Mdm2 (Honda et al., 1997) which targets p53 for degradation by the 26S 
proteasome (Haupt et al., 1997; Kubbutat et al., 1997). Thus expression of the p53 mRNA 
may not provide a comprehensive picture. By systematic analysis of sections through the 
entire brain by immunohistochemistry, p53 protein was detected in most regions, also in 
neurogenic sites, in the same pattern as its mRNA (Table 1 and Table 2). Exceptions are the 
sulcus ypsiloniformis (SY) in the telencephalon and the lateral division of the valvula cerebelli 
(Val) in the hindbrain where both p53 and p73 mRNA are expressed but no p53 protein 
expression was noted (Table 1). Although the levels of p53 protein are strictly regulated in 
mammals (Haupt et al., 1997; Kubbutat et al., 1997; Wu et al., 1993) the p53 protein seems 
to be present in a detectable amount in the same regions as the mRNA suggesting that 
levels of mRNA reflect protein expression in the brain of the zebrafish. In FISH experiments, I 
detected the p53 protein but not the p53 mRNA in the ventral telencephalic area. This is a 
technical limitation of the double labeling procedure. In ISH experiments with p53 mRNA 
alone and colorimetric visualization of the p53 probe, mRNA expression was clearly 
detectable in the ventral telencephalic area. The p53 protein showed nuclear localisation, 
contrary to the mammalian brain where p53 shows a weak cytoplasmic staining in neurons 
(Inamura et al., 2001; Plesnila et al., 2007). The nuclear localization was confirmed by 
double staining with the nuclear marker DRAQ5.  
 
When the activity of the p53 protein is not required it is rapidly degraded but when p53 is 
needed p53 and Mdm2 dissociate and p53 becomes also posttranslationally modified. Thus 
p53 is activated, rescued from degradation and is able to accumulate to high levels. 
Subsequently the transcription factor p53 transactivates target genes, which results in 
apoptosis, cell cycle arrest or senescence (reviewed in(Boehme and Blattner, 2009). Cell 
cycle arrest is controlled by p53 via activation of p21 (el-Deiry, 1998; Wang et al., 2007b). 
p53 additionally induces the transcription of its own negative regulator Mdm2 (Barak et al., 
1993; Juven et al., 1993) because both are connected in an autoregulatory feedback loop 
(Wu et al., 1993). In zebrafish p53 is negatively regulated by Mdm2 as well (Thisse et al., 
2000). It was shown that Mdm2 and p21 are also target genes of p73 (Zhu et al., 1998a). To 
assess whether the pattern of expression of p53 and p73 in the zebrafish brain coincides 
with the target genes known from the mammalian literature I analyzed the expression of the 
zebrafish homologues in the brain relative to that of p53 and p73. In the telencephalon Mdm2 
and p21 mRNA had a similar pattern of expression. However, mRNA of the two genes could 
only be detected in some of the regions which expressed p53 and p73 mRNA. For example, 
Mdm2 and p21 were not expressed in the medial, lateral, dorsal and posterior zone of the 
dorsal telencephalic area (see Table 3 for comparative overview). Hence, p53 and p73 do 
not always activate the two downstream genes at least in the uninjured brain. In addition, I 
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observed also Mdm2 and p21 expressing regions where p53 and p73 expression was not 
detected, namely the central zone of the dorsal telencephalic area (Table 3). Taken together 
these results suggest additional and/or alternative mechanisms of regulation of Mdm2 and 
p21 in different brain areas. As p73, p63 is almost ubiquitously expressed in the adult 
mammalian brain (Hernandez-Acosta et al., 2011; Jacobs et al., 2005). Moreover, p63 is 
able to induce the expression of the p53 target genes p21 and Mdm2 (De Laurenzi and 
Melino, 2000; Levrero et al., 2000; McKeon and Melino, 2007; Murray-Zmijewski et al., 2006; 
Pietsch et al., 2008). Thus, p63 may be an alternative regulator of Mdm2 and p21 expression 
in the adult zebrafish brain. 
 
 
         p53 p73 Mdm2 p21 
TelV     
Vc     
Vd     
Vv     
Vp     
Dc 
  
  
Dm   
  
Dl   
  
Dd   
  
Dp   
  
SY    
 
 
Table 3: The table compares the expression of p53, p73, Mdm2 and p21 mRNA in different domains 
of the adult zebrafish telencephalon. Expression is indicated by a check. 
Abbreviations: D: dorsal telencephalic area; Dc: central zone of D; Dd: dorsal zone of D; Dl: lateral 
zone of D; Dm: medial zone of D; Dp: posterior zone of D; SY: sulcus ypsiloniformis; TelV: 
telencephalic ventricle; V: ventral telencephalic area; Vc: central nucleus of V; Vd: dorsal nucleus of V; 
Vp: postcommissural nucleus of V; Vv: ventral nucleus of V. 
 
 
4.2 p53 and p73 expression in the injured brain 
 
Injury of the adult zebrafish telencephalon by a stab wound leads to dramatic changes which 
entail cellular stress at the site of lesion followed by apoptosis and necrosis of damaged cells 
(Kroehne et al., 2011). Blood cells enter the brain at the lesion site and OPCs increase at the 
site of lesion (März et al., 2011). Within 2 to 3 days the neural stem cells at the ventricular 
zone start to proliferate and new neurons are born that migrate to the site of lesion 
(Baumgart et al., 2012; Kroehne et al., 2011; März et al., 2011). p53 (Boehme and Blattner, 
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2009; Levrero et al., 2000; Murray-Zmijewski et al., 2006; Pietsch et al., 2008) and p73 
(Chen et al., 2001; Melino et al., 2002; Wang et al., 2007a) respond to several sorts of 
cellular stress. In p53-deficient mice proliferation of neural stem cells is highly increased (Gil-
Perotin et al., 2006) suggesting that p53 is a negative regulator of neurogenesis. However, 
due to the anti-proliferative activity of p53 it may maintain the stem cell pool and thus 
neurogenesis in the adult mammalian brain (Gil-Perotin et al., 2006; Medrano et al., 2009; 
Meletis et al., 2006). In the medaka brain, p53 seems to positively regulate neurogenesis 
because a p53 null mutation does not increase but inhibit neurogenesis in the telencephalon 
of medaka (Isoe et al., 2012). p73 positively regulates self-renewal and promotes 
proliferation in the adult mammalian brain (Agostini et al., 2010; Fujitani et al., 2010; Talos et 
al., 2010). 
Given these well-documented functions of p53 and p73 in cellular stress responses and 
neurogenesis in mammals, I investigated if the expression of p53 and p73 is changed at 
different time points after introducing a stab injury into the adult zebrafish telencephalon by 
ISH and immunohistochemistry. I observed an up-regulation of p53 mRNA expression at 1, 
3, 5, 7 and 9 dpl at the ventricular zone in the injured telencephalic hemisphere in contrast to 
the uninjured control hemisphere. In addition, p53 mRNA was up-regulated at the site of the 
lesion, particularly at 5 dpl. The up-regulation of p53 mRNA was less pronounced at 1 dpl. At 
9 dpl the expression of p53 mRNA was still increased. A very similar pattern and kinetics of 
expression was noted for p73 mRNA. The p53 protein showed also an up-regulation at the 
ventricular zone at 1, 3, 5, 7 and 9 dpl. However, the expression of p53 protein was not 
increased at the site of the lesion, contrary to the mRNA. Thus, p53 protein and p53 mRNA 
are regulated differentially at the site of the lesion. Interestingly, the target genes Mdm2 and 
p21 were also up-regulated at the site of lesion but not at the ventricular zone. It is tempting 
to speculate that p53 protein levels at the site of lesion may be regulated by Mdm2 via 
degradation resulting at levels of p53 protein beyond detection. As there is no up-regulation 
of p53 target genes at the ventricular zone after stab injury, p53 may exert its functions at the 
ventricular zone via other mechanisms. 
 
p53 is able to induce apoptosis and therefore I examined if there is apoptosis following stab 
injury. TUNEL staining revealed that there is an induction of apoptosis in the lesioned 
hemisphere near the site of the lesion at 4 hpl as well as at 1 dpl. In the uninjured 
hemispheres, no apoptotic cells were detected. As the p53 protein is not up-regulated at the 
site of lesion it is unlikely that p53 induced apoptosis in cells residing close to the lesion 
following stab injury. In the mammalian brain, necrotic cell death is predominantly observed 
after injury (Liou et al., 2003; Vajda, 2002) but some apoptosis does also occur in regions 
surrounding the necrotic injury core (Liou et al., 2003). Necrosis leads to much stronger 
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inflammatory responses than apoptosis and causes a progressive loss of neural cells and 
scar formation (Zhang et al., 1997). In the mammalian brain, the pro-apoptotic p53 induces 
neuronal apoptosis following brain damage (Miller et al., 2000; Morrison and Kinoshita, 
2000). However, it was also reported that p53 is activated after neuronal injury but it may not 
be responsible for the death of neurons and that brain injury is worse after ischemia without 
p53 (Maeda et al., 2001; Tomasevic et al.). In zebrafish, cell death is an early response to 
stab injury of the adult zebrafish brain and involves both apoptosis and necrosis (Kroehne et 
al., 2011). In lesions of the cerebellum of adult fish, apoptosis seems to be the predominant 
mechanism to eliminate damaged cells (Zupanc et al., 1998). The precise role of p53 at the 
lesion site remains to be determined - especially as the p53 mutant tp53M214K does not show 
a phenotype. Possible explanations of this lack of a phenotype will be discussed below.  
 
 
4.3 Expression of the p53 protein in the neural stem cell zone 
 
In response to injury, p53 expression is increased in the neurogenic region of the 
telencephalon residing in the walls of the ventricles. There are distinct progenitor cell types 
present at the ventricular zone of the adult zebrafish telencephalon. They can be classified 
into at least four distinct cell types: Type I, Type II, Type IIIa and Type IIIb cells (März et al., 
2010a). These cell types can be distinguished by their expression of specific markers (see 
chapter 1.1.2.1.1). p53 is expressed in a subset of Tg(gfap:GFP)-positive cells in uninjured 
brains. GFAP is a marker for quiescent Type I as well as proliferating Type II radial glial cells 
(RGCs) and is also weakly expressed still in Type IIIa neuroblasts (März et al., 2010a; 
Schmidt et al., 2013). Since p53 was expressed in cells strongly positive for GFAP and 
negative for the proliferation marker PCNA, I concluded that p53 is expressed in quiescent 
RGCs. In the adult mammalian brain, p53 is expressed in neural stem cells as well as 
progenitor cells. It suppresses the self-renewal of adult neural stem cells (Meletis et al., 
2006).  By modulating self-renewal, differentiation and proliferation, p53 plays a critical role in 
regulating the number of cells in the mouse SVZ (Gil-Perotin et al., 2006). Proliferation of 
neuronal stem cells is highly increased in p53-deficient mice and the number of new 
oligodendrocytes and neurons is enhanced after loss of p53 (Gil-Perotin et al., 2006; Li et al., 
2008). It was suggested that it could be crucial to suppress self-renewal of stem cells by p53 
for long-term maintenance of the stem cell population (Meletis et al., 2006). The expression 
of p53 protein in quiescent Type I cells in the adult zebrafish telencephalon is consistent with 
a possible anti-proliferative role of p53. However, I did not observe a change in proliferation 
rate in p53 mutants (see below for an in-depth discussion). In contrast p53 is not expressed 
in proliferating Type II cells. Most of the RGCs in the adult zebrafish telencephalon are Type I 
Discussion 
150 
 
 
cells and therefore quiescent. However, I noted also Tg(gfap:GFP)-positive cells that are 
negative for p53 and PCNA. Thus, p53 is not expressed in all Type I cells and seems to mark 
a subpopulation of Type I cells. These p53-positive Type I cells are scattered all over the 
ventricular zone of the adult zebrafish telencephalon. 
Additionally, p53 is expressed in PCNA-positive and Tg(gfap:GFP)-negative cells. These 
cells are Type IIIb cells that express also PSA-NCAM that marks committed neural 
progenitors (März et al., 2010a). Staining with the neuroblast marker PSA-NCAM and the 
progenitor marker Nestin revealed that the p53 protein is expressed in Type IIIa (Tg(-
3.9nestin:GFP)- and PSA-NCAM-positive) as well as in Type IIIb (Tg(-3.9nestin:GFP)-
negative and PSA-NCAM-positive) cells in the RMS. Type III cells are predominantly located 
in the RMS (März et al., 2010a). Since p53 is not expressed in PCNA- and Tg(gfap:GFP)-
positive cells this could suggest that p53 is not expressed in Type IIIa cells. However, the 
staining for nestin:GFP, p53 and PSA-NCAM shows, that this assumption is wrong and that 
p53 is also expressed in Type IIIa cells. Probably the staining for Tg(gfap:GFP) was just too 
weak to be detected in Type IIIa cells which normally show a much weaker GFAP staining 
than Type I or Type II cells (März et al., 2010a). In agreement, differentiating neuroblasts of 
the RMS of the mammalian brain express also p53 (Meletis et al., 2006). In summary, at the 
ventricular zone of the adult zebrafish telencephalon, 2 distinct cell types express p53: 
quiescent Type I RGCs and proliferating neuroblasts. In contrast, proliferating Type II RGCs 
do not express the p53 protein.  
 
Stab injury leads to a dramatic increase of cell proliferation at the ventricular zone which 
peaks around 3 to 5 dpl and fades away until around 14 dpl (März et al., 2011). p53 
expression is up-regulated at 5 dpl at the ventricular zone. However, most of these p53-
expressing cells are PCNA-negative und are thus non-proliferating. Therefore, these cells 
represent Type 1 RGCs. A very similar profile of expression is presented by the helix-loop-
helix protein Id1 in response to injury (Rodriguez Viales et al., in revision). Id1 suppresses 
proliferation of RGCs and is also up-regulated in wounded brains thus forming a feedback 
loop bringing proliferating RGCs back to quiescence after expansion in response to injury 
(Rodriguez Viales et al., in revision). It is tempting to speculate that p53 has a similar role in 
Type I cells, which show p53 expression in the uninjured brain and up-regulate the 
expression of p53 following injury to prevent exceeding proliferation of stem cells and thus 
depletion of the stem cell pool. p53 may maintain the stem cell population in the uninjured 
adult mammalian brain (Meletis et al., 2006). Therefore p53 may also be crucial to maintain 
the stem cell pool in the adult zebrafish telencephalon after injury. However, it was shown 
that in the embryonic murine brain p53 represses the transcription of Id1 in NSCs. p53 
deficiency leads to an enhanced expression of Id1, which results in increased proliferation 
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and neuronal differentiation of NSCs but less gliogenesis. There is a high level of p53 
expression during neuronal differentiation and p53 most likely prevents proliferation and 
neuronal differentiation of NSCs but it positively regulates gliogenesis (Liu et al., 2013). In 
contrast to other observations, where Id1 reacts as a negative regulator of neuronal 
differentiation of NSCs (Miyazono and Miyazawa, 2002), enhanced expression of Id1 results 
in increased neuronal differentiation of NSCs deficient for p53 (Liu et al., 2013). 
In the injured zebrafish brain, the p53 protein was also present in a few PCNA-positive cells, 
which are most likely Type III cells. The p53 protein was expressed in Type III cells in the 
uninjured brain as well. After stab injury of the adult zebrafish telencephalon both RGCs and 
neuroblasts show an increase of proliferation at the ventricular zone (März et al., 2011). After 
brain injury radial glial progenitor cells residing at the ventricular zone proliferate and give 
rise to neuroblasts. These neuroblasts migrate to the site of the lesion and differentiate into 
neurons which express mature neuronal markers and survive for more than 3 months 
(Kroehne et al., 2011). Contrary to constitutive neurogenesis, where newborn neurons settle 
mainly at the subventricular zone, in regenerative neurogenesis newborn neurons migrate 
longer distances into the injured parenchyma (Baumgart et al., 2012; Kroehne et al., 2011). 
 
Glial cells accumulate at the site of lesion and they are also known in mammals to be key to 
scaring of injured neural tissue. The zebrafish brain does not contain astrocytes as known 
from the mammalian brain (Adolf et al., 2006; Grandel et al., 2006; März et al., 2010a; März 
et al., 2011). Abundant OPCs in the zebrafish brain may have taken over their function. I 
noted scattered p53 cells in the parenchyma of the telencephalon in a pattern characteristic 
of OPCs. However, mapping with respect to the OPC and mature oligodendrocyte marker 
olig2 did not reveal expression of p53 in OPCs or myelin basic protein (Mbp)-positive mature 
oligodendrocytes (Lyons et al., 2005; März et al., 2010b; Roth et al., 1986). Rather, I found 
p53 expression in scattered neurons located next to the OPCs. These p53-positive neurons 
located next to olig2-positive cells were not labeled by the proliferation marker BrdU at all 3 
time points investigated. This indicates that the p53-positive neurons associated with cells 
from the oligodendrocyte lineage in the parenchyma are not newborn or immature neurons 
that become newly myelinated. In the mouse telencephalon similar observations were made 
for OPCs (Trotter et al., 2010). These slowly cycling OPCs in the adult mammalian brain 
generate mature oligodendrocytes that take part in myelin repair (Gensert and Goldman, 
1997; Nait-Oumesmar et al., 1999; Polito and Reynolds, 2005). In the adult mammalian brain 
p53 is constitutively expressed at low levels in neurons as well and it becomes up-regulated 
after injury (Inamura et al., 2001; Plesnila et al., 2007). p53 retains the post-mitotic character 
of mammalian neurons, at least in cell culture experiments (Miller et al., 2003). Thus, it is 
tempting to speculate that p53 may have the same function in the adult zebrafish brain. The 
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anti-proliferative p53 protein may impede the cell cycle re-entry and proliferation of 
differentiated neurons. In the mammalian brain, it was demonstrated that p53 plays a role in 
the development of oligodendrocytes and the differentiation of OPCs (Billon et al., 2004). The 
observation that p53 is not expressed in the OPC lineage in the uninjured brain excludes 
such a function in the zebrafish brain.  
In the injured adult zebrafish telencephalon the expression of p53 in HuC/D-positive neurons 
is not changed. However, quite in contrast to the uninjured brain, I found expression of p53 
protein in Tg(olig2:EGFP)-positive cells that have accumulated at the site of lesion at 5 dpl. 
Importantly these OPCs at the site of lesion proliferate only moderately suggesting that most 
of the OPCs accumulated at the site of lesion have migrated into the damaged area. In 
mammals, Olig2 is highly up-regulated in cells at the lesion and these OPCs start to 
proliferate near the lesion. These events result in impaired neuronal regeneration (Buffo et 
al., 2005; Dimou et al., 2008; Hampton et al., 2004; Magnus et al., 2007; Robel et al., 2011; 
Sofroniew, 2009). It is thus possible that p53 has a role in zebrafish to prevent OPCs to 
proliferate and may thus contribute to the remarkable ability of the zebrafish brain to 
regenerate without scar formation. In mice p53 is important for the recovery of motor function 
after spinal cord injury. In p53 -/- mice the spinal cords show a larger scar at the lesion site 
and an increased number of activated microglia/macrophages (Floriddia et al., 2012). 
However, the mammalian literature reports also contradictory functions of p53: Deletion of 
p53 improved the recovery of neuromotor function following experimental brain trauma 
(Tomasevic et al., 2010) and the time to recover from a lesion is shorter in p53-negative mice 
than in wildtype mice (Uberti et al., 2001). This may reflect the complexity of the p53 
regulated processes and also tissue specific functions including neurogenesis (Uberti et al., 
2001), control of OPCs, macrophages and microglia at the site of lesion (Floriddia et al., 
2012), axonal regeneration and neurite outgrowth (Di Giovanni et al., 2006; Tedeschi et al., 
2009). As p53, p73 plays a role in the differentiation of oligodendrocyte progenitor cells 
(OPCs) in the mammalian brain (Billon et al., 2004). 
 
 
4.4 The tp53M214K mutant zebrafish 
 
The tp53M214K mutation is located in the DNA-binding domain. The mutant p53 transcription 
factor is not able to bind to the p53 recognition sequences and therefore activation of target 
genes is prevented (Berghmans et al., 2005). The tp53M214K mutant zebrafish are viable. The 
adult homozygous fish are, however, tumor-prone and start to develop tumors at the age of 
8.5 months (Berghmans et al., 2005). 
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Systematic analysis of neurogenesis, cell proliferation and apoptosis in the intact and injured 
zebrafish telencephalon did not reveal any deviation from the wildtype situation. Specifically, 
in tp53M214K mutant zebrafish, apoptosis is induced at 4 hpl and 1 dpl, as in the wildtype 
brain. In contrast, the induction of apoptosis after γ-irradiation is suppressed in homozygous 
tp53M214K mutant embryos (Berghmans et al., 2005). It was shown by(Berghmans et al.)that 
Mdm2 and p21 were not up-regulated in homozygous tp53M214K mutant zebrafish embryos 
after γ-irradiation compared to wildtype embryos. However, I observed an up-regulation of 
both Mdm2 and p21 mRNA at 4 hpl and 1dpl at the site of the lesion, as in wildtype zebrafish 
although, the expression of Mdm2 and p21 was weaker than in the wildtype brains. 
Apoptosis can also be induced by p53 independent of transcription via the mitochondria 
(Galluzzi et al., 2008) or by p73 (Levrero et al., 2000; Murray-Zmijewski et al., 2006). 
However, it was also demonstrated that tumor-derived mutants of p53 failed to induce cell 
death transcription-independently (Pietsch et al., 2008). In mammals p53 exhibits anti-
proliferative capacities since p53 becomes activated after cellular stress and induces the 
expression of p21, which leads to cell cycle arrest (el-Deiry et al., 1993; Harper et al., 1993). 
One possibility to explain the lack of a phenotype in the adult zebrafish brain is that the 
mutant p53 protein retained some transcriptional regulatory activity. However with this 
scenario it is difficult to explain why the target genes Mdm2 and p21 are not induced in the 
mutant embryos after γ-irradiation. Therefore the most likely explanation is that p73 or the 
related p63 can compensate for the loss of p53. First, p73 is expressed in almost identical 
patterns in the intact and injured brain as p53. Second, p73 is able to induce apoptosis and 
the expression of Mdm2 and p21 in mammalian systems (Zeng et al., 1999; Zhu et al., 
1998a). Furthermore, p63 is able to induce apoptosis (Levrero et al., 2000; Murray-Zmijewski 
et al., 2006) and to activate Mdm2 and p21 as well (Levrero et al., 2000; Murray-Zmijewski et 
al., 2006). Thus, the lack of clear phenotypes in the adult brain in tp53M214K mutants is most 
likely a reflection of redundancy between p53 and p73 and potentially also p63. 
 
In the intact and injured zebrafish telencephalon, the tp53M214K mutant protein shows the 
same expression pattern as wildtype p53 protein and was also up-regulated at the ventricular 
zone of the injured hemisphere at 5 dpl as the wildtype p53 protein. Thus it appears that p53 
expression does not require p53 DNA binding activity. Published data from analysis of 
tp53M214K mutant embryos are contradictory with respect to increase of the mutant gene in 
response to γ-irradiation. (Berghmans et al.)did not observe an up-regulation of mutant p53 
mRNA in homozygous tp53M214K mutant embryos in response to γ-irradiation. However,(Guo 
et al.)showed that mutant p53 protein accumulated in tp53M214K mutant embryos after 
ionizing irradiation.  
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In the mammalian brain pro-apoptotic TAp73 isoforms induce neuronal cell death whereas 
anti-apoptotic ∆Np73 isoforms support the survival of neurons (Pozniak et al., 2002; Pozniak 
et al., 2000). It was shown that adult neurons are relatively invulnerable after injury and it 
was hypothesized that this is achieved by increasing the ratio of ∆Np73 to p53 (Jacobs et al., 
2004; Walsh et al., 2004). Thus, if a neuron lives or dies depends on the relative levels of 
pro-survival (∆Np63, ∆Np73) and pro-apoptotic (p53, TAp63, TAp73) proteins (Jacobs et al., 
2004). Thus the balance of the proteins may play a role and as ∆Np73 isoforms support 
regeneration with p53 playing a less prominent role this fact may in addition contribute to the 
lack of a phenotype in regenerating p53 mutant brains. 
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4.5 Conclusion and future perspectives 
 
I demonstrated that p53 and p73 are co-expressed in many domains of the adult zebrafish 
brain. In addition, the expression patterns of the p53/p73 target genes p21 and Mdm2 
overlap in several but not all domains of the telencephalon with the expression patterns of 
p53 and p73. After stab injury I observed an up-regulation of p53, p73, Mdm2 and p21 as 
well as induction of apoptosis. I also showed that p53 is expressed in Type I and III cells but 
not in proliferating Type II cells in the stem cell niches of the adult zebrafish telencephalon. 
p53 is expressed in mature neurons and some of these p53-positive differentiated neurons 
are located next to OPCs. Furthermore, OPCs start to express p53 close to the wound 
suggesting a specific function in these cells after injury. I analysed in depth constitutive and 
reactive neurogenesis in tp53M214K mutant zebrafish. However, there was no difference 
concerning the reaction to stab injury between wildtype and mutant fish. These results 
possibly indicate that p53 and p73 act redundantly and that p73 takes over the functions of 
p53 in case of p53 deficiency. Although my expression analysis suggests that p53 plays 
crucial roles in various processes during adult neurogenesis, the ultimate experimental 
evidence was masked by the lack of a phenotype of p53 mutants. The next steps should 
therefore be the generation of a knock-out of p73 and the analysis of double mutants. With 
help of a transgenic line for p73 or a p73 specific antibody, the expression of p73 in the 
different cell types in the adult zebrafish telencephalon should be examined and compared to 
the expression of p53 to further proof interaction and redundancy of these proteins. 
Furthermore, it would be interesting to investigate the putative interaction between p53 and 
Id1 and if p53 indeed confers quiescence to Type I cells by knock-down and overexpression 
experiments. 
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